University of Wollongong

Research Online
University of Wollongong Thesis Collection
2017+

University of Wollongong Thesis Collections

2020

Development of fibre-optic dosimetry system as a quality assurance tool
for High Dose Rate Brachytherapy
Mohammed Al Towairqi
University of Wollongong
Follow this and additional works at: https://ro.uow.edu.au/theses1
University of Wollongong
Copyright Warning
You may print or download ONE copy of this document for the purpose of your own research or study. The University
does not authorise you to copy, communicate or otherwise make available electronically to any other person any
copyright material contained on this site.
You are reminded of the following: This work is copyright. Apart from any use permitted under the Copyright Act
1968, no part of this work may be reproduced by any process, nor may any other exclusive right be exercised,
without the permission of the author. Copyright owners are entitled to take legal action against persons who infringe
their copyright. A reproduction of material that is protected by copyright may be a copyright infringement. A court
may impose penalties and award damages in relation to offences and infringements relating to copyright material.
Higher penalties may apply, and higher damages may be awarded, for offences and infringements involving the
conversion of material into digital or electronic form.
Unless otherwise indicated, the views expressed in this thesis are those of the author and do not necessarily
represent the views of the University of Wollongong.

Recommended Citation
Al Towairqi, Mohammed, Development of fibre-optic dosimetry system as a quality assurance tool for
High Dose Rate Brachytherapy, Doctor of Philosophy thesis, School of Physics, University of Wollongong,
2020. https://ro.uow.edu.au/theses1/966

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

Development of fibre-optic dosimetry system as a quality
assurance tool for High Dose Rate Brachytherapy

Mohammed Al Towairqi
BSc. (Physics), MSc. (Medical Physics)

Supervisors:
Distinguished Prof. Anatoly Rosenfeld
Dr. Enbang Li
Dr. Dean Cutajar

This thesis is presented as part of the fulfillment of the requirement for the conferral of the degree:
Doctor of Philosophy

The University of Wollongong
Faculty of Engineering and Information Sciences
School of Physics
Centre for Medical Radiation Physics
(CAMPEP-Accredited)

April 2020

Certification
I, Mohammed Al Towairqi, declare that this thesis submitted in fulfilment of the requirements
for the conferral of the degree Doctor of Philosophy, from the University of Wollongong –
Centre for medical Radiation Physic, is wholly my own work unless otherwise referenced or
acknowledged. This document has not been submitted for qualifications at any other
academic institution.

Mohammed Hamed Al Towairqi
16 April 2020

Page i

Table of Contents
Certification ...................................................................................................................... i
Table of Contents ............................................................................................................. ii
List of Tables .................................................................................................................. xi
Table of Figures ............................................................................................................. xii
Abstract ........................................................................................................................ xvii
Acknowledgments ........................................................................................................ xix
List of Publications...................................................................................................... xxii
List of Conference Presentations .............................................................................. xxiii
Media Coverage .......................................................................................................... xxiv
Introduction ............................................................................................. 1-1
.1.1 Overview: ....................................................................................................................................... 1-1
1.2. Description of the research study: .................................................................................................. 1-2
1.2.1

Research problem: ............................................................................................................... 1-2

1.2.2

Significance and motivation: ............................................................................................... 1-3

1.2.3

Research hypothesis: ........................................................................................................... 1-4

1.2.4

Aim and objectives: ............................................................................................................. 1-4

1.3. Thesis Outlines: .............................................................................................................................. 1-5

Literature Review .................................................................................... 2-7
2.1. Cancer Statistics: ............................................................................................................................ 2-7
2.2. Radiation therapy treatment options:.............................................................................................. 2-7
2.2.1

External radiation therapy: .................................................................................................. 2-8

2.2.2

Internal radiation therapy (brachytherapy): ......................................................................... 2-8

2.3. Radiation protection principles: ..................................................................................................... 2-8
2.4. The need for dosimetry and quality assurance (QA) in radiation therapy: ..................................... 2-9
2.5. The TG-43 Brachytherapy Dosimetry Formalism (2-D): ............................................................. 2-10
2.6. Quality assurance (QA) tools used for HDR Brachytherapy:....................................................... 2-13
2.6.1

Ionization Chambers: ........................................................................................................ 2-13

2.6.2

Thermoluminescent dosimeters (TLDs): ........................................................................... 2-13

2.6.3

Semiconductor dosimeters: ............................................................................................... 2-14

2.6.3.1. Silicon diodes: ............................................................................................................... 2-14
2.6.3.2. Metal Oxide Semiconductors – Field Effect Transistors (MOSFETs): ......................... 2-15
2.6.4

Films:................................................................................................................................. 2-16

2.6.5

Scintillation detectors: ....................................................................................................... 2-17

2.6.5.1. Scintillation mechanism: ............................................................................................... 2-17
Page ii

2.6.5.2. Progression of scintillation detectors over time: ........................................................... 2-18
2.6.5.3. Inorganic scintillators: ................................................................................................... 2-18
2.6.5.4. Organic scintillators: ..................................................................................................... 2-19
2.6.5.5. Applications of fibre optics: .......................................................................................... 2-20
2.6.5.6. Structure of optical fibre: .............................................................................................. 2-20
2.6.5.7. Limitations of scintillation fibre optic dosimetry: ......................................................... 2-21
2.6.5.7.1.

Cerenkov radiation: ............................................................................................ 2-21

2.6.5.7.2.

Temperature dependence: ................................................................................... 2-22

2.6.5.7.3.

Energy dependence:............................................................................................ 2-22

2.6.5.7.4.

Quenching effect: ............................................................................................... 2-23

2.6.5.7.5.

Radiation damage of scintillator: ........................................................................ 2-23

2.6.5.8. Applications of scintillation detectors in advanced radiotherapy treatment modalities:2-24
2.6.5.8.1.

Photon external beam radiation therapy: ............................................................ 2-24

2.6.5.8.2.

Electron beam radiation therapy: ........................................................................ 2-25

2.6.5.8.3.

Proton beam radiation therapy:........................................................................... 2-26

2.6.5.8.4.

Microbeam radiation therapy (MRT): ................................................................ 2-26

2.6.5.8.5.

Small-field radiation therapy: ............................................................................. 2-26

2.6.5.8.6.

Internal radiation therapy (Brachytherapy): ....................................................... 2-27

2.7. Photodetector options for scintillation fibre optic systems: ......................................................... 2-27
2.8. Existing QA tools for source localization during HDR Brachytherapy: ...................................... 2-28
2.8.1

Imaging-based modalities:................................................................................................. 2-29

2.8.1.1. Transrectal ultrasound ................................................................................................... 2-29
2.8.1.2. Magnetic resonance imaging ......................................................................................... 2-29
2.8.1.3. Electro-magnetic tracking (EMT): ................................................................................ 2-30
2.8.1.4. Digital X-ray imaging: .................................................................................................. 2-30
2.8.1.5. 3D Brachy-View: .......................................................................................................... 2-31
2.8.2

Dosimetry modalities: ....................................................................................................... 2-31

2.9. Research gaps identified in the research literature: ...................................................................... 2-32

Materials & Methodology: .................................................................... 3-34
3.1. Overview: ..................................................................................................................................... 3-34
3.2. Scintillation Detector: .................................................................................................................. 3-34
3.2.1

Scintillating optical fibre: .................................................................................................. 3-34

3.2.2

Transmission (waveguide) fibres: ..................................................................................... 3-35

3.3. Fibre optic termination: ................................................................................................................ 3-35
3.3.1

Optical fibre termination tool kit: ...................................................................................... 3-35

3.3.2

Fabrication and preparation of the fibre optic probes: ....................................................... 3-37

3.3.2.1. Termination process: ..................................................................................................... 3-37
3.3.2.2. Hand-polishing process: ................................................................................................ 3-37
3.3.2.3. Optical coupling: ........................................................................................................... 3-38
3.4. Photodetector: .............................................................................................................................. 3-39
3.4.1

PIN-photodiodes: .............................................................................................................. 3-39
Page iii

3.5. SMA-to-photodiode receptacle: ................................................................................................... 3-39
3.6. In-lab design of a photodiode-housing assembly: ........................................................................ 3-39
3.7. Electronic readout systems: .......................................................................................................... 3-40
3.7.1

CMRP operational trans-impedance photodiode amplifier: .............................................. 3-41

3.7.2

Upgraded CMRP (MkII) operational trans-impedance photodiode amplifier: ................... 3-41

3.7.3

Gigahertz-Optik operational trans-impedance photodiode amplifier: ............................... 3-42

3.7.4

Design of adjustable green Light Emitting Diode (LED) Opto testing system: ................ 3-42

3.7.4.1. Design: .......................................................................................................................... 3-43
3.7.5

In house based- current-voltage (I-V) tracer system: ........................................................ 3-44

3.7.5.1. IV Characteristics analysis: ........................................................................................... 3-44
3.8. Power supply: ............................................................................................................................... 3-45
3.8.1

Regulated AC coupled-power supply:............................................................................... 3-45

3.8.2

DC coupled-power supply: ................................................................................................ 3-46

3.9. Data logging systems: .................................................................................................................. 3-47
3.9.1

Single channel ACT Data Logger: .................................................................................... 3-47

3.9.2

HOBO 4-Channel Analog Data Logger (UX120-006M): ................................................. 3-47

3.10. Phantoms: ................................................................................................................................... 3-48
3.10.1

Solid-water phantom: .................................................................................................... 3-48

3.10.2

. Water-gel phantom:..................................................................................................... 3-48

3.10.3

. Perspex solid “water” phantom: .................................................................................. 3-49

3.11. Clinical HDR Brachytherapy apparatus: .................................................................................... 3-50
3.11.1

. Treatment Planning System: ....................................................................................... 3-50

3.11.2

. Nucletron HDR after loading machine: ...................................................................... 3-51

3.12. Overall clinical based- experimental methodology: ................................................................... 3-52

Design and evaluation of a CMRP trans-impedance photodiode
amplifier as an optical fibre-based dosimetry system for brachytherapy quality
assurance ..................................................................................................................... 4-53
4.1.

Introduction: .......................................................................................................................... 4-53

4.2.

Materials and Methods: ......................................................................................................... 4-54

4.2.1.

Scintillating detectors: ....................................................................................................... 4-54

4.2.2.

Photodetectors (PIN photodiodes): .................................................................................... 4-55

4.2.2.1.
4.2.3.

IV characteristics of PIN photodiode with different setups: ..................................... 4-55

Data acquisition system configurations: ............................................................................ 4-56

4.2.3.1.

Opto green light emitting diode (LED) testing system: ............................................ 4-56

4.2.3.2.

The in-house designed CMRP trans-impedance photodiode amplifier: ................... 4-56

4.2.4.

Data logging system: ......................................................................................................... 4-60

4.2.5.

IV characteristics and reverse current of PIN-photodiodes: .............................................. 4-61

4.2.6.

Slew rate and timing: ......................................................................................................... 4-61

4.2.7.

In-lab stability test: ............................................................................................................ 4-61
Page iv

4.2.8.

In-lab LED linearity test: ................................................................................................... 4-62

4.2.9.

Dose rate linearity & Dose linearity tests: ......................................................................... 4-62

4.2.10.
4.2.

Feasibility of the CMRP system for HDR brachytherapy quality assurance: ............... 4-64

Results & discussion: ............................................................................................................. 4-65

4.3.1.

Theoretical estimation of electrical current: ...................................................................... 4-65

4.3.2.

Estimation of electrical current based on an experimental study: ..................................... 4-68

4.3.3.

IV characteristics of PIN photodiode with different setups:.............................................. 4-69

4.3.3.1.

Reverse current of bare photodiodes: ....................................................................... 4-69

4.3.3.2.

Reverse current of photodiodes in a completely dark environment: ......................... 4-69

4.3.3.3.

Reverse current of photodiodes in different light conditions: ................................... 4-70

4.3.4.

Slew rate and timing: ......................................................................................................... 4-71

4.3.5.

In-lab stability test: ............................................................................................................ 4-72

4.3.5.1.

Photodiode amplifier only connected: ...................................................................... 4-72

4.3.5.2.

Photodiode amplifier connected to a scintillation fibre detector: ............................. 4-73

4.3.6.

In-lab LED linearity test: ................................................................................................... 4-74

4.3.7.

Dose rate & dose linearity tests: ........................................................................................ 4-75

4.3.8.

Feasibility of the CMRP DAQ system for HDR brachytherapy quality assurance: .......... 4-77

4.3.9.

The dynamic technical properties of the proposed system: ............................................... 4-78

4.3.9.1.

The dynamic range of the amplifier:......................................................................... 4-78

4.3.9.2.

Speed of the amplifier: ............................................................................................. 4-79

4.3.9.3.

Signal to noise (S/N) ratio: ....................................................................................... 4-80

4.4.

Conclusion: ............................................................................................................................ 4-80

Design and investigation of an upgraded CMRP MKII trans-impedance
photodiode amplifier for quality assurance of high dose rate brachytherapy ..... 5-82
5.1. Introduction: ................................................................................................................................. 5-82
5.2. Materials & methodology:............................................................................................................ 5-84
5.2.1

Design of printed circuit board layout: .............................................................................. 5-84

5.2.2

Data acquisition system configurations: ............................................................................ 5-85

5.2.2.1. The upgraded CMRP MKII trans-impedance photodiode amplifier: ............................. 5-85
5.2.2.1.1.

Time constant (RC) filters: ................................................................................. 5-86

5.2.2.2. Data logging system: ..................................................................................................... 5-86
5.2.3

Slew rate and timing: ......................................................................................................... 5-87

5.2.4

In-lab stability test: ............................................................................................................ 5-87

5.2.5

In-lab LED linearity test: ................................................................................................... 5-87

5.2.6

Dose linearity test: ............................................................................................................. 5-87

5.3. Results & Discussion: .................................................................................................................. 5-88
5.3.1

Slew rate and timing: ......................................................................................................... 5-88

5.3.2

In-lab stability test: ............................................................................................................ 5-89

5.3.3

In-lab LED linearity test: ................................................................................................... 5-92
Page v

5.3.4

Dose linearity test: ............................................................................................................. 5-93

5.4. Conclusion: .................................................................................................................................. 5-94

Adaptation and in-lab experimental evaluation of Gigahertz Optik™
trans-impedance photodiode amplifier as an optical fibre-based dosimetry system
for brachytherapy quality assurance ....................................................................... 6-95
6.1. Introduction: ................................................................................................................................. 6-95
6.2. Materials and Methods: ................................................................................................................ 6-96
6.2.1

Scintillating detectors: ....................................................................................................... 6-96

6.2.2

Data acquisition system configurations: ............................................................................ 6-96

6.2.2.1. The Gigahertz Optik™ trans-impedance photodiode amplifier: ................................... 6-96
6.2.2.1.1.

In-house adaptation of the commercial amplifier system: .................................. 6-97

6.2.2.2. Data logging system: ..................................................................................................... 6-99
6.2.3

Slew rate and timing: ......................................................................................................... 6-99

6.2.4

In-lab stability test: ............................................................................................................ 6-99

6.2.5

In-lab LED linearity test: ................................................................................................... 6-99

6.2.6

Dose rate linearity & Dose linearity tests: ......................................................................... 6-99

6.2.7

Feasibility of the system for HDR brachytherapy quality assurance: .............................. 6-100

6.3. Results & discussion: ................................................................................................................. 6-100
6.3.1

Slew rate and timing: ....................................................................................................... 6-100

6.3.2

In-lab stability test: .......................................................................................................... 6-102

6.3.2.1. The front-end photodiode response: ............................................................................ 6-102
6.3.2.2. Photodiode amplifier connected to a scintillating fibre: .............................................. 6-103
6.3.3

In-lab LED linearity test: ................................................................................................. 6-104

6.3.4

Dose rate & Dose linearity: ............................................................................................. 6-105

6.3.5

The feasibility of the adapted amplifier for HDR brachytherapy quality assurance: ...... 6-107

6.3.6

The dynamic technical properties of the Optik DAQ system: ......................................... 6-108

6.3.6.1. The dynamic range of the amplifier: ........................................................................... 6-108
6.3.6.2. Speed of the amplifier: ................................................................................................ 6-108
6.3.6.3. Signal to noise (S/N) ratio: .......................................................................................... 6-109
6.4. Conclusion: ................................................................................................................................ 6-109

Pre-clinical optimisation and characterisation of a polymer fibre optic
sensor for high dose rate brachytherapy quality assurance ................................ 7-111
7.1. Introduction: ............................................................................................................................... 7-111
7.2. Materials & Methods:................................................................................................................. 7-112
7.2.1

Scintillation detectors: ..................................................................................................... 7-112

7.2.2

Data acquisition system configurations: .......................................................................... 7-112

7.2.2.1. In house designed CMRP trans-impedance photodiode amplifier system: ................. 7-112
7.2.2.2. Gigahertz Optik™ trans-impedance photodiode amplifier system: ............................ 7-112
7.2.2.3. Data logging system: ................................................................................................... 7-113
Page vi

7.2.3

Monte Carlo (MC) simulation of the scintillation response: ........................................... 7-113

7.2.4

Experimental work in HDR brachytherapy room:........................................................... 7-113

7.2.4.1. Treatment plan system by the Ocentra (TPS): ............................................................ 7-113
7.2.4.2. General experimental setup: ........................................................................................ 7-114
7.2.4.3. Optimisation of experimental setup & detector’s optical properties: .......................... 7-114
7.2.4.4. Investigating the optimal length of plastic scintillating fibre: ..................................... 7-114
7.2.4.5. Investigating the positional sensitivities of the optimal fibre length: .......................... 7-115
7.2.4.6. Feasibility of HDR Brachytherapy source localisation based on triangulation method: ... 7115
7.3. Results & Discussion: ................................................................................................................ 7-115
7.3.1

Verification of the planned HDR treatment: ................................................................... 7-115

7.3.2 Monte Carlo (MC) simulation of the response of a scintillating material upon irradiation
with HDR 192Ir:.............................................................................................................................. 7-116
7.3.3

Pre-clinical optimisations of the produced signal:........................................................... 7-117

7.3.3.1. Sensitivity of both in house designed CMRP & adapted Gigahertz Optik amplifiers . 7-117
7.3.3.2. Optical properties of the multi-mode scintillating optical fibres used: ....................... 7-118
7.3.3.3. Optical properties of multi-mode non-scintillating fibre (BCF-98): ........................... 7-119
7.3.3.4. The effect of backscatter on the signal produced: ....................................................... 7-120
7.3.3.5. The effect of scintillating fibre shape (round – square): ............................................. 7-121
7.3.3.6. The effect of polishing and coating on the acquired signal: ........................................ 7-122
7.3.3.7. TO-5 photodiode (S1223-01) induced signal with lead shielding: .............................. 7-124
7.3.4

Background signal produced by clear polymer fibres: .................................................... 7-127

7.3.4.1. Bare fibre probe inserted in the centre of the phantom X at three “y” heights: ........... 7-127
7.3.4.2. Bare fibre probe placed at the beginning edge (X-axis) of the phantom at two “y” heights:
................................................................................................................................................. 7-129
7.3.4.3. Bare fibre probe inserted the whole way through the (X-axis) of the phantom at three
vertical (Y) distances: .............................................................................................................. 7-130
7.3.5

Optimisation of the optimal length of the scintillating fibre: .......................................... 7-130

7.3.5.1. Fully scintillating fibre: ............................................................................................... 7-130
7.3.5.2. Composite scintillating fibre plus clear waveguide:.................................................... 7-131
7.3.6

Determining the optimal distance (height y) from the detector to the HDR source: ....... 7-134

7.3.7

Investigating positional sensitivities of the proposed QA system: .................................. 7-135

7.3.8 Feasibility of HDR Brachytherapy source localisation utilizing polymer scintillation
detectors: ....................................................................................................................................... 7-137
7.4. Conclusions: ............................................................................................................................... 7-138

Characterisation of an inorganic scintillator for HDR brachytherapy
for real-time quality assurance of high dose rate brachytherapy utilizing photodiode
based- fibre optic data acquisition systems............................................................ 8-140
8.1. Introduction: ............................................................................................................................... 8-140
8.2. Materials & Methods:................................................................................................................. 8-141
8.2.1

Scintillation detectors: ..................................................................................................... 8-141

8.2.2

Readout data acquisition system configurations: ............................................................ 8-141
Page vii

8.2.2.1. In house designed CMRP trans-impedance photodiode amplifier system: ................. 8-141
8.2.2.2. Gigahertz Optik™ trans-impedance photodiode amplifier system: ............................ 8-141
8.2.2.3. Data logging system: ................................................................................................... 8-141
8.2.3

Experimental setup at brachytherapy room: .................................................................... 8-142

8.3. Results & discussion: ................................................................................................................. 8-143
8.3.1

The in-house designed CMRP fibre optic system: .......................................................... 8-143

8.3.1.1. Photodetector-induced signal: ..................................................................................... 8-143
8.3.1.2. Depth response and positional sensitivities: ................................................................ 8-144
8.3.1.3. Determination of dwell time and dwell position: ........................................................ 8-146
8.3.2

The adapted Gigahertz Optik fibre optic system: ............................................................ 8-150

8.3.2.1. Photodetector-induced signal: ..................................................................................... 8-150
8.3.2.2. Depth response and positional sensitivities: ................................................................ 8-150
8.3.2.3. Determination of dwell time and dwell position: ........................................................ 8-152
8.4. Conclusion: ................................................................................................................................ 8-156

On the use of a CMRP-designed fibre-optic system for HDR
Brachytherapy quality assurance ........................................................................... 9-157
9.1. Introduction: ............................................................................................................................... 9-157
9.2. Materials & Methods:................................................................................................................. 9-158
9.2.1

Scintillation detector: ...................................................................................................... 9-158

9.2.2

Data acquisition system (DAQ) configuration: ............................................................... 9-158

9.2.2.1. CMRP trans-impedance photodiode amplifier system: ............................................... 9-158
9.2.2.2. Data logging system: ................................................................................................... 9-158
9.2.3

In-clinic experimental setup at brachytherapy room: ...................................................... 9-158

9.2.4

Phantom design: .............................................................................................................. 9-159

9.2.5

Positional sensitivities for all dwell positions within the phantom: ................................ 9-160

9.2.5.1. Measurement of pure scintillation signal: ................................................................... 9-160
9.2.5.2. Measurement of stem-effect signals: ........................................................................... 9-160
9.2.6

Localisation of HRR 192Ir Brachytherapy source: ........................................................... 9-161

9.2.6.1. Source to detector distances (SDDs) for all sampled positions: .................................. 9-161
9.2.6.2. Calculating corresponding source to detector distances (SDD): ................................. 9-161
9.2.6.3. Calibration curves: ...................................................................................................... 9-162
9.2.6.4. Triangulation methodology of HRR 192Ir Brachytherapy source: ............................. 9-162
9.3. Results & Discussion: ................................................................................................................ 9-163
9.3.1

Positional sensitivities for all dwell positions within the phantom: ................................ 9-163

9.3.1.1. Measurement of pure scintillation signal: ................................................................... 9-163
9.3.1.2. Measurement of stem-effect signal: ............................................................................ 9-165
9.3.2

Corresponding source to detector distances (SDD) for all sampled positions: ................ 9-165

9.3.3

Calibration curves: .......................................................................................................... 9-167

9.3.4

Localisation of HRR 192Ir Brachytherapy source: ........................................................... 9-170

9.4. Conclusions: ............................................................................................................................... 9-172
Page viii

Fibre optic system for HDR Brachytherapy quality assurance: a
feasibility study of HDR source localisation ........................................................10-173
10.1. Introduction: ........................................................................................................................... 10-173
10.2. Materials & Methods:............................................................................................................. 10-173
10.2.1

Scintillation detector: ................................................................................................ 10-173

10.2.2

Data acquisition (DAQ) system configuration: ......................................................... 10-173

10.2.2.1. Gigahertz Optik™trans-impedance photodiode amplifier system: ......................... 10-173
10.2.2.2. Data logging system: ............................................................................................... 10-174
10.2.3

. In-clinic experimental setup at brachytherapy room: .............................................. 10-174

10.2.4

. Phantom design: ...................................................................................................... 10-174

10.2.5

. Positional sensitivities for all dwell positions within the phantom ......................... 10-175

10.2.5.1. Measurement of pure scintillation signals: .............................................................. 10-175
10.2.5.2. Measurement of stem-effect signal: ........................................................................ 10-176
10.2.6

. Localization of HRR 192Ir Brachytherapy source: ................................................... 10-176

10.2.6.1. Source to detector distances (SDD) for all sampled positions: ............................... 10-176
10.2.6.2. Calculating corresponding source to detector distances (SDD): ............................. 10-176
10.2.6.3. Calibration curves: .................................................................................................. 10-177
10.2.6.4. Triangulation methodology of HRR 192Ir Brachytherapy source: ........................... 10-177
10.3. Results & Discussion: ............................................................................................................ 10-178
10.3.1

Positional sensitivities for all dwell positions within the phantom: .......................... 10-178

10.3.1.1. Measurement of pure scintillation signal: ............................................................... 10-178
10.3.1.2. Measurement of stem-effect signal: ........................................................................ 10-180
10.3.2

. Corresponding source to detector distances (SDD): ............................................... 10-180

10.3.3

. Calibration curves: .................................................................................................. 10-182

10.3.4

. Localisation of HRR 192Ir Brachytherapy source: ................................................... 10-184

10.4. Conclusions: ........................................................................................................................... 10-186

Radiation damage study of fibre optic-based scintillation detectors
used for quality assurance of high dose rate radiotherapy ................................11-187
11.1. Introduction: ........................................................................................................................... 11-187
11.2. Materials & Methodology: ..................................................................................................... 11-189
11.2.1

Scintillation optical fibre detectors: .......................................................................... 11-189

11.2.2

. Real-time data acquisition system configurations: .................................................. 11-189

11.2.2.1. Gigahertz OptikTM trans-impedance photodiode amplifier system: ......................... 11-189
11.2.2.2. Data logging system: ............................................................................................... 11-190
11.2.3

. Phantom design for radiation damage studies at ANSTO: ...................................... 11-190

11.2.4

. Irradiation of detector samples with Cobalt-60 gamma irradiator (Co60): .............. 11-190

11.2.5

. Performing subsequent sensitivity tests with photon beam energy: ........................ 11-191

11.3. Results & discussion: ............................................................................................................. 11-192
11.3.1

. Total accumulative doses given: ............................................................................. 11-192
Page ix

11.3.2

. Sensitivity response for the inorganic scintillating crystal, CsI (Tl): ...................... 11-193

11.3.3

Sensitivity response for the organic BCF-60 polymer scintillator fibre:................... 11-194

11.3.4

Sensitivity response for the non-scintillating optical fibre (clear wave guide): ........ 11-195

11.4. Conclusion: ............................................................................................................................ 11-196

General Discussion ..........................................................................12-198
12.1. Performance of data acquisition readout systems: ................................................................. 12-198
12.1.1

. The CMRP photodiode amplifier: ........................................................................... 12-198

12.1.2

. The upgraded CMRP MK11 photodiode amplifier: ................................................. 12-199

12.1.3

. Gigahertz OptikTM photodiode amplifier: ............................................................... 12-199

12.2. Characterisation of plastic scintillator detector: ..................................................................... 12-200
12.3. Characterisation of inorganic scintillator & Determination of dwell time and position:........ 12-201
12.4. Localisation of HDR Brachytherapy source:.......................................................................... 12-201
12.4.1

. CMRP photodiode amplifier: .................................................................................. 12-204

12.4.2

. Gigahertz Optik photodiode amplifier: ................................................................... 12-204

12.5. Radiation damage studies for scintillators used in HDR Brachytherapy: ............................... 12-205

Conclusion & Future Directions: ...................................................13-207
Bibliography ................................................................................................................ 211
Appendices ................................................................................................................... 219
Supplementary Materials ........................................................................................... 220

Page x

List of Tables
Table 3.1: Properties of the scintillating detectors used which are produced by SGC, USA .................. 3-35
Table 3.2: Properties of transmission fibres used which are used as light waveguides ........................... 3-35
Table 3.3: Properties of PIN-photodiodes used with different wavelength sensitivities. ........................ 3-39

Table 4.3: Amplifier sensitivities for all gain switch settings
Table 4.4: Sensitivity range expressed in different units
Table 4.5: Time constant (RC) filters used on the amplifier output
Table 4.4: Equivalences of TrueBeam radiation Monitor Units and dose
Table 4.5: Equivalences of TrueBeam radiation rates and total dose

4-58
4-58
4-60
4-63
4-63

Table 6.3: Sensitivity range expressed in different units

6-98

Page xi

Table of Figures
Figure 2.1: Geometry of dose calculations formalism of point brachytherapy source using TG-43 ....... 2-11
Figure 2.3: Illustration of scintilation mechanism ................................................................................... 2-17
Figure 2.4: Light spectrum illustrating the scintillation light produced within the range of visible light 2-18
Figure 2.2: A typical internal structure for an optical fibre cable ........................................................... 2-20

Figure 3.1: Plastic optical fibre termination tool kit with other additional tools that are not included with
the standard tool kit ................................................................................................................................. 3-36
Figure 3.2: Practical demonstration on optical fibre preparation and coupling. ...................................... 3-38
Figure 3.3: PIN-photodiodes with a receptacle ....................................................................................... 3-39
Figure 3.4: Sketch illustrating a proposed photodiode-housing assembly to a female receptacle ........... 3-40
Figure 3.5: Illustration of the final prototype of the CMRP-deigned photodiode amplifier .................... 3-41
Figure 3.6: Illustration of the upgraded version of the CMRP-deigned photodiode amplifier ................ 3-41
Figure 3.7: Illustration for physical components of the Gigahertz Optik photodiode amplifier DAQ
system after modifications ...................................................................................................................... 3-42
Figure 3.8: Electronic circuit of the Opto green LED testing system and view inside circuit housing ... 3-43
Figure 3.9: In-house setup of IV tracer system illustrating the apparatus used to capture IV curves ...... 3-45
Figure 3.10: Illustration of the regulated power supply adapted for CMRP amplifier ............................ 3-46
Figure 3.11: Illustration of the regulated power supply adapted for Gigahertz Optik amplifier ............. 3-46
Figure 3.12: Rechargeable sealed lead acid (SLD) battery adapted for our DAQ system ...................... 3-46
Figure 3.13: The EL-USB-ACT single-channel data logger is shown (left-hand side), with the HOBO
UX120-006M Analog four-channel data logger also shown (right-hand side) ....................................... 3-47
Figure 3.14: Illustration of Gammex RMI457 Solid Water phantom...................................................... 3-48
Figure 3.15: Step by step- illustrative procedures for in-house preparation of water-gel phantom......... 3-49
Figure 3.16: Phantom design for of HDR brachytherapy source verification ......................................... 3-50
Figure 3.17: CT image used for TPS dwell position digitisation (Left), control panel for HDR
brachytherapy source delivery (right) ..................................................................................................... 3-51
Figure 3.18: Nucletron microSelectron® mHDR-v.2. afterloader produced by Nucletron..................... 3-51
Figure 3.19: Over-all experimental setup performed within Brachytherapy room which fulfills all
experiments’ requirements ...................................................................................................................... 3-52

Figure 4.1: Schematic diagram illustrating the proposed photodiode amplifier system (operated in
photoconductive mode) with components of the regulated power supply at the upper right and timeconstant selector at the lower right. ......................................................................................................... 4-57
Figure 4.2: Optical fibres inserted inside a solid water equivalent (PMM) phantom under reference
conditions ; Right hand side: Datalogger ................................................................................................ 4-63
Figure 4.3: World coordinate system of experimental setup ................................................................... 4-64
Figure 4.4: Photodiode amplifier circuit designed by Aoyama et al which was used for electron beam
therapy..................................................................................................................................................... 4-68
Figure 4.5: IV characteristics of bare TO5 PIN-photodiodes .................................................................. 4-69
Figure 4.6: Reverse current of TO-5 (S1223-01) photodiode connected to different components in a
completely dark environment .................................................................................................................. 4-70
Figure 4.7: Reverse current of TO-5 (S1223-01) photodiode connected to different components in
different light conditions ......................................................................................................................... 4-71
Figure 4.8: Slew rate and rise time for the output of the CMRP amplifier with different time constant
(RC) filters .............................................................................................................................................. 4-72
Figure 4.9: Response of CMRP photodiode amplifier in a dark room for a period of 3 h. Top Inset:
Magnified voltage scale view, Bottom Inset: Magnified Timescale view of 1st 500 s ........................... 4-73

Page xii

Figure 4.10: CMRP photodiode amplifier response while connected to a jacketed optical fibre for 3h in a
completely dark environment .................................................................................................................. 4-74
Figure 4.11: Response of CMRP photodiode amplifier upon exposure to green LED signal with LED
currents in the µA range .......................................................................................................................... 4-75
Figure 4.12: Linear response of CMRP photodiode amplifier upon exposure to different intensities of
green LED light ....................................................................................................................................... 4-75
Figure 4.13: Dose rate linearity of CMRP photodiode amplifier system ................................................ 4-76
Figure 4.14: Dose linearity of CMRP photodiode amplifier system ....................................................... 4-76
Figure 4.15: Response of the CMRP system when placing a fibre probe in the middle of a phantom (x =
45 mm), at three vertical displacements y of 1 cm, 2 cm, and 3 cm delivering the 192Ir radiation at
multiple dwell positions and varied SDDs .............................................................................................. 4-78

Figure 5.1: Practical steps for producing a Printed Circuit Board (PCB)-based photodiode amplifier ... 5-85
Figure 5.2: Schematic diagram illustrating the upgraded CMRP photodiode amplifier system (operated in
photoconductive & photovoltaic modes) with component of the DC-coupled power supply and RC filters
on the right .............................................................................................................................................. 5-86
Figure 5.3: Slew rate and timing of the upgraded CMRP amplifier when exposed to a green LED light
source applying three different RC filters ............................................................................................... 5-88
Figure 5.4: Slew rate and timing of the upgraded CMRP amplifier while exposed to an actual HDR
Brachytherapy source applying three different RC filters ....................................................................... 5-89
Figure 5.5: Stability test of the upgraded CMRP amplifier system without and with detector connected, in
photoconductive mode ............................................................................................................................ 5-90
Figure 5.6: Stability test of the upgraded CMRP amplifier system without and with detector connected, in
photovoltaic mode ................................................................................................................................... 5-90
Figure 5.7: Stability test of the upgraded CMRP amplifier system without detector connected, in both
photoconductive & photovoltaic modes .................................................................................................. 5-91
Figure 5.8: Stability test of the upgraded CMRP amplifier system with detector connected, in both
photoconductive & photovoltaic modes .................................................................................................. 5-91
Figure 5.9: Response of the upgraded CMRP photodiode amplifier with both photodiodes when exposed
to green LED signal with LED currents in the µA range ........................................................................ 5-92
Figure 5.10: Linear response of the upgraded CMRP photodiode amplifier with both photodiodes when
exposed to green LED signal with LED currents in the µA range .......................................................... 5-93
Figure 5.11: Dose linearity of the proposed CMRP system .................................................................... 5-93

Figure 6.1: Schematic block diagram of the amplifier system (operated in photovoltaic mode) (shaded,
left) with the adapted power supply and time constant (RC filter) selector switch (right) ...................... 6-96
Figure 6.2: World coordinate system of experimental setup ................................................................. 6-100
Figure 6.3: Slew rate and rise time for the output of the amplifier when applying time constant (RC)
filters of a)5.6 m Sec, b) 185 m Sec, and c) 821 m Sec ....................................................................... 6-101
Figure 6.4: Response of Gigahertz Optik™ amplifier for a period of 2 h (RC=5.6 ms) ....................... 6-102
Figure 6.5: Response of Gigahertz Optik™ amplifier for a period of 0.5 h (RC=821 ms) ................... 6-103
Figure 6.6: Response of Gigahertz Optik photodiode amplifier connected to a jacketed optical fibre for
almost 2 h .............................................................................................................................................. 6-104
Figure 6.7: Response of the Optik photodiode amplifier upon exposure to green LED signal with LED
currents in the µA range ........................................................................................................................ 6-105
Figure 6.8: Linear response of Optik photodiode amplifier upon exposure to LED ............................. 6-105
Figure 6.9: Dose Rate Linearity of Gigahertz Optik photodiode amplifier system ............................... 6-106
Figure 6.10: Dose Linearity of Gigahertz Optik photodiode amplifier system ..................................... 6-106
Figure 6.11: Response of the Gigahertz Optik amplifier as a function of time when delivering the 192Ir at
vertical displacement y of 1 cm along the z-axis for multiple dwell positions, and various SDDs ....... 6-107

Page xiii

Figure 7.1: CT image used for TPS dwell position digitisation (Left), Oncentra TCS interface for HDR
brachytherapy source delivery (right) ................................................................................................... 7-113
Figure 7.2: Illustration showing the general “phantom” stack experimental setup performed in the HDR
Brachytherapy room. The close-up view of the phantom stack shows the fibre probe and Brachytherapy
source location within the phantom....................................................................................................... 7-114
Figure 7.3: EPT3 film used as verification tool of an HDR Brachytherapy treatment delivery ............ 7-115
Figure 7.4: Monte Carlo simulation of the response of scintillating fibres with HDR 192Ir .................. 7-116
Figure 7.5: Relative response of a scintillator versus y-offset in cm with HDR 192Ir ............................ 7-116
Figure 7.6: Comparison of the sensitivity of two amplifiers ................................................................. 7-117
Figure 7.7: Attenuation of fully scintillating plastic fibre when interacting with HDR 192Ir radiation . 7-118
Figure 7.8: Comparison of three different plastic fibre probe responses (A, B, C) using identical lengths
and irradiating with HDR192Ir, y = 1 cm ............................................................................................... 7-119
Figure 7.9: Comparison of three different fibre probe configurations .................................................. 7-120
Figure 7.10: Effect of backscatter material on the acquired response ................................................... 7-121
Figure 7.11: Actual Response of 3.80 cm length round & square scintillating fibres coupled to 1 m clear
plastic fibre (left) and averaged response (right) of the same fibres for multiple dwell positions at a
vertical displacement of 0.5 cm ............................................................................................................. 7-122
Figure 7.12: Effect of polishing and TiO2 reflective coating on the response of a 9 cm scintillating fibre
coupled to 1 m long clear fibre placed on the right perimeter of the phantom a vertical displacement of 0.5
cm .......................................................................................................................................................... 7-123
Figure 7.13: Effect of coating on the response of 2.8 cm scintillating fibre coupled to 1 m long clear fibre
placed in the middle of the phantom at a vertical displacement of 0.5 cm ............................................ 7-124
Figure 7.14: Effect of coating on the response of 0.5 cm scintillating fibre coupled to 1 m long clear fibre
placed in the middle of the phantom at a vertical displacement of 0.5 cm ............................................ 7-124
Figure 7.15: Response of photodiode amplifier upon HDR 192Ir treatment delivery at multiple dwell
positions for different distances to the afterloading machine without lead shielding ............................ 7-125
Figure 7.16: Response of photodiode amplifier, upon HDR 192Ir treatment delivery at multiple dwell
positions, placed at 80 cm to the afterloading machine with and without lead shielding ...................... 7-126
Figure 7.17: Response of non-scintillating fibre at different vertical displacements (y) with and without
lead sheading ......................................................................................................................................... 7-126
Figure 7.18: Response of clear polymer fibre sections inserted from the opposite direction to the HDR
192
Ir source catheter when irradiated at various y positions................................................................... 7-128
Figure 7.19: Response of clear plastic fibre inserted from the same direction as the HDR 192Ir source
catheter when irradiated at various y positions ..................................................................................... 7-128
Figure 7.20: Response of photodiode amplifier, upon HDR 192Ir treatment delivery at multiple dwell
positions, when the bare fibre placed on the edge of the phantom at two vertical displacements ......... 7-129
Figure 7.21 : Response of photodiode amplifier, upon HDR 192Ir treatment delivery at multiple dwell
positions, when the bare fibre placed the whole way through the phantom at three vertical displacements
............................................................................................................................................................... 7-130
Figure 7.22: Responses of a 1 m fully scintillating fibre when irradiated by HDR 192Ir at different y
heights ................................................................................................................................................... 7-131
Figure 7.23: Responses of different lengths of scintillating fibres when irradiated by HDR 192Ir
sequentially advanced through the middle of the phantom at y = 0.5 cm height .................................. 7-132
Figure 7.24: Responses of 3.8 cm, 2.8 cm, 2 cm, and 1 cm scintillating fibre coupled to 1 m long clear
fibre when irradiated with HDR 192Ir sequentially advancing through the middle of the phantom at various
y heights ................................................................................................................................................ 7-133
Figure 7.25: Responses of different lengths of scintillating fibres when irradiated with HDR 192Ir placed in
the middle of the phantom at y = 0.5 cm ............................................................................................... 7-134
Figure 7.26: Responses of different lengths of scintillating fibres when irradiated with HDR 192Ir placed in
the middle of the phantom at y = 2 cm .................................................................................................. 7-134
Figure 7.27: Responses of different lengths of scintillating fibres when irradiated with HDR 192Ir placed in
the middle of the phantom at y = 5 cm .................................................................................................. 7-135
Figure 7.28: Responses of different lengths of scintillating fibres coupled to a 1m long clear fibre when
irradiated by HDR 192Ir placed stepping through the middle of the phantom at various y heights....... 7-135
Figure 7.31: Responses of 2.8 cm, 2 cm & 1 cm scintillating fibres coupled to 1 m long clear fibre when
irradiated with HDR 192Ir placed at sequential x locations inside a phantom at y = 0.5 cm ................. 7-136
Page xiv

Figure 7.32: Responses of different lengths of scintillating fibre coupled to 1 m long clear fibre when
irradiated with HDR 192Ir dwelling at different sequential x locations inside the phantom at y = 0.5cm,
different “z” locations ........................................................................................................................... 7-137
Figure 7.31: Positional sensitivity when scintillating polymer detector is placed 1 cm (left, centred or and
right) above the HDR source axis ......................................................................................................... 7-138

Figure 8.1: Illustration showing the general experimental setup with source, phantom and processing
electronics in the HDR brachytherapy room control room. .................................................................. 8-142
Figure 8.2: Detail of phantom setup shows fibre probe location within the phantom (Left), and the World
Coordinate System of experimental setup (Right) ................................................................................ 8-143
Figure 8.3: Response of photodiode amplifier (with a gain of 405 mV/nA) and no scintillator while
stepping the 192Ir source at multiple dwell positions placed at 80 cm, with lead shielding between source
and amplifier ......................................................................................................................................... 8-143
Figure 8.4: Depth response and positional sensitivities of the CMRP fibre optic DAQ system when the
fibre detector is within the phantom at three Z positions (middle, right, left) upon delivering the 192Ir at
multiple dwell positions for varied y heights 1 cm, 2 cm, and 3 cm ..................................................... 8-145
Figure 8.5: Determination of dwell time and dwell position of the CMRP system when the fibre probe is
within the phantom in the middle Z position when delivering the 192Ir at multiple dwell positions for
varied y heights 1 cm, 2 cm and 3 cm ................................................................................................... 8-147
Figure 8.6: Determination of dwell time and dwell position of the CMRP system when the fibre probe is
within the phantom in the right Z position when delivering the 192Ir at multiple dwell positions for varied
y heights 1 cm, 2 cm and 3 cm .............................................................................................................. 8-148
Figure 8.7: Determination of dwell time and dwell position of the CMRP system when the fibre probe is
within the phantom in the left Z position when delivering the 192Ir at multiple dwell positions for varied y
heights 1.5 cm, 2.5 cm and 3.5 cm ........................................................................................................ 8-149
Figure 8.8: Depth response and positional sensitivities of the Gigahertz Optik DAQ system when
sequentially the fibre is within the phantom at three Z positions (middle, right, left) when delivering 192Ir
radiation at multiple dwell positions for y heights 1 cm, 2 cm, and 3 cm ............................................. 8-151
Figure 8.9: Determination of dwell time and dwell position of the Gigahertz Optik system when
sequentially the fibre probe is within the phantom at the middle Z position when delivering 192Ir radiation
at multiple dwell positions for various y heights................................................................................... 8-153
Figure 8.10: Determination of dwell time and dwell position of the Gigahertz Optik system when
sequentially the fibre probe is within the phantom at the right Z position when delivering 192Ir radiation at
multiple dwell positions for various y heights ...................................................................................... 8-154
Figure 8.11: Determination of dwell time and dwell position of the Gigahertz Optik system when
sequentially the fibre probe is within the phantom at the left Z position when delivering 192Ir radiation at
multiple dwell positions for various y heights ...................................................................................... 8-155

Figure 9.1: Illustration of the experimental setup inside the clinical HDR brachytherapy room .......... 9-159
Figure 9.2: Illustration of the phantom tower clamp stand assembly (Up), and World Coordinate System
and dimensions of the phantom setup (Down) ...................................................................................... 9-159
Figure 9.3: Response of fibre optic DAQ system to HDR source vs. dwell time
a) detector fibre at
left (z = -10 mm), b) middle (z= 0), c) right (z=+10 mm) ..................................................................... 9-164
Figure 9.4: Measured signal from a clear fibre inserted 1cm above the path of the HDR source ......... 9-165
Figure 9.5: Computed SDDs between fibre optic detector and HDR source position when the fibre probe
is placed above the source at different heights (y= 10, 20 & 30 mm) and at different lateral positions a)
left (z = -10 mm), b) middle (z= 0), c) right (z=+10 mm) ..................................................................... 9-166
Figure 9.6: Calibration Curves of the fibre optic DAQ system for HDR source tracking when the fibre
probe is placed above the source at different heights (y= 10, 20 & 30 mm) and at different lateral
positions a) left (z = -10 mm), b) middle (z = 0), c) right (z = +10 mm) .............................................. 9-169
Figure 9.7: Differences between reconstructed (triangulated) and directly measured dwell positions of a
scintillating crystal irradiated by an 192Ir source a) y = 10 mm, b) y = 20 mm, c) y = 30 mm. ........... 9-171
Page xv

Figure 10.1: illustration of the experimental setup inside the clinical HDR brachytherapy room ...... 10-174
Figure 10.2: Response of fibre optic DAQ system to HDR source vs. dwell time a) detector fibre at left (z
= -10 mm), b) middle (z= 0), c) right (z=+10 mm) ............................................................................. 10-179
Figure 10.3: Measured signal from a clear fibre inserted 1cm above the path of the HDR source when
applying adapted Gigahertz Optik amplifier ....................................................................................... 10-180
Figure 10.4: Computed SDDs between fibre optic detector and HDR source position with Gigahertz Optik
amplifier and fibre probe placed above the source at different heights (y= 10, 20 & 30 mm) and at
different lateral positions a) left (z = -10 mm), b) middle (z= 0), c) right (z=+10 mm) .................... 10-181
Figure 10.7: Calibration Curves for the fibre optic DAQ system with Gigahertz Optik amplifier for HDR
source tracking with fibre probe placed above the source at different heights (y= 10, 20 & 30 mm) and at
different lateral positions a) left (z = -10 mm), b) middle (z = 0), c) right (z = +10 mm) ................... 10-183
Figure 10.6: Differences between reconstructed (triangulated) and directly measured dwell positions of a
scintillating crystal irradiated by an 192Ir source a) y = 10 mm, b) y = 20 mm, c) y = 30 mm. ........... 10-185

Figure 11.1: Experimental irradiation setup at GATRI, ANSTO (left) with the phantom holding the
samples in place (right) ....................................................................................................................... 11-191
Figure 11.2: Detector samples inserted into a PMMA phantom, before irradiation at 0 KGy, (left) 40KGy
(middle) and 100 KGy (right) ............................................................................................................ 11-191
Figure 11.3: Experimental setup at ICCC illustrating detector samples attached to optical fibres which
was inserted inside a “solid water” (PMMA) phantom under reference conditions (SSD of 100cm), with
sensitivity response acquired using a datalogger................................................................................. 11-192
Figure 11.4: Total accumulative dose given over a period of 5 weeks ............................................... 11-193
Figure 11.5: Response of CsI (Tl) scintillating crystal fibre probe vs. accumulated dose .................. 11-194
Figure 11.6: Response of BCF-60 scintillating polymer fibre vs. accumulated dose.......................... 11-195
Figure 11.7: Response of non-scintillating optical fibre vs. accumulated dose .................................. 11-196

Figure 12.1: An ideological diagram showing the theoretical concept of implementing multiple long
scintillating plastic fibres .................................................................................................................... 12-202

Figure 13.1: Illustration for physical components of the CMRP-adapted photodiode-based multichannel
AFE DAQ system ............................................................................................................................... 13-208

Page xvi

Abstract
Brachytherapy is an advanced technique of cancer treatment, where a high dose rate
radioactive source, typically 192Ir, is inserted within a tumour volume to destroy the spread
of cancerous cells. The complexity of such advanced treatment options requires accurate
quality assurance (QA) tools to verify the treatment plan and track the High Dose Rate
(HDR) source position as clinically prescribed. The misplacement of a HDR

192

Ir

brachytherapy source by several millimetres within a treatment volume is not clinically
tolerated, and must be addressed prior to conducting the actual treatment. For the safety
of patients benefiting from this treatment, it is ideal if the planned position of the HDR
192

Ir brachytherapy source position is verified in the targeted volume and tracked online

throughout the entire treatment procedure. Sophisticated quality assurance tools are now
widely implemented in clinical scenarios within treatment rooms to acquire online
feedback of the treatment process to assure the treatment is going as clinically prescribed.
The limitations of currently used QA tools for HDR brachytherapy have necessitated the
development of innovative tools for performing accurate QA tests without the need for
further measurement corrections. Fibre optic-based scintillation detectors have clinically
demonstrated desirable properties over other conventional detectors, and show great
potential to be reliably applied for dosimetric purposes in a variety of radiotherapy
techniques
The Centre for Medical Radiation Physics at the University of Wollongong, Australia has
a long history and become distinguished for developing sophisticated real-time QA tools
for various radiotherapy applications. The aim of this research project was to develop an
innovative scintillating fibre optic system as real-time QA tool for HDR Brachytherapy.
The in-house development of a photodiode amplifier-based data acquisition system
(DAQ) designed for this purpose has been demonstrated. In addition, the proposed system
has been clinically characterised and optimised for both green emitters scintillating fibres
(BCF-60) and Thallium Doped-Caesium Iodide CsI (Tl) scintillation crystals. A
triangulation method of applying multiple fibre probes using our developed system was
capable of localizing source position within +/- 1.0 mm when using our CMRP amplifier,
or to within +/- 0.6 mm when using an adapted Gigahertz Optik™ commercial amplifier.
Hence, using our system for clinical HDR source localization routinely seems feasible.
Based on pre-clinical investigations obtained, the feasibility of localizing a

192

Ir HDR
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source was shown to have more reliability and accuracy when using a CsI (Tl) crystal due
to its higher signal to noise ratio compared with polymer fibres. However, scintillating
polymer detector fibres were very convenient, functional and reliable, and experimental
results described herein indicate that the developed system is also eligible to be employed
for real-time HDR source tracking. Polymer fibres as detectors are inexpensive,
convenient and accurate, except at the very lowest end of the absorbed dose spectrum.
Radiation damage to the polymer fibres was found to be minimal and fibres could have
useful lifetimes of several years in clinical use.
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Introduction
1.1. Overview:
In the recent years, radiation therapy has become one of the primary modalities of cancer
treatment besides other therapeutic options such as surgery, gene therapy and
chemotherapy. Radiation therapy has been considered as an effective treatment option,
especially in the early stages, using highly energetic x-ray or ion beams to destroy
cancerous cells while sparing the surrounding healthy cells, with around 52% of cancer
patients gaining its benefits. Due to the inhomogeneity of the structure of cells and organs
within the human body, the decision of what type of treatment to pursue is made
depending on a number of factors based upon the severity and the location of the targeted
tumour. Thus, patients can receive optimal treatment via external radiation therapy
provided by X-ray or ion beams produced by linear or cyclotron-type accelerators.
Another treatment technique is internal radiation therapy or so-called Brachytherapy
(short-distance treatment) where Low Dose Rate (LDR) or High Dose Rate (HDR)
radioactive sources are temporarily or permanently inserted through needles into the
tumour volume being treated.(Khan & Gibbons, 2014; Metcalfe, Kron, & Hoban, 2012)
For the safety of patients from the risk of ionizing radiation, the International Atomic
Energy Commission and the Global Radiation Protection Committee have enacted laws
and regulations to provide proper radiation protection to patients during treatment
sessions. Thus, the patients should receive the least possible dose according to the “as low
as reasonably achievable” (ALARA) radiation safety principle, commensurate with the
location and tumour status (Hendee & Edwards, 1986). The high quality of radiotherapy
begins with a few pre-treatment procedures that include simulation and calculation of the
radiation dose which will be effectively appropriate to treat the cancerous cell, and the
sequential imaging of the diagnosed cancerous organ for tracking the progress of the
treatment.
The quantification of radiation dose is a high-priority aspect prior to and during the
treatment sessions. Calibrated radiation detectors must then be utilized for machinespecific quality assurance (QA) tests to verify the functionality of the device used to
generate the radiation beam prior to initiating the actual treatment session. Additionally,
patient-specific QA tests that include pre-treatment QA and in-vivo dosimetry are
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important procedures that need to be regularly checked to confirm that the radiation dose
delivered to the patient consistently agrees with the radiation dose prescribed in the
treatment planning system. Then, the radiation dose must be agreed within a close
tolerance to the amount of radiation dose measured by any pre-treatment QA devices
(Kron, Lehmann, & Greer, 2016).
In brachytherapy, QA testing is accomplished by validating the dose received by a patient
according to the current activity of the radioactive source used (Wilkinson, 2006).
Moreover, another essential aspect of QA procedure for in-vivo dosimetry during HDR
brachytherapy is that the verification of the dwell time along with real-time tracking of
the HDR 192Ir source (eg: 192Ir) position within the treatment volume which must highly
conform to the pre-defined and prescribed treatment plan This is usually checked by
means of medical imaging modalities which can prompt operators to discontinue the
treatment process if something going wrong, but otherwise completing the treatment plan
if it is successfully performed as pre-clinically planned (Valentin, 2005).

1.2. Description of the research study:
1.2.1 Research problem:
Statistics have shown that prostate cancer is the most prevalent cancer worldwide and
among Australian males in-specific (McIntosh et al., 2019). The treatment for this type
of cancer involves the implementation of brachytherapy along with a combination of
other radiotherapy techniques, with doses administered in a few treatment factions
(Hoskin et al., 2012). One important QA aspect is the discrepancy in HDR brachytherapy
source positioning. Such an error is considered a major concern that may lead to
dangerous consequences and unexpected accidents (Valentin, 2005). The misplacement
of an HDR

192

Ir brachytherapy source into a treatment volume of several millimetres is

not clinically tolerated and must be addressed as a necessary step prior to conducting
actual treatment (Nath et al., 1997). Another challenge facing clinicians is that there is
still a lack of precise devices that can simultaneously provide real-time tracking of the
radioactive seeds inside the treatment volume, and also perform in-vivo verification of the
dose given to the patients (Kubo, Glasgow, Pethel, Thomadsen, & Williamson, 1998).
This shortage of technical QA devices for use in the treatment process is still problematic
within the ideal clinical scenario. It is thus essential that this gap in capability is urgently
addressed for the improvement health care for today and tomorrow’s cancer patients.
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The implementation of sophisticated QA tools during radiotherapy treatment sessions has
played a key role in preventing unwanted errors that may arise during treatment. QA
programs have been established to maintain a high-quality level of health care provision
and have thus increased the survival rate of treated cancer patients (Kubo et al., 1998).
The currently used QA tools for HDR brachytherapy are, to some extent, technically
limited for performing accurate in-vivo tracking of HDR

192

Ir brachytherapy sources

during actual treatment sessions. This limitation has necessitated the development of an
innovative QA tool, with desirable features, that may have an immense potential for
fulfilling this required purpose. Lately, fibre optic based scintillation detectors have been
implemented into clinical scenario and have shown the capability to maximise desired
properties over other conventional detectors (Beaulieu & Beddar, 2016). Applying such
detectors into routine QA HDR Brachytherapy will assist in avoiding routine errors and
reducing the overall treatment time for acquiring real-time data. The Centre for Medical
Radiation Physics (CMRP) at the University of Wollongong, Australia has a long and
distinguished history for developing sophisticated real-time QA tools for various
radiotherapy applications (AB Rosenfeld, 2006). In this thesis, some innovative and highperforming optical detection systems are described and evaluated, aimed at filling some
of the described gaps in radiotherapy real-time dosimetry.

1.2.2 Significance and motivation:
The importance of this research study springs from the increasing number of people
affected by cancer all over the world, requiring intervention to reduce its unpleasant
effects. As stated by the World Health Organization (WHO, 2020), cancer is the leading
cause of death worldwide, with approximately 8.2 million deaths counted in 2012 .
Moreover, radiotherapy has become a common technique of cancer treatment for most
clinical scenarios in many countries; and around 52.3% of patients are estimated to
undergo radiotherapy for their cancer treatment (Delaney, Jacob, Featherstone, & Barton,
2005; Tobias, 1992). Therefore, it has become internationally mandatory to improve
treatment plans and hence ensuring the safe delivery of radiation dose to patients
commensurate with international radiation protection regulations as reported in the annual
International Commission on Radiological Protection (ICRP) reports (Valentin, 2005).
There has also been an increasing demand for real-time clinical QA devices for dosimetric
purposes in various radiotherapy applications (Fraass et al., 1998). An openness for such
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new reliable QA tools has become mandatory due to the shortcomings of currently
existing tools in the clinical toolkit used for Brachytherapy applications. The limitations
of currently used QA tools for HDR brachytherapy have necessitated the development of
innovative QA tools with desirable features that have an immense potential for
performing accurate QA tests without the need for further corrections. Fibre optic-based
scintillation detectors have clinically demonstrated desired properties over other
conventional detectors which will assist in avoiding routine errors and reducing the
overall treatment time by allowing real-time data acquisition (S Beddar & Beaulieu,
2016).

1.2.3 Research hypothesis:
The unique features of scintillating fibre optic detectors (SFOD) have recently marked
such detectors as the technology of choice among researchers for treatment QA and
dosimetry purposes (Beaulieu & Beddar, 2016). The research summarised in this Thesis
is based on the hypothesis that a system which utilises scintillating optical fibres placed
inside catheters, within the treatment volume of a HDR brachytherapy treatment, may be
used to monitor the location of the source to provide real time in-vivo quality assurance
of the treatment (Al Towairqi et al., 2019). In addition, the research hypothesis suggests
that the position of an HDR 192Ir Brachytherapy source can be verified within a prostate
treatment volume utilizing either long scintillating optical fibres or scintillating crystals
that possess a tiny volume size. Either of these scintillators can be inserted inside an HDR
catheter during the actual treatment without the need for discontinuing the treatment
process in order to re-measure source strength or scattered intensity. This feature is
effectively required for real-time data acquisition which will assist in assuring the quality
of radiotherapy offered to prostate cancer patients and permit immediate clinical decisions
for either continuing the treatment plan or to be revising the plan.

1.2.4 Aim and objectives:
Developing an innovative fibre optic dosimetry system for the purpose of HDR
Brachytherapy QA is the ultimate goal of this research project. Generally, the main aim
of the research study is to develop and carry out comprehensive investigations on a
portable fibre-optic dosimetry system dedicated for real-time monitoring and verification
of high dose rate (HDR) brachytherapy, with the further aim of developing a localising
system that accurately determines the location of the HDR Brachytherapy source in-vivo.
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The system is based on the placement of thin scintillating fibre elements within the
treatment volume (through catheters) to provide a triangulated localisation of the source
in the 3D space for in-vivo dose verification in HDR brachytherapy.
The research objectives are divided into separate tasks that fall into a number of initial
steps for the preparation of scintillation detectors, extended optical fibres, and a suitable
optical readout system as follows:
•

Design a fibre optic readout system for scintillating detectors used as QA tool
for HDR Brachytherapy.

•

Quantify the positional sensitivity to a HDR brachytherapy source when
interacting with scintillating fibre optic detectors.

•

Providing a response map with look-up tables for all possible dwell positions
at varying distance from the source,

•

Reconstruct the HDR source position in 3D space with respect to the
coordinates of radioactive sources.

1.3. Thesis Outlines:
This doctoral thesis has been designed as a collection of several main chapters which have
been written to match easily with the styles and formats of journal articles in suitable
technical journals as the following:
-

Chapter (2):

In this chapter, an overall literature survey of relevant currently used QA tools for
radiotherapy applications is chronically demonstrated. It is much focused on the
application of scintillation fibre optic detectors in in advanced radiotherapy applications.
Finally, it gives a rough review on the QA modalities used for the verification and tracking
of HDR Brachytherapy source, followed by research gaps identified based on the
literature.
-

Chapter (3):

In this chapter, the materials and methods needed to carry out this research project are
demonstrated. It involves the fabrication and preparation of both plastic (organic) and
crystal (inorganic) scintillators, design of photodiode amplifier based-data accusation
systems (DAQ), and in-clinic experimental work using Brachytherapy facilities.
-

Chapter (4):

This chapter investigates the in-house design and in-lab evaluation of the CMRP transPage 1-5

impedance photodiode amplifier as an optical fibre-based dosimetry system for
brachytherapy quality assurance.
-

Chapter (5):

This chapter discusses the in-house design and in-lab investigation of an upgraded CMRP
MKII trans-impedance photodiode amplifier for quality assurance of high dose rate
brachytherapy.
-

Chapter (6):

This chapter explores the adaptation and in-lab experimental evaluation of a Gigahertz
Optik trans-impedance photodiode amplifier as an optical fibre-based dosimetry system
for brachytherapy quality assurance
-

Chapter (7):

This chapter shows a pre-clinical optimisation and characterisation of a polymer fibre
optic sensor for high dose rate brachytherapy quality assurance.
-

Chapter (8):

This chapter demonstrates, based on a phantom study, the characterisation of an inorganic
scintillator for real-time quality assurance of high dose rate brachytherapy utilizing
photodiode based- fibre optic data acquisition systems.
-

Chapter (9):

This chapter investigates the utilisation of the CMRP-designed fibre-optic system with a
feasibility study of high dose rate Brachytherapy source verification and localization:
Proof-of-Concept and pre-clinical validation.
-

Chapter (10):

This chapter examines the utilisation of the adapted Gigahertz Optik fibre-optic system
with a feasibility study of high dose rate Brachytherapy source verification and
localization: Proof-of-Concept and pre-clinical validation.
-

Chapter (11):

This chapter presents radiation damage studies for fibre optic- based scintillation
detectors used for quality assurance of high dose rate radiotherapy
-

Chapter (12):

This chapter provides a general discussion based on all data presented in previous
chapters.
-

Chapter (13):

This chapter draws a conclusion of the whole thesis with throwing light on outlook and
future directions.
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Literature Review
Every day, recent scientific discoveries are developed into innovative technology with
new properties and features to meet people’s needs. Moreover, with rapid developments
in the medical field, radiotherapy experts have researched and developed new cancer
treatment techniques. This chapter will briefly summarise the developments in the area
of radiotherapy treatment techniques from the two years before this thesis work was
commenced to the present time. Surveying this literature provides information on
essential dosimetry basics applied in radiation therapy and quality assurance techniques
and tools which have been applied since 2016 and are currently being researched or
implemented in clinical use (in 2020). A brief survey of commercially available radiation
detectors is provided with a brief discussion of their features and limitations. Finally, this
literature review concentrates on previous work that has already been done by developing,
studying and experimenting with scintillating detector-based fibre optic technology.

2.1. Cancer Statistics:
Cancer is a most threatening disease, with an occurrence rate which has increased
dramatically in recent decades. According to (Australian.Institute.of.Health.and.Welfare,
2019), “Between 1982 and 2014, the number of new cancer cases diagnosed more than
doubled from 47,417 to 123,920 comprising 72,110 men and 56,180 women.” As stated
by the World Health Organization, cancer is the leading cause of death worldwide, with
approximately 8.2 million deaths counted in 2012 (Torre et al., 2015). A report published
by EdCaN, The Cancer Australia educational resource site for nurses states that “Prostate
cancer is the most commonly diagnosed cancer in Australia”. Between 1982 and 2014,
the age-standardised incidence of prostate cancer is estimated to increase from 79.5 to
128.7 per 100,000. In 2013 there were 19, 233 new cases of prostate cancer. In 2017, it
is estimated that 16,665 new cases of prostate cancer will be diagnosed in Australia.”
(Australian.Government, 2019)

2.2. Radiation therapy treatment options:
The ultimate goal of radiotherapy is to deliver an ionizing radiation beam to kill cancerous
cells while sparing all other surrounding healthy tissues. In the context of cancer treatment
options (i.e. surgery, radiotherapy and chemotherapy), radiotherapy has been the
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preferred option for most patients, especially in the early stages prior to any spreading of
tumours. 2011 statistics for NSW, Australia show that more than 52.3% of cancer patients
undergoing radiotherapy for their cancer treatments (NSW Department of Health, 2011).
Clinical radiotherapy procedures provide doctors, oncologists and cancer patients with a
range of treatment options based on their treatment needs, falling broadly into two main
techniques: external radiotherapy and internal radiotherapy (brachytherapy) (Khan &
Gibbons, 2014).

2.2.1 External radiation therapy:
External radiation therapy uses sources of ionising radiation from outside the patient’s
body (eg: from a clinical linear accelerator machine X-ray beam). Radiotherapy
techniques have advanced during the time of this thesis study, and the most recent
techniques have introduced new conformal radiotherapy approaches. These novel
techniques are capable of treating cancer in small areas with inhomogeneous dose
distributions to enable the efficient delivery of desired radiation doses to the targeted
organs while sparing other healthy critical structures (Khan & Gibbons, 2014).

2.2.2 Internal radiation therapy (brachytherapy):
Brachytherapy is a form of radiation therapy administered by a thin branch (hence
“brachy”) introduced into the patient’s body, bearing a small radioactive source (“seed”
or wire). From outside the body, the small radioactive source can be located nearby or
within the tumour, to eliminate the cancerous cells. Brachytherapy has become a common
treatment option for gynaecological, breast, and prostate cancers and is characterised by
very high dose gradient. Radiation can be delivered from a Low Dose Rate (LDR) source,
< 2 Gy/h, where very low activity seeds such as:

125

I or

131

Cs are semi-permanently

implanted inside the patient’s body to deliver a low radiation dose rate to a tumour. If the
treatment application requires a dose rate (higher than 12 Gy/h), then a High Dose Rate
(HDR) radiation source is needed, such as very high activity

192

Ir, which is temporarily

implanted inside the patient’s body by employing an afterloading machine to deliver the
radioactive source through a thin catheter to the desired treatment area (Devlin, 2015).

2.3. Radiation protection principles:
Ionizing radiation has a negative impact on the human body because the radiation has
enough energy to ionise atoms, which may lead to biological damage. Therefore, there
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was an important motivation to create an independent, international, and nongovernmental organization that is highly concerned with radiation protection: the
International Commission on Radiation Protection (ICRP). It aims to provide
recommendations and guidance for radiation protection for the environment and humans
involved with any ionising radiation sources. It also aims to prevent side effects
associated with radiation exposure such as cancer. The main task of ICRP has been to
introduce radiation protection principles that are highly recommended before conducting
any radiation activities in both medical and industrial practices (ICRP, 2014). Radiation
protection principles are reported and taught by the ICRP in their annual reports and also
by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA).
ARPANSA is an Australian governmental body that provides a system of radiation
protection in Australia, directly derived from the recommendations of the ICRP.
According to ARPANSA, radiation protection principles must be applied prior to
performing any radiation practice. The general principles are justification, optimization,
and dose limitation. “Justification” means that the benefits of conducting a radiation
activity must outweigh the risks which might be caused by being exposed to radiation. In
addition, “optimization” ensures that individual doses and number of people exposed to
radiation follow the “ALARA” radiation principle: “As Low As Reasonably Achievable”.
Lastly, “limitation” means radiation doses to individuals involved in the justified
activities must be kept limited to fall below maximum acceptable dose limits
(ARPANSA, 2007).

2.4. The need for dosimetry and quality assurance (QA) in
radiation therapy:
Radiation therapy requires radiation devices that can accurately measure the radiation
dose delivered to patients. However, quantification of the delivered doses must be
regularly verified, checked, and assured so that patients continue to receive the planned
treatment doses as they are clinically prescribed. This justifies the need for modern and
highly accurate, preferably real-time, dosimeters to be effectively used in treatment rooms
prior, during and after each treatment session for treatment verification purposes. The
main benefits of real-time dose measurements are to deliver the full prescribed doses and
prevent patients from being overexposed during their radiation treatments (Fraass et al.,
1998; Kron et al., 2016).
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Current dosimetry technologies in radiotherapy fall into two main categories: MachineBased Dosimetry and Patient-Specific Dosimetry, both of which are of a huge importance
prior to conducting any clinical radiation activity. Machine-Based Dosimetry, which
involves routine checks of equipment used for treatment purposes to detect any
mechanical, electrical or other technical errors. In contrast to Patient-Specific Dosimetry
which is concerned with pre-treatment verifications and in-vivo dosimetry at the exact
time of treatment delivery. These aspects are to deliver the treatment as intended; and
allow for real time monitoring of the treatment plans being delivered respectively (Wilson
& Gete, 2017) (Zhu et al., 2011).
More recently, in vivo dosimetry, therefore, has been applied in radiotherapy departments
for verifications of treatment plans. It is described as real-time measurements of radiation
doses delivered to patients to ensure that the outcome of treatment delivery is carried out
as exactly planned. Therefore, its main aim is to provide the quality assurance (QA) of
the radiotherapy procedures conducted in routine clinical practice. Procedures follow the
recommendations from authority bodies such as the World health Organization (WHO),
the International Commission on Radiological Protection, and the International Atomic
Energy Agency (IAEA) (Kukolowicz et al., 2013).
Quality assurance tests are required to assure the safe delivery of radiation doses by
various machines used for treatment purposes. Medical physicists play an important role
in applying physics concepts for developing, calibrating and using reliable dosimeters
with appropriate features. Therefore, many dosimeters have been created and developed
over time for different applications. The ideal dosimeters should, in principle, possess
the following characteristics in order to be excellent candidates for dosimetric purposes:
ease of use and availability, high accuracy and precision, high spatial resolution, flat
energy response, linearity across a wide range of dose, known dose rate dependence or
independence, known directional (angular) dependence, known energy dependence,
known temperature dependence and tissue-equivalence.

2.5. The TG-43 Brachytherapy Dosimetry Formalism (2-D):
Task Group 43 and its following update (TG43-U1) were formed by the Radiation
Therapy Committee of the American Association of Physicists in Medicine (AAPM) to
recommend a dosimetry standardised formalism for describing brachytherapy dose
calculations (Rivard et al., 2007; Rivard et al., 2004). The TG-43 geometry of
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brachytherapy source used for point dose calculations is shown in Fig. 2.1, where r is
defined as the distance (cm) from the measuring point of interest to the centre of the active
source; 𝐫° is defined as the reference distance from the detector to the centre of the active
source at a reference point 𝐏(𝐫° , 𝛉° ) (specified as r° = 1 cm in this protocol & the
reference polar angle formed between the detector and the source at a reference point of
interest is θ° = 90˚); 𝛉 is the polar angle that determines the measuring-point-ofinterest 𝐏(𝐫, 𝛉), relative to the longitudinal axis of the source.

Figure 2.1: Geometry of dose calculations formalism of point brachytherapy source using TG-43

For brachytherapy line source, the two-dimensional dose-rate equation 𝐃(𝐫, 𝛉) (dose
rate to water in water at point P (r,)) is described as:
𝑫(𝒓, 𝜽) = 𝑺𝑲 . .

𝑮𝑳 (𝒓, 𝜽)
. 𝒈𝑳 (𝒓). 𝑭(𝒓, 𝜽)
𝑮𝑳 (𝒓° , 𝜽° )

Air KERMA strength, 𝐒𝐊 :
The air kerma strength is defined as:
𝑆𝑘 = 𝐾𝛼 (𝑑). 𝑑2
The air kerma rate in a vacuum at a distance d multiplied by the square of the distance d2.
The distance is usually determined at 1 m to be larger than the source size for the sake of
geometry effects elimination. Thus, correction must be applied to account for the effects
of attenuation and scatter in air. Air kerma strength has a unit which is denoted by U
where 1 U = 1 μGy m2 h-1 = 1 cGy cm2 h-1
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Dose-rate constant,  :
The dose-rate constant in water is defined as:
 =

𝑫∙ (𝒓∘ , Ɵ∘ )

𝑆𝑘

The ratio of the dose rate at a reference point of interest to the air kerma strength 𝑆𝐾 . The
constant is known as 1.109 cGy . h-1 . U-1
Geometry function, 𝐆𝐋 (𝐫, 𝛉) :
For improving the accuracy of the dose rates, a geometry factor is used to provide
correction of the inverse square law based on the distribution of the radioactivity in the
source. It can be interpolated from data calculated at specific points. For line source
approximations, where the angle Ѳ of the source with respect to the point of interest is not
equal to zero, it is calculated as:
𝑮𝑳 (𝒓, Ѳ) =

𝜷
𝑳 𝒓 𝐬𝐢𝐧 Ѳ

L: the length of the source, typically 35 mm.
Ө: the angle formed between the centre of source to the point of interest.
𝜷: the angle subtended by both ends of the source to the point of interest.
𝜷 = Ѳ𝟐 − Ѳ𝟏 , Ө1 is smaller than Ө, and Ө2 is larger than Ө.
𝐫: the distance from the detector to the centre of the active source at any given
position.
Geometry function, 𝐆𝐋 (𝐫° , 𝛉° ) :
The concept of this geometry factor is used if the detector is placed at a reference point
position, where the distance to the source to the reference point of interest is 𝑟° = 1 cm
and the angle between the detector and the source at a reference point angle is 𝜃° = 90˚.
Radial dose function, 𝐠 𝐋 (𝐫) :
The radial dose function is applied to account for the dose fall-off due to the attenuation
and scattering of photons in the medium. It can be interpolated from data calculated at
specific points for both the point and line source approximations.
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2-D anisotropy function, 𝐅(𝐫, 𝛉) :
The two-dimensional anisotropy function is applied to consider the variations in dose rate
due to the activity distribution, and photon attenuation in the source. It can be interpolated
from data calculated at specific points.

2.6. Quality assurance (QA) tools used for HDR Brachytherapy:
The following are the main QA tools used for dosimetry purposes in Brachytherapy.

2.6.1 Ionization Chambers:
Dosimetry with ionization chambers has a long history and is one of the most common
types of radiation detectors used in radiation therapy for dosimetric purposes and for
primary/secondary calibration. The principle operation of ionization chambers basically
relies on the determination of ionization caused by radiation in air, gas, or any other
medium and is still used as a primary calibration standard for all dosimetric techniques.
Due to the interaction of ionizing radiation with the chamber medium, ions are created,
and charge generated is then collected by an electrometer which is meant to measure the
chamber current (Amps) and charge (Coulombs). During the recent two decades, ion
chambers have been increasingly developed and shaped in many forms to meet the
requirements of various clinical applications (Metcalfe et al., 2012; Podgorsak, 2003).
Cylindrical and parallel plate ionization chambers are the most common types for
dosimetry of photons, electrons, protons, or ion beams. However, the parallel-plate
chamber is most recommended for electron beam dosimetry lower than 10 MeV and
surface depth dose measurements of the build-up region for megavoltage photon beams.
Ionization chambers are well known for their reusability, ruggedness, and reliability
(Knoll, 2010) (Podgorsak, 2003).

2.6.2 Thermoluminescent dosimeters (TLDs):
TL dosimetry is considered to be one of the oldest dosimetric technique and has been
used for more than a hundred years for dosimetric purposes (Metcalfe et al., 2012). The
principle operation of a TLD depends on the absorption of radiation by crystals. When
the crystal material is subsequently warmed, a release of energy will occur as an emission
of light (referred to as thermally stimulated luminescence). Crystals are generally nonconducting which means that the conduction band of the crystal is empty and electrons
are restricted to the valence band at room temperature (Metcalfe et al., 2012; Podgorsak,
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2003). Upon irradiation, crystals absorb a part of the energy and some electrons gain
sufficient energy to transit to the crystalline conduction band. In addition, due to
imperfections in the crystals, electrons may be trapped in local energy bands midway
between the conduction and valence band, and then combined with a positive hole. When
raising temperature to “read” the TL crystal material, trapped electrons may then be
stimulated by a small energy increment to join the conduction band. When they
subsequently fall from the conduction band back to the valence band, energy is then
released in the form of light (luminescence). Since heat is applied to stimulate the process
of luminescence, this phenomenon is referred to as thermoluminescence (TL). However,
if light is applied instead, then optically stimulated luminescence (OSL) will result
(Podgorsak, 2003) (Knoll, 2010) . The most commonly used TL dosimeters in medical
applications are LiF:Mg,Ti, LiF:Mg, Cu,P, and Li2B4O7:Mn as they are reasonably
tissue-equivalent. Due to the high demand for TLD systems, they have been commercially
available in many forms such as powder, chip, rod, and ribbon. An important aspect of
TLD is that the TLD crystalline material need to be “annealed” to delete any of the
previous signal prior to usage. Most TLD readers consist of a heating planchet for holding
the TLD medium, a PMT for detecting and converting TL emission light to an electrical
signal, and an electrometer for recording the signal as current or charge (Podgorsak, 2003)
(Horowitz, 2020)

2.6.3 Semiconductor dosimeters:
Numerous types of semiconductor devices have been recently released (Metcalfe et al.,
2012) for the dosimetry of ionizing radiation. In contrast to ionization chambers,
semiconductor detectors are well known for their small sensitive volume and immediate
dose measurements. Moreover, the principle operation slightly differs from that of other
detectors where the interaction of the ionizing radiation is with a solid medium rather than
a gaseous. Two common types are described in more depth (Knoll, 2010).

2.6.3.1. Silicon diodes:
Most of semiconductor detectors are based on silicon which is generally referred to as a
“semiconductor” but is essentially a non-conductor when in an un-doped form. Silicon
can be doped with electron donor or electron receptor impurities to produce n-type
semiconductors and p-type Si respectively (Knoll, 2010). Si semiconductor radiation
detectors are typically an area of p-type Si on an area of n-type Si to form an area of P-N
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junction. The interface area between the two materials is a “depletion layer” where the
density of mobile charged particles (electrons or electron holes) is small (i.e. depleted).
Irradiating the semiconductor results in a flow of charge carriers across the junction.
Silicon diode dosimeters can be described as positive-negative junction diodes that are
designed for dosimetric applications. They can be referred as n-Si or p-Si dosimeters
depending on the base material used (Metcalfe et al., 2012; Podgorsak, 2003). Both types
are commercially available. However, the p-Si type seems to be favoured as the best
choice for radiation detection and in-vivo dosimetry as it is considerably less sensitive to
radiation damage (Metcalfe et al., 2012; Podgorsak, 2003). Diodes can be generally
operated in two different modes: with and without bias. Only a small mean energy is
required for producing a charge carrier, and the small device size gives semiconductor
detectors an advantage traditional ionization chamber detector. These advantages
definitely make them desirable choices for performing dose measurements in various
radiotherapy applications such as steep dose gradients and small fields. Moreover, they
are known for being reliable, relatively cheap, and constant over the wide range of
electron energies without the need for correction (Metcalfe et al., 2012; Podgorsak, 2003)
Despite the obvious advantages of semiconductor dosimeters, they still have some
limitations which introduces challenges for some specific radiotherapy applications for a
variety of radiotherapy applications. Dose rate dependence, directional dependence,
temperature dependence, and field size dependence need to be considered and corrected
by comparison (calibration) against standardized ionization chambers. Another important
problem is that the relatively high atomic number of silicon (Z= 14) which is very high
compared to air (Z= 7.78) (AB Rosenfeld, 2006) (Knoll, 2010).

2.6.3.2. Metal Oxide Semiconductors – Field Effect Transistors
(MOSFETs):
MOSFETs are a newly established semiconductors dosimeter that has been introduced
since the early 1980s. The principle operation of a MOSFET depends upon the
measurement of a threshold voltage, due to ionising radiation, which is linearly
proportional to the absorbed dose (Metcalfe et al., 2012; Podgorsak, 2003). The main
desirable characteristics of MOSFETs are the immediate dose readout and the small
physical size compared to other available dosimeters. Due to their small physical size,
MOSFETs are particularly suitable for some advanced radiotherapy application such as
brachytherapy and microbeam radiotherapy, and in mixed radiation fields (Metcalfe et
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al., 2012). However, they are still not typically ideal for dosimetry and some important
aspects need to be taken into account when they are used. In the first instance, a
temperature dependence is exhibited by all semiconductors. MOSFETs need to be
connected to a bias voltage which must be stable without change during irradiation
(Metcalfe et al., 2012; Podgorsak, 2003). Also, the gradual accumulation of trapped
charges causes a slight drift in the output reading over time. Moreover, individual
MOSFETs show nonlinear dose response and therefore dose response correction is
needed, especially with single detectors. Lastly, there are not tissue-equivalent which
gives an opportunity for other systems to compete with their use in the field of radiation
dosimetry (Metcalfe et al., 2012) (Knoll, 2010) (AB Rosenfeld, 2006). A comprehensive
review on innovative QA semiconductor dosimeters in modern external-beam radiation
therapy has been extensively covered by a research group at the Centre for Medical
Radiation Physics, University of Wollongong (Rozenfeld et al., 2020).

2.6.4 Films:
After William Rontgen’s discovery of fogging of photographic film by a radioactive
source, photographic film has been used to image radiation fields (or objects silhouetted
by them) and was soon used to detect, record and gauge intensity or total doses of
radiation. Photographic camera and emulsion companies such as Eastman-Kodak, Agfa,
GAF and Fuji corporation developed silver-halide (and later colour-linked) photographic
emulsions optimised for general (visual light) photography, IR photography and
radiometric purposes. This later type is referred to as “radiochromic’ films. In the postWW2 period, it was common for radiological ward hospital staff, users of industrial
isotopes and workers in nuclear reactors to carry radiation badges (“rad-badges”, clip-on
swatches of sealed radochromic film) which were developed and “read” by a dosimeter
to determine the total dose received by the carrier of the rad-badge, to ascertain worker’s
radiological health and protection. More recent formulations include “EBT2” and
“EBT3” films. EBT2 film (Reinhardt et al. 2012) has a radiochromic layer deposited on
a layer of polyester. More recently, a much more sophisticated “Gafchromic EBT3” film
was developed (Ashland ISP Advanced Materials, NJ, USA), available from late 2011.
EBT3 is a self-developing film composed of an active radiochromic layer of 26–30 μm
thickness, laminated between twin, textured polyester layers (each 125 μm thick), creating
a symmetric structure. The matte-textured polyester layer contains microscopic silica
spheres near the surface, to eliminate Newton’s Rings scanning artefacts. This film has
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an effective atomic number Zeff (EBT3) = 6.84 compared to Zeff (water) = 7.3, so it is near
water-equivalent (Arjomandy et al., 2010). Despite the clever features of this modern
radiochromic film, it has the disadvantages of being a “single use” system and it is not a
“real time” measuring system. There is usually a considerable time delay (hours – days)
between exposure to ionising radiation and developing and densitometric scanning of the
film to reveal integrated absorbed dose. Hence radiochromic film is still relevant for
applications like routine staff monitoring, but it is not the system-of-choice for patient
treatment monitoring (Knoll, 2010; Metcalfe et al., 2012).

2.6.5 Scintillation detectors:
2.6.5.1. Scintillation mechanism:
The mechanism behind any scintillation fibre-optic system basically, shown in Fig. 2.3,
relies upon the interaction of radiation beams with scintillating materials which is
responsible for light generation within the visible light spectrum shown in Fig. 2.4. The
operation of scintillation fiber optic detectors depends on the generation of scintillation
light upon irradiation within the core of through plain (clear) optical fibers. The light
produced is guided through a optical cable served as waveguide for signal detection and
amplification using light photodetectors such as a photomultiplier tube (PMT) or a
photodiode (Knoll, 2010), placed outside the irradiation room and hence electrical signal
is acquired (Knoll, 2010) (Podgorsak, 2003).

Figure 2.2: Illustration of scintilation mechanism
By Adrie J.J. Bos, (2017) Materials 10(12):1357
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Figure 2.3: Light spectrum illustrating the scintillation light produced within the range of visible light
(Source: sciencing.com)

2.6.5.2. Progression of scintillation detectors over time:
The limitations of currently used QA tools for HDR brachytherapy have necessitated the
development of innovative QA tools with desirable features for performing accurate QA
tests without the need for major corrections for output of beam qualities. Therefore, fibre
optic-based scintillation detectors (FODs) have been recently introduced in radiation
detection and being successfully capable of being the technology of choice. In addition,
they have clinically demonstrated to have desirable properties over other conventional
detectors such as water-equivalence, dose rate independence, and energy independence.
Interest in this research area with demand increasing on such favourable radiation
detectors have been noticed with research and publications rapidly expanding, over the
years. Two research groups published review articles on the use on scintillation detectors
for advanced radiotherapy applications (O'Keeffe et al., 2015) (Beaulieu & Beddar,
2016). By 2014, increasing numbers of researchers were experimenting with fibre optics
for use in various fields, including radiotherapy dosimetry (Park, Lee, Kim, & Moon,
2014). In general, scintillation detectors fall into two main categories, based on the
component material used for creation of the scintillating light emission: organic
scintillators (plastic) and inorganic scintillators such as NaI (S Beddar & Beaulieu, 2016)
as it is discussed in the following sections.

2.6.5.3. Inorganic scintillators:
Inorganic scintillators (IOSs) have widely been used for dosimetry purposes in a range of
radiotherapy applications. Unlike organic scintillators, these are characterized by a high
atomic number and light yields can have intensities up to 1800 times higher than organic
scintillators (G Kertzscher & Sam Beddar, 2017). This yields higher signal to noise ratios
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so that pure scintillation signal is much higher than stem effect signals. These unique
qualities make IOSs very good candidates for radiation detection, but other properties
such as water-equivalence, energy- & temperature-dependence may need to be corrected
for when measuring absorbed dose for in-vivo dosimetry applications (Gustavo
Kertzscher & Sam Beddar, 2017). In addition, another research group has investigated
the use of an innovative inorganic scintillation dosimetry system and showed good
characterization results for dose measurement of external beam photon energy (Alharbi
et al., 2018; Alharbi et al., 2019). Derenzo, et.al (2003) have an excellent review article
showing the range of inorganic scintillator materials (principal material and dopant where
applicable) which have been discovered and applied from the late nineteenth century to
the early 2000’s.

2.6.5.4. Organic scintillators:
Polymer (plastic) scintillation detectors (PSD) have successfully shown great potential
for dosimetry purposes in photon, electron, and proton energy beam. Not only limited to
therapeutic energy range but also, they have been extended to cover other applications in
diagnostic energy and interventional radiology (Beaulieu & Beddar, 2016). Polymer
scintillation detectors have been developed for radiotherapy dosimetry since the 1990’s
(A Beddar, T Mackie, & F Attix, 1992a, 1992c). Despite this long connection with
dosimetry applications in health physics, they are not yet routinely used in clinical
applications. A Beddar et al. (1992a) stated that plastic scintillators are well known to
possess some favourable properties which make them excellent candidates for dosimetry
purposes of advanced radiotherapy techniques. These properties include water
equivalence, high spatial resolution (small size), linear dose response, dose rate
independence, directional

independence,

negligible

energy independence

and

reproducibility with stability. Moreover, due to its relative small sizes and high special
resolution, plastic scintillators are excellent candidates for high dose gradient regions,
small field dosimetry, and brachytherapy applications (Metcalfe et al., 2012; Podgorsak,
2003) (Knoll, 2010) However, scintillators exhibit a small temperature dependence
between 20 ˚C and 50 ˚C (Metcalfe et al., 2012). In the reference book “Scintillation
Dosimetry” by (S Beddar & Beaulieu, 2016), Table 1.2 and Part 1 (Section 4) detail
organic and polymer materials used as organic scintillators.
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2.6.5.5. Applications of fibre optics:
Fibre optics technology has now become the state-of-art-technology worldwide which
and thus it has found many applications in various fields. Current applications of fibre
optics are immensely numerous and varied from the medical to industrial applications.
Due to the properties of optical fibre cables for fast signal transmission and the immunity
to EM interferences, so it has been used in the medical filed for surgical operations as
speculum. More recently, it has been successfully applied in the quantification of
radiation doses and verification of pre-treatment and in-vivo dosimetry quality assurance
procedures for advanced radiotherapy applications. Therefore, Fibre optic dosimetry
(FOD) has been a hot topic of and attracted interest for many researchers from all over
the world (Krohn, MacDougall, & Mendez, 2014).

2.6.5.6. Structure of optical fibre:
As appears in Fig. 2.2 that the optical fibre is structured from three main layers: Core,
cladding, and buffer which is surrounded by a jacket to maintain protection against
surrounding environmental interferences. Optical fibres serve as light guides that transmit
entire light emissions. The physical phenomenon behind this is known as Total Internal
Reflection (TIR) where the incident light transmits from a medium (n1) of higher
refractive index, typically the fibre core, to another medium (n2) of lower refractive index
which is the cladding. When the angle (Ѳ) of the incident light reaches a value that is
larger than the critical angle (Ѳc), the total light will be then internally reflected into (n2)
(Zanoon, 2014).

Figure 2.4: A typical internal structure for an optical fibre cable
(Source: timbercon.com)
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2.6.5.7. Limitations of scintillation fibre optic dosimetry:
The unique features mentioned have recently marked scintillating fibre optic detectors
(SFOD) as the technology of choice among researchers for treatment quality assurance
and dosimetry purposes (Beaulieu & Beddar, 2016). There are still some disadvantages
of such SFOD when applying such system into the clinical scenarios which are the
production of a stem effect signal (Cerenkov light) especially within therapeutic energies,
temperature dependence, energy dependence, and quenching effect, which is only
problematic for proton/ion therapy (S Beddar & Beaulieu, 2016).

2.6.5.7.1.

Cerenkov radiation:

Cerenkov (or Cherenkov) radiation is an electromagnetic radiation produced when
charged particles travel in dielectric medium at a speed that is larger than the speed of
light in that medium (Cherenkov, 1937). The phenomenon was discovered in 1934 and is
named after the Soviet physicist Pavel Cherenkov, who shared the Nobel Prize in
Physics in1958 for appreciating his discovery. Beddar and Beaulieu, in the preface of
their reference book “Scintillation Dosimetry” (2016, p. xiv), note that the Cerenkov
Effect is variously referred to as Cherenkov, Čerenkov and Cerenkov in the literature.
They have a thorough description of Cerenkov radiation in their Sections 20.1 & 20.2
(S Beddar & Beaulieu, 2016, pp. 367-374).
The main challenge with any scintillation dosimetry system is the production of Cerenkov
radiation when transmitting the light to a light detector via an optical fibre. This problem
becomes a major concern when using an optical fibre material that has a refractive index
(n) larger than one in megavoltage beams. This Cerenkov radiation affects the signal if
not controlled properly, and the production of such stem-effect signal (Cerenkov light)
becomes a worry especially within therapeutic energies when applying such system into
the clinical scenarios which needs to be corrected for when measuring the radiation dose
(Beaulieu & Beddar, 2016).
Several methods have recently been proposed in the literature to account for Cerenkov
radiation, control the stem effect signal, and separate them from the pure scintillation
signal such as reference method (A Beddar, T Mackie, & F Attix, 1992b; AS Beddar, T
Mackie, & F Attix, 1992), spectral filtration (Clift, Sutton, & Webb, 2000; De Boer,
Beddar, & Rawlinson, 1993) , chromatic filtration (Fontbonne et al., 2002), temporal
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filtration (Clift, Johnston, & Webb, 2002), air-core hallow fibre (J Lambert, Yin,
McKenzie, Law, & Suchowerska, 2008), and waveform separation (Archer, Madden, Li,
Wilkinson, & Rosenfeld, 2019). Beddar et al (A Beddar et al., 1992a, 1992c; Kron et al.,
2016) have proposed a reference method to correct the generated signal by using two
identical optical fibres which is known to be the most common technique of Cerenkov
removal. This was achieved by using an optical fibre with no scintillator attached as a
reference fibre probe for Cerenkov radiation correction beside the already existed optical
fibre probe attached to the scintillator for acquiring the scintillation signal. Therefore, this
method allows the subtraction of the background Cerenkov radiation (reference signal)
from the measured signal (scintillator signal). Beddar and Beaulieu (2016, pp. 77-81)
teach a range of Cerenkov subtraction techniques, which include simple optical filtering,
the twin-fibres method, time-filtering, chromatic removal and the use of air-cored fibres.

2.6.5.7.2.

Temperature dependence:

It was claimed in earlier studies (A Beddar et al., 1992a, 1992c) that scintillators are
temperature independent from 0 ⁰C to 45 ⁰C. However, more recent research by the same
group (Wootton & Beddar, 2013) has reversed this decision and noted a small but
measurable temperature dependence in some scintillating fibres such as BCF-60 which
exhibits a 0.15 % temperature dependence of measured dose between 15 ⁰C and 40 ⁰C.

2.6.5.7.3.

Energy dependence:

It has been found recently that plastic scintillation detectors (PSDs) have slight energydependence, especially in low energy photon beam. Beddar and Beaulieu in their 2016
published book analyse energy-dependence of some polystyrene-based scintillating fibres
(2016, pp. 58-59). In addition, a research study has assessed the energy dependence of a
plastic scintillator dosimeter (DosiRat) used for micro-irradiators dosimetry for different
beam qualities from 40 to 225 kV. They have found that a variation of 23% has been
observed for the selected energy range (Le Deroff, Frelin, & Ledoux, 2019). Another
recent study has investigated and evaluated the energy dependence of various polystyrene
based plastic scintillators in the effective energy range from 14 – 61 KeV. The main
findings indicate that the variation in scintillation response was found to be approx. 77 %
for the most scintillators that were investigated (Whittaker et al., 2019).

Page 2-22

2.6.5.7.4.

Quenching effect:

When a scintillating material is exposed to continued irradiation of sufficiently high
energy to excite electrons into trapping energy levels, the trapping sites throughout the
material will gradually become fully populated by electrons and cannot accommodate any
further excited electrons. The response of the material is then said to be “quenched”.
Beddar and Beaulieu devote an entire chapter (their Chapter 2) to quenching effects in
scintillation light. The quenching effect can be seen in the Figure below (reproduced from
the book). The gradual drop of the curve from the dotted linear behaviour with increasing
energy loss shows the effect of quenching. Beddar and Beaulieu detail methods for
correcting quenching effects in dose-measuring scintillators (2016, pp. 32-34)

2.6.5.7.5.

Radiation damage of scintillator:

Like any other detectors, scintillating detectors are vulnerable to radiation damage due to
constant repeated exposure to ionising radiation. In organic scintillators, radiation
absorbed by the scintillation molecules may be dissipated thermally and results in
temporary or permanent damage to the scintillator (S Beddar & Beaulieu, 2016). Different
studies have reported that organic scintillators are susceptible to radiation damage and
conclude that light output decreases as a function of increasing irradiation dose, although
there is a possibility of recovery in light output in some materials. Decreased light output
is an indication of either damage done to the fluorescent component or the light
transmission being decreased due to the creation of optical absorption centres by radical
species. Chemical reactions in the scintillators have a very big potential of causing
permanent damage. In addition, the nature of the radiation, the dose rate, and the presence
of oxygen are all factors which play a role in degradation of scintillation output. It has
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been found that regardless of the dose, there is always a certain amount of damage from
which there is no recovery (Biagtan, Goldberg, Stephens, Valeroso, & Harmon, 1996). A
study by Senchishin et al, published in 1995, has demonstrated that the loss of signal is
significant when typical plastics irradiated with a cumulative dose in the range of 103 –
104 Gy. However, there was little change in scintillation intensity for some radiationresistant polymers irradiated with a cumulated dose in the range of around 105 Gy
(Senchishin et al., 1995). Oxygen is another factor that affects the scintillator properties
during samples’ irradiation which can react to produce some radical species causing
radiation-induced damage. Damaging of the scintillator is proportional to the oxygen
found in the plastic. (Zorn, 1993). One of the clear evidences of damage is a colour change
of the scintillator turning into yellow or brown which is observed in some scintillators
after an exposure of ~10 kGy (Wick, Paul, Schröder, Stieber, & Bicken, 1991). The colour
change is attributed to the production of trapped electrons and free radicals from reacted
O2 molecules. More details about previous work are given in the “radiation damage” in
Chapter (11).

2.6.5.8. Applications of scintillation detectors in advanced
radiotherapy treatment modalities:
With the increased developments in radiation dosimeters throughout the most recent
decade, fibre optic dosimetry has attracted the interest of many researchers worldwide.
This section provides a review of research literature on the usage of fibre optic dosimetry
and its applications for radiotherapy treatment purposes which has been published during
this time period (Beaulieu & Beddar, 2016).

2.6.5.8.1.

Photon external beam radiation therapy:

The first use of fibre optic detectors (FOD) was pioneered by Beddar et al. in 1992. They
introduced the first system of water-equivalent plastic scintillators used for radiotherapy
purposes (A Beddar et al., 1992b; AS Beddar et al., 1992). Beddar and Beaulieu (2016,
Sections 4 & 5) extensively cover the use of scintillating fibre optic dosimeters for
external photon beam radiation therapy. In their Section 6, Beddar and Beaulieu mention
the “1D” (1-dimensional) nature of polymer scintillator detectors (PSDs) and how their
near water-equivalence allows them to map 2D (2-dimensional) radiation fields. In their
Section 6.5 and conclusions (pp. 98 – 103) they discuss 3D mapping of radiation fields
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using cylindrical arrays of PSDs and compare results to those obtained with other
modalities such as multiple CCD arrays (S Beddar & Beaulieu, 2016).
Recent developments in the field of clinical radiotherapy include convergences of
technology such as Linacs for radiation treatment being combined simultaneously with
diagnostic imaging modalities such as CT scanners or magnetic resonance imaging
(MRI). Such modalities can monitor patient coordinates and wellbeing in real time or very
near real-time (processing delay of the order of seconds only). Fibre optic detectors
(FODs) have a great advantage in such an application because they are very small and
slim and don’t require bulky supporting infrastructure such as power supplies, shielding
or cooling systems. Hence a FOD system adds very little extra clutter or complexity to
the already-bulky Linac and MRI equipment. The UOW CMRP group has conducted the
first measurements with polymer scintillation dosimeters in the Australian MRI-Linac.
They investigated use of polymer scintillator FODs for characterizing basic linac energy
parameters with a 6 MV photon beam energy. The findings demonstrate agreement with
previously standard QA tools. The mean difference in dose levels reported by the PSD
and a standard ionisation chamber was 1.2%, whereas the differences in dose levels
reported by a PSD and a microdiamond detector was 1.9%. Also, to maintain perspective,
there was an average of 1.3% in reported dose levels between the micro Diamond detector
and a standard ionisation chamber (Madden et al., 2019).

2.6.5.8.2.

Electron beam radiation therapy:

Beddar and Krishnan (2005) provide details of “intraoperative” radiotherapy (for a
retroperitoneal sarcoma case) using a mobile electron LINAC. Such a therapy involves
surgically exposing the treatment area in the patient, delivering the required radiation dose
of high energy electrons, then restoring structures in the patient and suturing shut the
operation area. The advantage of this procedure is that the radiation does not need to
transit through vulnerable and irrelevant areas of the patient’s anatomy in order to reach
the sarcoma. Such a procedure is amenable to fibre detectors, since they can be sterilised
in the same way as catheters before being presented into patients for dose monitoring. In
ground-breaking work Takahiko Aoyama and Shuji Koyama et al. of Nagoya performed
depth-dose measuring device using a multichannel scintillating fibre array for electron
beam therapy (Aoyama, Koyama, Tsuzaka, & Maekoshi, 1997). Yoo and Shin et al. of
South Korea (2013) performed measurements for electron beam therapy dosimetry using
four transmitting optical fibres, and a multichannel light-measuring system for
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simultaneous measurements of pure scintillation and Cerenkov signals in an integrated
fibre-optic system (Yoo et al., 2013).

2.6.5.8.3.

Proton beam radiation therapy:

In late 2007, Archambault and Polf et al. studied proton beams and characterised the
response of miniature scintillation detectors when irradiated with proton beams (Louis
Archambault, Polf, Beaulieu, & Beddar, 2008). In 2011, Jang and Yoo et al. of South
Korea were studying proton therapy using multi-dimensional fibre-optic radiation sensors
for ocular (eye) surgery dosimetry (K Jang et al., 2012). In addition, Jang and Yoo et al.
were also studying proton therapy dosimetry using fibre-optic sensors utilizing Cerenkov
radiation as the principal means of dose measurement (Jang, Yoo, Shin, Shin, & Lee,
2012). A research group at the University of Adelaide also investigated the response of
silica and PMMA optical fibre when irradiated with 16.5 MeV proton beams (Asp,
Santos, Afshar, Zhang, & Bezak, 2019).

2.6.5.8.4.

Microbeam radiation therapy (MRT):

In 2017, Archer and Li et al. of CMRP at UOW (and other affiliates) published “Highresolution fibre-optic dosimeters for microbeam radiation therapy” in which they reported
achieving a spatial resolution of +/- 100 μm in micro beam radiation therapy (Archer and
Li et al., 2017a) (Archer, Li, Petasecca, Lerch, et al., 2017). In subsequent work in the
Australian Synchrotron, this research group claimed a world-first water-equivalent
polymer scintillator applied in a microbeam dosimetry system, with the highest spatial
resolution found in the literature: +/- 50 μm (Archer and Li et al., Scientific Reports,
2017b) (Archer, Li, Petasecca, Dipuglia, et al., 2017). In even more recent work
completed in 2018, this group refined their techniques further and attained a resolution of
+/- 10 μm by using the Australian Synchrotron at a dose rate of 4435 Gy/s. (Archer and
Li et al., Scientific Reports, 2019) (Archer, Li, et al., 2019).

2.6.5.8.5.

Small-field radiation therapy:

Due to the distinctive properties that scintillators possess over other conventional
detectors, a variety of scintillators have shown capabilities to be well-suited for advanced
therapeutic applications such as small field and microbeam scenarios. The possibility of
fabricating small-diameter and length scintillators, as tiny as desired, is an important
feature that renders fibre scintillators great candidates for treatment techniques where
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high spatial resolution is essential (S Beddar & Beaulieu, 2016). Furthermore, other
features include ease of manufacturing, handling, and fabrication in any size ranging from
centimetres to a few millimetres, depending on the desired applications. In that era a
photomultiplier tube was used to receive the light signal from the optical fibre. Beddar
and Beaulieu’s review article summarises many aspects of use and challenges of applying
FODs in small field scenarios (Beaulieu & Beddar, 2016).

2.6.5.8.6.

Internal radiation therapy (Brachytherapy):

Scintillation detectors have been introduced into clinical brachytherapy for dosimetry
purposes. In 2006, Jamil Lambert and Tatsuya Nakano et al. (Jamil Lambert et al., 2007)
assessed the dosimetric performance of a novel scintillation detector, the Brachy-FOD™.
This FOD was evaluated and compared to three commercially available detectors, a
diamond detector, a MOSFET, and LiF TLD, using an 192Ir HDR brachytherapy source.
The Brachy-FOD™ was found to be accurate to within 3% for distances of 10 mm to 100
mm from an HDR

192

Ir brachytherapy source in water. In 2008, The same group

subsequently investigated their developed Brachy-FOD™ for real-time dosimetry of
various Brachytherapy applications (Jamil Lambert, Suchowerska, Jackson, McKenzie,
& Law, 2008; Suchowerska et al., 2011). In addition. The use of scintillation detectors in
Brachytherapy, by other researchers, has been extensively covered in the book of
Scintillation Dosimetry (S Beddar & Beaulieu, 2016), and the review article (Beaulieu &
Beddar, 2016) published by Beddar and Beaulieu.

2.7. Photodetector options for scintillation fibre optic systems:
The implementation of scintillating detectors in radiotherapy applications entails the
utilization of proper photodetectors for the purpose of radiation quantification from
photon beams in the form of light to a measurable electrical quantity. Throughout the
literature, there were a number of studies that have investigated the optimal selection of
available photodetectors such as photo-multiplier tube (PMT), Charged Cabled Device
(CCD) camera, and photodiodes. The studies provide recommendations and concluded
that the choice depends upon the level of amplification needed for a specific application
(Beaulieu & Beddar, 2016).
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Photodiodes are so far much favourable as they can be read with electrometers converting
the scintillation light to an electrical signal and being cost-effective, affordable and much
easier than PMTs and CCDs (Fontbonne et al 2002, Beierholm et al 2014, Carrasco et al
(Fontbonne et al., 2002) (Beierholm, Behrens, & Andersen, 2014) (Carrasco et al., 2015).
Due to the unique features of photodiodes compared to other photodetectors, it was
employed with the commercial PSD, the Exradin W1 (Archambault et al 2013)
(L Archambault et al., 2013). Boivin et al conducted a systematic study of the
performance of multiple photodetectors. They investigated properties including signalto-noise ratio as a function of dose and dose rates over a wide range of photon energy
with an emphasis on selecting a proper photodetector based on the application (Boivin,
Beddar, Guillemette, & Beaulieu, 2015).
In a previous work by Aoyama et al (Aoyama et al., 1997), a photodiode amplifier system
was used to measure radiation dose and characterise electron beam qualities utilising a
scintillating plastic fibre detector. By considering the photodiode amplifier circuitry
presented in their work, it is possible to roughly predict the current received by the
photodiode and estimate the potential output voltage and amplification range defined by
gain settings. Further details with an estimation of electrical current induced in the optical
fibre core are shown in Chapter 4.

2.8. Existing QA tools for source localization during HDR
Brachytherapy:
The HDR source verification has been traditionally performed using radiochromic films
and the recent commercial Gafchromic EBT3 film (Evans, Devic, & Podgorsak, 2007).
Such type of films exhibits high resolution, but unfortunately lack capabilities of in-vivo
source tracking and real-time localization. However, with the rapid progression in the
advanced radiotherapy technology, the trend has been going toward the real-time QA for
acquiring immediate treatment feedback on site simultaneously. Therefore, HDR source
verification and positioning have been investigated by means of detector-based imaging
modalities such as Flat Panel Detectors (FPDs), MRI, Ultrasound, and Pinhole Camera
as covered below.
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2.8.1 Imaging-based modalities:
2.8.1.1. Transrectal ultrasound
Transrectal ultrasound (TRUS) is one of the mostly used imaging modality utilized for
the guidance of BT needles in prostate cancer (Applewhite, Matlaga, McCullough, &
Hall, 2001). Such type of imaging modality is an admirable option for viewing soft tissue
volumes accurately. Nevertheless, it demonstrated a limitation of catheter position
verification, and this is due to its poor spatial resolution. For the purpose of verifying
catheter positions during treatment planning, TRUS is commonly integrated with
Computed tomography (CT). Visualisation of the prostate volume utilising CT imaging
can be problematic and the reason behind that is the low contrast introduced among soft
tissues. Furthermore, the movement of organ or applicator during imaging and treatment
course could adversely affect the accuracy of the dose distribution delivered to the organ
of interest. This can be avoided when imaging procedure was performed immediately
before conducting the actual treatment course (Batchelar et al., 2016).

2.8.1.2. Magnetic resonance imaging
Magnetic resonance imaging (MRI) is another highly-in-demand imaging modality which
has been implemented as an imaging technique used for treatment planning of the prostate
brachytherapy (D'Alimonte et al., 2017; Ménard et al., 2004). The image resolution of the
prostate volume is significantly improved, compared to TRUS imaging considered, which
is one of the advantageous features of using MRI for this purpose. However, it is relatively
an expensive technique and is still yet not a feasible selection for many treatment facilities
and patients who have internal metallic implantation that is non-MRI-well-suited such as
pacemakers or prostheses.
The previously discussed clinical approaches heretofore are normally practical
preoperatively for catheter position verification because they do not tolerate for
capabilities of intraoperative real-time verification of the HDR source position. However,
there has been an ongoing interest in quality assurance for HDR brachytherapy with
considerable amount of the current research’s orientation that is driven towards the
advance of real-time QA tools for the HDR source position and tracking. MR-based realtime source localization method has been developed as a real-time imaging modality for
HDR Brachytherapy (Beld et al., 2018). The HDR source localization was carried out by
simulation of the MR artefacts, and then followed by a correlation algorithm that is
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applied to the simulated images and MR. The accuracy of the HDR source localization
was successfully achieved and found to be within 0.4–0.6 mm and then was validated
using CT images.

2.8.1.3. Electro-magnetic tracking (EMT):
Electromagnetic tracking (EMT) is another approach which was introduced to reconstruct
implant and detect errors, applying fiducial sensors which was fixed inside catheters in
Brachytherapy (Bert, Kellermeier, & Tanderup, 2016). The proposed system was feasible
with an accuracy of less than 0.9 mm when applied in disturbances- free environments
such as metals which could block the path of the electrometric field. A pair of singlepixel gallium nitride (GaN) probes has been used and then investigated in a earlier study.
The probes were employed for real-time HDR brachytherapy source verification in by
being implanted at two pre-defined positions along the entire length of the HDR
brachytherapy catheter (Wang et al., 2014). The dose rates at the two defined probe
positions were measured and found to be within approx. 1% of the prescribed dose. The
dose rates measurements led successfully to the estimation of the HDR source dwell
position within the catheter. However, the only information can be provided is about the
source location in the dimension that is parallel to the catheters. The study has shown that
maximum uncertainty was found to be around 1 mm which was over a range of
approx.105 mm.

2.8.1.4. Digital X-ray imaging:
The use of the digital X-ray imaging with direct-conversion flat-panel detectors (d-FPDs)
was proposed as a potential technique for the HDR brachytherapy source position
verification QA by Miyahara et al (Miyahara et al., 2015). In addition, the evaluation of
both the temporal and spatial (2D) accuracy was achieved for the HDR

192

Ir source

positioning against a radiographic source using positional check ruler, and then a quick
check of the three dwell points using the d-FPD system to with successive weekly
imaging. The demonstration of results obtained confirmed the effectiveness of a d-FPD
to be clinically employed as a QA tool with measured dwell positions and were within 1
mm compared to the planned positions along the axis that is parallel to the catheter.
However, a limitation for this system is that 3D spatial details are not attainable as the
acquisition was only performed from one angle and the extra dose is relatively significant
that is delivered by the external x-ray source.
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2.8.1.5. 3D Brachy-View:
More recently, the Centre for Medical Radiation Physics at the University of Wollongong
has successfully established a 3D HDR brachytherapy source tracking system for the
prostate called HDR BrachyView. A real-time in-body (rectal) gamma camera probe is
an attractive feature of the developed system which employs a cylindrical 7-pinhole
tungsten collimator along with an array of pixelated silicon detectors which characterized
by high-resolution property (Alnaghy et al., 2016; Llopart, Ballabriga, Campbell, Tlustos,
& Wong, 2007; Mitra Safavi‐Naeini et al., 2015; M Safavi‐Naeini et al., 2013). Another
research study successfully demonstrated the original experimental validation of a wideranging real-time image acquisition HDR Brachy-View prototype with integrated TRUS.
The accuracy of source position estimation for both integrated systems were
experimentally investigated. Furthermore, a tissue equivalent gel prostate phantom was
used to validate a full clinical HDR treatment plan for the developed real-time DAQ
system. The capability of Brachy-View system was evaluated and shown that around 78%
of a total of 200 source positions were successfully measured with an overall accuracy
was found to be better than 1 mm (Alnaghy et al., 2019).

2.8.2 Dosimetry modalities:
The use of silicon-based radiation detectors was not limited to only dosimetry purposes
but also got employed for the verification of real-time HDR source tracking. Innovative
class of advanced 2D array silicon-based detectors, called “Magic Plate” detector, is
developed by the Centre for Medical Radiation Physics (CMRP) at the University of
Wollongong. Espinoza and et al (Espinoza et al., 2013; Espinoza, Petasecca, Cutajar, et
al., 2015; Espinoza, Petasecca, Fuduli, et al., 2015) worked extensively with a 2D CMRP
“Magic Plate 121 (MP121)” detector, and reported source localization accuracy of better
than 1 mm and timing resolution of 0.1 s. Another extended work by Poder and et al
(Poder et al., 2019; Poder et al., 2018) subsequently worked with an advanced 2D Magic
Plate of 900 detector elements. The simulation study demonstrated a source position
reconstruction accuracy of 11.9 ± 2.4 mm when using a Trans-rectal Ultrasound Source
(TRUS) probe and 1.5 ± 0.3 mm without the TRUS probe. These devices have shown
great potential for comprehensive HDR quality assurance procedures such as real-time
source verification, position determination, and relative accurate dose measurements.
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A recent interesting work was carried out by Haydee and et al (HM, Archambault,
Beddar, & Beaulieu, 2020; Linares Rosales, Duguay‐Drouin, Archambault, Beddar, &
Beaulieu, 2019) employing optimized three-point fibre optic sensor used for in vivo HDR
brachytherapy measurements. The system was composed of three scintillators with BCF60, BCF-12, and BCF-10 optimised for different wavelengths, and scintillation signal was
read by photomultiplier tubes (PMTs). The main findings showed a maximum
measurement uncertainty of 17 % for the BCF-60 scintillator at 10 cm from the source.
Overall, the system provided an average location accuracy with a standard deviation
under 1.7 mm. However, the maximum observed variation between measured and
expected values were found to be 1.82 mm and 1.8 mm in the x- and z-directions.

2.9. Research gaps identified in the research literature:
A review of the literature which has appeared during the research and writing of this thesis
reveals there is no clear understanding that scintillation detectors using optical
transmission fibres are inexpensive, convenient, fast, accurate, needing only infrequent
calibration and fairly immune to influence of unwanted effects. Only if working at low
dose rates or in dose field edges may it become necessary to make a small, easy correction
for stem effect signals (fluorescence and Cerenkov radiation). There are also very few
publications recognising that this is a promising technique for convenient and accurate
quality assurance (QA) for both dose measurement and HDR source verification in
Brachytherapy.
Based on the literature search which has been periodically updated throughout the time
of the research and thesis-writing, the following strategic gaps found in the topic matter
covered by existing journal and conference publications:
1. The majority of commercial DAQ systems for scintillation dosimetry are based
on high gain amplification photodetectors such as PMTs, and CCD arrays which
are very expensive for primary health care applications.
2. Based on the circuit presented by Aoyama et al (Aoyama et al., 1997) and the
amplifiers being used with such high gain, it is assumed that noise and drift could
be a problem. In addition, the photo-voltaic mode for the photodiode was chosen
to lower the dark current of the selected photodiode as it is negligible in this mode.
However, it is viable to design a similar amplifier circuit and further improve it to
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reduce drift and noise in a way that assists in fulfilling the target of real-time
tracking of the HDR Brachytherapy source.
3. Only a few publications recognise that inorganic based crystal detectors such as
CsI(Tl) shows a great potential for dosimetry and can be employed for both
dosimetry and source verification and tracking due to their higher light output
compared to polymer scintillators.
4. No existing system described in the literature seems to have been designed with
overall economy in mind, using readily available technical components. The
equipment needed for cancer therapy is already in the most expensive category of
hospital instrumentation costs, and health departments have finite budgets. Using
optical fibres and a photodiode front-end to the DAQ system allows a standard
instrumentation amplifier to perform accurate, reliable and repeatable dosimetry
measurements. Other benefits and versatility include the ability to operate in either
of two modes (photoconductive or photovoltaic).
5. There is also no clear recognition in the literature that a fibre DAQ system such
as described in this thesis research can be accurately calibrated without needing a
hospital environment (i.e. without needing to reserve and occupy time in the
patient treatment room). Instead, most of the routine calibration needed to verify
that measured output signal accurately reflects received dose can be done in the
lab without needing any sources of ionising radiation.
6. It is possible for the fibre detector and amplifier system to be relatively portable
and operating at low DC voltage with very low power requirements. A fibre optic
radiotherapy dose-monitoring and/or source localising system can be packaged as
an ALL-IN-ONE QA tool for HDR Brachytherapy.
7. Existing literature does not recognise that this system is commercially versatile
and could also be used for other industrial applications such as dose monitoring
in hard-to-reach or dangerous environments.
8. Existing literature describes some multi-channel systems for radiotherapy
measuring and monitoring, but there is no publication mentioning a low-cost
system such as ours coupled to a multichannel rather than single-channel DAQ,
whereby a suite of scintillating detector fibres (and, optionally, non-scintillating
fibres for “Background” monitoring) can be simultaneously read at one time.
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Materials & Methodology:
3.1. Overview:
Carrying out such a multidisciplinary research project at CMRP where an HDR fibre optic
quality assurance tool is to be developed requires a vast amount of work based on the
experience accumulated from the previous generation of fibre, sensor and dosimetry
technology. Fabrication of the radiation detector with attainable specific properties, and
progressive development of suitable readout systems required parallel developments
combined to fulfil the ultimate goal of the project. The Materials used to conduct the
project and the methods developed for detector fabrication, the Data Acquisition System
(DAQ) readout systems, and clinic-related apparatuses have been comprehensively
illustrated. This chapter will demonstrate in-depth all the materials utilised, along with a
practical demonstration of methods developed for both in-lab preparations and clinicalbased experimental procedures.

3.2. Scintillation Detector:
3.2.1 Scintillating optical fibre:
Scintillating detectors have been purchased from Saint-Gobain Crystals (SGC) USA. The
standard plastic fibre produced by SGC consisting of a polystyrene-based core and a
PMMA cladding. As table 1 shows, the BCF-60 is a scintillating plastic single-clad
multimode fibre with a diameter of 1mm where the cladding thickness forms around 3 %
of the fibre’s diameter. The light yields for this type of fibre are about 7100 photons per
MeV from a minimum ionizing particle at a wavelength of 530 nm. Another scintillating
detector used was CsI (Tl) Thallium activated Caesium Iodide (also called ThalliumDoped Caesium Iodide, as Thallium is the doping agent that is used to activate this type
of scintillator). CsI (Tl) has been known as one of the brightest scintillators where light is
mostly emitted at the long wavelength at 550 nm with light yields of (52 – 56) × 10³
photons per MeV. The crystal used was 3mm long with a diameter of 1mm.
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Detector

Emission
colour &
Peak

Decay
Time

No. of photons
per MeV

BCF-60

Green
530 nm

7 ns

7100

CsI (Tl)

Green
550 nm

1 µs

52- 56 x10³

Notes
Scintillating plastic Multimode fibre
Core (Polystyrene n1= 1.60), Cladding
(Acrylic n2= 1.49)
Refractive index at emission maximum
1.79

Table 3.1: Properties of the scintillating detectors used which are produced by SGC, USA

3.2.2 Transmission (waveguide) fibres:
This type of non-scintillating fibre that was used to guide the light emitted from the core
of scintillators used. BCF-98 was a standard guide-light cable produced by SGC. Another
clear plastic optical fibre used was CK-40 (Eska) which is a single-mode optical fibre
cable known for low attenuation over long distances.
Waveguide

Emission
colour &
Peak

Decay
Time

BCF-98

N/A

N/A

CK-40

N/A

N/A

Notes
Non- scintillating plastic Multimode fibre,
Clear waveguide
Non- scintillating plastic single mode fibre,
Clear waveguide

Table 3.2: Properties of transmission fibres used which are used as light waveguides

3.3. Fibre optic termination:
Terminations of optical fibres requires specific tools to terminate the cables with a desired
connector. However, a standard plastic optical fibre termination tool kit can be a good
option to undertake this task, but it may not include all tools, so some tooling may need
to be purchased separately. The followings are the main tools that have been used to
perform the task.

3.3.1 Optical fibre termination tool kit:
POF Tool Kit (Industrial Fiber Optics, USA) is a standard tool kit which consists of a set
of general-purpose tools required to terminate plastic optical fibre cables. Please refer to
the manual for more details.
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-

Connector Crimp tool:

The crimp tool (USA) was used to terminate standard connectors for optical cables such
as SMA, FC, SC, and ST connectors.
-

Room temperature curing two part-blue epoxy:

This is a room temperature-curing optical connector adhesive (USA) which is blue in
appearance when thick and consists of two parts which have a reasonably long working
time when mixed.
-

Araldite Ultra Clear Epoxy Adhesive:

This is a fast-curing two-part epoxy adhesive (Selleys, Australia) that is ultra-clear,
making it ideal for fibre ends to be optically coupled where a matching-index adhesion
(i.e. invisible bond) is highly required. UHU super glue ultra-fast adhesive solution (UHU
GmbH & Co. KG, Germany) proved to be an alternative option and showed strong
bonding ability of two fibre ends within a few seconds.
-

SMA 95 -Style Connector:

SMA 905-11040A (Thorlabs Inc, USA) is a standard multimode connector for optical
fibres with a stainless-steel ferrule which is ideally suited for large core fibres.
-

LC polishing puck:

This type of polishing puck is used to polish the naked fibre end with a diameter of 1 mm.
-

SMA Polishing Puck:

This type of metal stainless polishing puck is used to polish the SMA terminated-fibre
end where the ferrule diameter is much larger than the diameter of the bare fibre.

Figure 3.1: Plastic optical fibre termination tool kit with other additional tools that are
not included with the standard tool kit
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3.3.2 Fabrication and preparation of the fibre optic probes:
Fig 3.2 shows the steps required with materials shown in Fig 3.1 to prepare an optical
fibre probe with desired properties for radiation detection. The procedure divides into
three main processes as follows:

3.3.2.1. Termination process:
1. The desired length of non-scintillating plastic fibre was cut using the cutter by
holding the fibre straight to get a fine sharp cut with a soft, homogenous end.
2. Room temperature curing of the two part-blue epoxy is dissolved in a warm water
for around 10 minutes and then the two-part epoxy was hand-mixed for five
minutes till it is homogenously mixed.
3. The prepared fibre was terminated with a standard male SMA connector by gluing
the body of the fibre to the ferrule of the SMA connector using the epoxy supplied
via a syringe.
4. Upon making sure that the ferrule had enough epoxy inside, the fibre was pushed
the whole way through until the tip of the fibre end emerges. A period of 24 hours
was to be allowed for the fibre and connector to become totally adhered.
5. Using the cutter, the protruding fibre must be cut so that its length exactly matches
the top surface of the SMA body as seen in Fig.3.2 A - D

3.3.2.2. Hand-polishing process:
1. Both ends of SMA-terminated fibre must be polished using polishing glass,
different thicknesses of polishing films, and an LC polishing puck for the bare
fibre and or an SMA puck for the SMA-terminated fibre. The polishing is done
by abrading the connector on the polishing glass surface until the resistance of the
fibre to motion vanish is minimised.
2. A of “Figure Eight” abrasion path should be followed five times for each fibre to
be polished. This will allow removal of residual glue contamination that might
prevent light from being smoothly transferred and increase the optical reflection
within the core.
3. A microscopic eye-check was performed to inspect the fibre end face after
polishing, and to decide whether the fibre surface is satisfactory, or the fibre needs
to be polished again as seen in Fig.3.2 E & F.
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3.3.2.3. Optical coupling:
1. A desired length of the scintillating material either a crystal Thallium-Doped
Caesium Iodide CsI (Tl) or polymer fibre (BCF-60) such as must be polished at
both ends, and then optically coupled to the non-scintillating fibre by a suitable
adhesive glue as seen in Fig.3.2 C & D
2. A hollow tube of diameter slightly larger than the fibre’s diameter can be used to
accommodate both fibres’ ends and handle the attachment process comfortably.
The fibres are adhered to the inner wall of the hollow tube. This technique allows
the fibres to be adhered in place, aligned and facing each other, without the need
to have any adhesive in between the critical transmission faces (which might
prevent the smooth transmission of the optical signal) as seen in Fig.3.2 B & C.
3. Adhesive optical grease with a matching refractive index is to be applied to
perform optical coupling of the end of the previously prepared non-scintillating
fibre probe to the required scintillating material. This ensures that the total internal
reflection (TIR) is minimised at that interface and hence minimises losses due to
poor optical coupling as seen in Fig.3.2 C.
4. It is recommended to coat the end face of the fibre that is going to be irradiated
with a high Z-number material like Titanium Dioxide-(TIO2)-based-reflective
paint. This promotes reflection of photons, which significantly assists in
increasing the efficiency of the optical signal produced as seen in Fig.3.2 H.

Note: a plastic scintillating fibre can be coated with such a high Z reflective paint, but this
does not apply to the crystal as it is susceptible to damage by any water content in the
paint.
A

E

B

F

D

C

G

H

Figure 3.2: Practical demonstration on optical fibre preparation and coupling.
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3.4. Photodetector:
3.4.1 PIN-photodiodes:
This part represents the light-sensing detector, inserted into a female receptacle-to-SMAconnector, used to convert the optical light produced into measurable electrical signal.
PIN-photodiodes with a different active area and dark current were chosen as the
following:

Photodiode

Packaging

S1223
S1223-01

TO-5

BPW21
BPX61

TO-18

Effective active

Maximum Voltage

area (mm2)

Vmax (V)

6.6

30

0.1 nA at VR= 20 V

13

30

0.2 nA at VR= 20 V

7.45

10

7.02

32

2 nA at VR= 5 V
2 nA at VR= 10 V

Dark current

Table 3.3: Properties of PIN-photodiodes used with different wavelength sensitivities.

3.5. SMA-to-photodiode receptacle:
Insert Fibre Optic standard SMA Connector to a TO5 receptacle for multimode fibres
(Amphenol, USA) was best-fitted for securely inserting the selected photodiode to
maintain high level accuracy of optical coupling.

Figure 3.3: PIN-photodiodes with a receptacle

3.6. In-lab design of a photodiode-housing assembly:
Following a construction method illustrated in Fig 3.4 illustrates, photodiodes were
assembled into a receptacle to allow them to be ideally interfaced with optical fibres
carrying photons to be measured. A sketch shown illustrates that - after cutting the key
(tag) out of the diode’s case - the diode can be pushed and held in the receptacle by a
piece of polymer tubing which crumples slightly (compressing as a spring) between the
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retaining plate and the flat front of the SMA receptacle. The hole in the compression plate
(around 5 mm) is large enough to pass the leads of the diode, but smaller than the tube
diameter. However, it was observed that the cathode of the PIN diode was connected to
the case, which hence needed to be electrically isolated so that it is not electrically
connected to the SMA hardware (which may be earthed to equipment earth) which assure
that no additional noise can originate from inconsistent mounting. Isolating the body of
the photodiode is performed by wrapping the photodiode with a Teflon™ tape so that there
is no electrical conduction to its case when it is physically attached to the diecast amplifier
box. By having only one receptacle for multiple diodes, the assembly must allow for
quickly and smoothly changing diodes interfaced to the receptacle.

Figure 3.4: Sketch illustrating a proposed photodiode-housing assembly to a female receptacle

3.7. Electronic readout systems:
This section documents the design and adaptation of the electronics and readout system
implemented to carry out the planned experimental work. The configuration of readout
systems developed are shown as the following:
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3.7.1 CMRP operational trans-impedance photodiode amplifier:
The in-house design of trans-impedance photodiode amplifier system for the purpose of
HDR radiation detection is shown in Fig. 3.4. The photodiode amplifier was designed to
combine a process of two stages. The final prototype for the in-house CMRP designed
photodiode amplifier with the electronic circuit is illustrated below. Design and
description of this system will be extensively discussed in Chapter 4.

Figure 3.5: Illustration of the final prototype of the CMRP-deigned photodiode amplifier

3.7.2 Upgraded CMRP (MkII) operational trans-impedance photodiode
amplifier:
The first prototype of the CMRP photodiode amplifier system was only operated in
photoconductive mode, so it was decided to upgrade the initial version of the CMRP
amplifier (Op-Amps and discrete components on perf-board) to a newer version with a
printed circuit board (PCB) layout with two operating modes, and two photodiodes
channel with different wavelengths. The final prototype for the in-house upgraded CMRP
(MkII) designed photodiode amplifier with the electronic circuit is illustrated below.
Design and description of the upgraded CMRP (MkII) system will be extensively
discussed in Chapter 5.

Figure 3.6: Illustration of the upgraded version of the CMRP-deigned photodiode
amplifier
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3.7.3 Gigahertz-Optik

operational

trans-impedance

photodiode

amplifier:
For the benefit of getting a more sensitive photodiode amplifier-based DAQ system for
all of our scintillating fibre detectors, a commercially available Gigahertz optik transimpedance photodiode Universal amplifier (P-9202-5 - USA) was in-house adapted to fit
for the purpose of HDR radiation measurements. The final prototype for the Gigahertz
Optik photodiode amplifier as a readout DAQ system is shown below. Design and
description of the adapted Gigahertz-Optik amplifier system will be extensively discussed
in Chapter 6.

Figure 3.7: Illustration for physical components of the Gigahertz Optik photodiode
amplifier DAQ system after modifications

3.7.4 Design of adjustable green Light Emitting Diode (LED) Opto
testing system:
The green Light Emitting Diode (LED) testing system was built in-house with an
adjustable light intensity to allow evaluating the performance of the proposed systems
prior to carrying out the actual ionising radiation tests in a Brachytherapy treatment room.
It also provides a hospital-like environment by simulating green light intensity that is
matched with the wavelength of the selected scintillating fibre, simulating the interaction
of photons which would be produced by an HDR (eg:

192

Ir) source with our proposed

fibre optic systems, and adjustable current in which is commensurate with expected
current induced in the photodiode upon interaction of the scintillating fibre with an 192Ir
source. This green LED testing system also allows testing and calibrating the remainder
of the measuring system within the lab to simulate the exact experimental conditions
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expected in the clinic. This is to make sure that the fibre optic system is behaving ideally
and suitable for further clinical tests and ready to be tested under ionising radiation
conditions. By performing well with the green LED testing system, the proposed system
should be able to function well under actual radiation conditions. The in-house designed
adjustable green (LED) as a simulating system for the proposed amplifiers was
demonstrated in Fig. 3.7.

3.7.4.1. Design:
Electronic components illustrated in Fig. 3.7 mentioned below of the circuit were
included inside a shielded box to maintain protection against ambient light. The
scintillating fibre probe was inserted into the LED housing with the fibre tip being
immediately alongside the LED for the sake of light exposure when shining into the
sensitive volume of the fibre (scintillating part) 1 m of clear fibre was provided, connected
to the photodiode in the exterior DAQ system. The intensity of green light was controlled
and regulated by adjusting the current through the LED to a defined value matched with
the desired output voltage.

Figure 3.8: Electronic circuit of the Opto green LED testing system and view inside circuit housing
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3.7.5 In house based- current-voltage (I-V) tracer system:
A current-voltage (I-V) study of the selected PIN diodes was performed utilising a
Keithley 230 programmable voltage source in order to apply the detector bias. A Keithley
199 System DMM/Scanner and Keithley 614 Electrometer, coupled to the voltage source,
is used to measure the reverse current across the diodes. The I-V characteristic curves can
be used to evaluate the consistency of the detectors’ performance ready for routine
production, study the effect of noise due to ambient light illumination, and investigate
proposed setups of fibre-probe combinations and assess the effectiveness of the light-tight
jacket used.

3.7.5.1. IV Characteristics analysis:
In this section, current-voltage (I-V) analysis and experimental methods of acquiring IV
curves for selected PIN- photodiodes are described. Four types of different PIN- diodes
were tested before irradiation and prior to being attached to the photodiode’s amplifier
shielded-box. A negative bias (from 0 to -20 V) was applied on the diode, and current
was measured across the P-N junction. During the measurement process, the PIN-diode
was placed in a light-tight enclosure at normal room temperature (~295 K) and dark &
normal ambient light illumination were used to replicate the conditions in which the
diodes would possibly be used during clinical applications. Fig. 3.8 displays the diagram
of IV setup for in-house testing the PIN diodes, illustrating the apparatus used to capture
the IV curves using in-house developed IV tracer system,
The data measurements and parameters were controlled by a custom LabVIEW software
driver. This software has the capability to self-determine the parameters of the experiment
as appropriately fitting for the purpose such as positive & negative voltage ranges, step
size amplitude and delay time interval. Furthermore, the software interface exhibits the
variation of the current as a function of the bias applied on the diode terminals with the
increment that was previously defined by the user. However, the current range is to be
manually adjusted gradually from a smaller value (at pico-scale) toward a higher value
(at nanoscale) if measurements acquired have been found to be out of the range.
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Figure 3.9: In-house setup of IV tracer system illustrating the apparatus used to capture IV curves

3.8. Power supply:
3.8.1 Regulated AC coupled-power supply:
The mains power-driven supply (Ac- coupled) used for our amplifiers was adapted for
our purpose using Zener diodes to limit the output voltage to be compatible with the
required operating voltage of the amplifiers used. Fig. 3.9 and 3.10 show the configuration
of the regulated mains power supply that was adapted in-house with the power socket for
both amplifiers’ systems.
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Figure 3.11: Illustration of the regulated power supply adapted for CMRP amplifier

Figure 3.11: Illustration of the regulated power supply adapted for Gigahertz Optik amplifier

3.8.2 DC coupled-power supply:
A pair of × 12V 1.3 Ah (non-spillable) Sealed Lead Acid (SLA) rechargeable battery
(Australia, JayCar SB2480) has been chosen as a bi-polar DC power supply for the
proposed fibre-optic system used for HDR brachytherapy. This type of DC power supply
is highly favourable for this application as it does not generate noise. An AC switch mode
power supply would be unsuitable. For ease of use, as shown in Fig, 3.11 that both SLA
batteries were included in a metal box and connected through wires to a microphone plug
which will be plugged into a microphone socket on the amplifier box to provide the
bipolar power supply for the amplifier. A 0.3 amp poly fuse was added as a safety feature
to protect the wiring and prevent fire if there is a short circuit.

Figure 3.12: Rechargeable sealed lead acid (SLD) battery adapted for our DAQ system
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3.9. Data logging systems:
Data logging systems (Single & Multichannel Channels) were applied and incorporated
with the introduced fibre optic systems to serve as data loggers for real-time acquisition
and monitoring of HDR brachytherapy applications

3.9.1 Single channel ACT Data Logger:
The EL-USB-ACT Data Logger (Lascar Electronics Inc. US) is a suitable for a wide
variety of applications. The logger is supplied with free software and a friendly interface
that allows the user to view downloaded data by plugging the data logger into a PC’s USB
port. The data stored upon acquisition over time can then be flexibly graphed, printed and
exported to other applications for additional data processing and manipulation. USB Easy
Logger was used to readout scintillation signal in the form of electrical voltage. For both
DAQ systems, the gain applied was carefully selected to suit the dynamic range of the
datalogger used which has a maximum voltage output capability of 1284.7 mV.
Therefore, the gain for each experiment was adjusted to a reasonable sensitivity setting
to ensure that the maximum response of the scintillation signal was just slightly less than
the maximum dynamic range of the datalogger.

3.9.2 HOBO 4-Channel Analog Data Logger (UX120-006M):
The HOBO UX120-006M Analog Data Logger (Oneset, USA) is a high-performance
device that has four channels which is ideally suited for real-time data logging of different
monitoring applications. A Voltage Input Cable (CABLE-2.5-STEREO) was chosen to
be incorporated with this data logger to readout the signal.

Figure 3.13: The EL-USB-ACT single-channel data logger is shown (left-hand side), with
the HOBO UX120-006M Analog four-channel data logger also shown (right-hand side)

Page 3-47

3.10. Phantoms:
3.10.1 Solid-water phantom:
Gammex RMI457 Solid Water phantom of different slab thicknesses were used with most
of the work performed in order to mimic human tissue and replicate the interactive
medium where the detector will be placed.

Figure 3.14: Illustration of Gammex RMI457 Solid Water phantom

3.10.2 . Water-gel phantom:
A water-gel phantom is an alternative option to a solid “water” phantom that can be used
for performing experimental tests to mimic the actual clinical scenario for any HDR
treatment case. A box to include the gel and hold the catheters in place was designed inhouse. The box designed for that purpose assisted to function as a standard HDR
applicator that allows multiple catheters to be simultaneously inserted within the
treatment volume. In this section, a demonstration of the preparation process for the
water-gel preparation is shown as follows:
1. Add 100 ml of boiling water to the container.
2. Add 2 g of Gelatine Powder for each 100 ml and mix until completely “dissolved”
3. Add another 8 g of Gelatine Powder gradually and make sure it is completely
dissolved with hot water.
4. Add400 ml of normal water and continue mixing the components together
5. Make sure you have 500 ml of suspension that is completely homogenous.
6. Add the gel suspension from the container to the phantom mould using a strainer for
filtration to eliminate impurities.
7. Transfer the phantom mould to a refrigerator for several hours until it becomes a solidlike gel.
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Figure 3.15: Step by step- illustrative procedures for in-house preparation of water-gel phantom

3.10.3 . Perspex solid “water” phantom:
This sketch shows the design of the Phantom Tower clamp assembly that has been used
for the purpose of carrying out radiation measurements for high dose rate brachytherapy.
The material used in this phantom is made from Polymethyl Methacrylate (PMMA or
Perspex™) in order to provide a tissue-equivalent medium that mimics the radiationabsorbing properties of human tissue. To mimic the size of an adult human (male) prostate
gland, five sets of 10mm PMMA slabs were used to achieve a 50 mm total phantom
thickness. For achieving the backscatter and build-up conditions, 75 mm extra thickness
of support blocks were added to both the top and bottom (3 × 25 mm slabs glued together
with Chloroform (bonding agent) which takes about 30 mins to set).
Phantom blocks were designed in CAD and the file downloaded to a Laser Cutter. Laser
Cutting was then used to produce the squares (90 mm × 90 mm) from 10mm thick
Perspex. Then, 3.90 mm diameter holes were drilled in the phantom. The other 25 mm
thick blocks were prepared on a milling machine to produce a excellent finish. The holes
were then drilled to the required / stated depths as modelled in CAD. Also, other phantom
blocks with a 5mm spacing, were designed in the same way as outlined above.
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Figure 3.16: Phantom design for of HDR brachytherapy source verification

3.11. Clinical HDR Brachytherapy apparatus:
The successful implementation and experimentation with the proposed fibre optic tool for
clinical HDR brachytherapy quality assurance requires initial arrangements of HDR
brachytherapy facilities. This includes a previous-preparation of appropriate Gammex
RMI457 Solid Water phantom & water-gel phantoms that precisely assure accurate
clinical measurements. By carefully taking these steps into account, it will assist to satisfy
the requirements of the experimental plans and practically mimic the real clinical situation
in which the proposed systems is to be clinically investigated. The following section will
introduce the materials & methodology that should be considered for carrying out clinical
measurements within a HDR brachytherapy room.

3.11.1 . Treatment Planning System:
A dedicated workstation known as the treatment planning system (TPS) was used to
define the volume, organ at risk, planning target volume, and the position of the catheter
within the volume treated. It also performs the treatment planning for the afterloading
delivery of the HDR 192Ir source as clinically prescribed. For all experiments introduced
in this thesis, Nucletron ONCENTRAR TPS version 4.5 (Nucletron, Elekta, Sweden) was
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applied to determine the placement of the HDR source inside the catheter, intended total
number of dwell positions and dwell times which define the time of the HDR source spent
at each position. In our case, a solid “water” slab that includes the HDR catheter (inserted
the whole way through) was CT scanned. Thereafter, this CT image was imported to the
TPS and a number of dwell positions (#37 positions along the 9 cm × 9 cm slab) were
defined and then digitized using the TPS Oncentra interface as depicted in Fig. 3.16.

Figure 3.17: CT image used for TPS dwell position digitisation (Left), control panel for HDR
brachytherapy source delivery (right)

3.11.2 . Nucletron HDR after loading machine:
The Nucletron microSelectron® mHDR-v.2. afterloader produced by Nucletron
(Nucletron, an Elekta company, Stockholm, Sweden) was used as an afterloading
machine to deliver treatment fraction HDR

192

Ir brachytherapy source. The HDR

192

Ir

source is delivered through the programmable remote afterloader, to pre-determined
dwell positions within the targeted treating volume, using a transfer tube that is connected
to the remote afterloader. Specific types of applicators, particularly designed for a variety
of HDR treatment options, are applied to control the delivery process via F6 gauge
catheters that are inserted into the treatment volume to accurately deliver the source to
the specific area of organ at risk.

Figure 3.18: Nucletron microSelectron® mHDR-v.2. afterloader produced by Nucletron
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3.12. Overall clinical based- experimental methodology:
This section presents the overall experimental setup along with the main methodology
utilized to acquire the clinical based-data for a variety of investigative research questions.
Investigations were done for pre-clinical optimisation of the proposed system and basic
characterisation of radiation response of selected fibre optic scintillating detectors upon
interacting with an HDR 192Ir Brachytherapy source. Progression in this research project
has led to an in-depth pre-clinical investigation and acquisition of positional sensitivity
of the proposed system when the 192Ir source is consistently dwelling within a Perspex™
phantom or gel-water phantom customized especially for this purpose. This significant
step has resulted in creation of look-up tables for positional sensitivities of both
scintillation detectors that can be easily applied to accurately identify the actual position
of the HDR source within the phantom with a requirement for some other factors to be
considered for additional required corrections.
The general experimental setup is demonstrated in Fig. 3.18 below. This setup has been
applied throughout the experimental procedures to fulfil the goals of the project. The
research methodology is almost identical for most of the work done unless otherwise
stated. In some chapters there are some minor amendments mentioned for specific goals
to be achieved experimentally.

Figure 3.19: Over-all experimental setup performed within Brachytherapy room which fulfills all
experiments’ requirements
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Design and evaluation of a CMRP transimpedance photodiode amplifier as an optical fibre-based dosimetry
system for brachytherapy quality assurance

4.1. Introduction:
In the explosive era of science and technology, fibre optics has emerged as a state-of-theart technology worldwide and has witnessed a tremendous growth in recent years. The
advantages of optical fibres are known and appreciated: they are dielectric, immune to
electromagnetic interference, flexible, and small in size, which has attracted the interest
of users around the world, and thus found various innovative applications (Udd &
Spillman Jr, 2011). The progression of fibre optic technology has been hugely noticeable,
not only being used as an ultra-fast data transferring method in telecommunication
(Willner, 2019) but also evolved as optical sensors for numerous sensing applications
ranging from industry to medicine (Narayanaswamy & Wolfbeis, 2013) (Cusano, Cutolo,
& Albert, 2011). Hence, fibre optic sensing applications have been employed with optical
sensors widely implemented in industrial environmental applications for remote
measurements and monitoring of pressure, temperature (Cusano et al., 2011), other oil
industry parameters (Kersey, 2000), and hard-to-reach or hazardous environments
(Delepine-Lesoille et al., 2012) (Woliński, Domański, Ertman, Goleniewski, &
Wydmański, 2007). In addition, the use of optical fibre sensors is noticeable in medical
applications for endoscopic imaging (Fujimoto, 2003) and blood flow measurement
(Heijmans, Cheng, & Wieringa, 2009).
Quantification of radiation by means of scintillation mechanisms was introduced in the
last century (Knoll, 2010). Radiotherapy nowadays, including external & internal beams
or so-called Brachytherapy, is one of several techniques that have benefited from
implementing scintillation fibre optic detectors in clinical scenarios as quality assurance
(QA) tools to monitor radiation delivered to cancer patients during their actual treatment
sessions. More recently, there has been a huge interest in utilizing fibre optic-based
systems in radiotherapy treatment rooms to verify radiation doses especially in
Brachytherapy where a high dose rate (HDR) radioactive source, typically

192

Ir, is

temporarily inserted in or close to tumours to destroy cancerous cells (Beaulieu & Beddar,
2016) (S Beddar & Beaulieu, 2016).
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Several types of photodetectors such as photomultipliers (PMT), Charged Coupled
Devices (CCDs), and PIN photodiodes have been widely applied in dosimetry
applications to quantify radiation received by patients which in turn assures the safe
delivery of treatment as clinically prescribed. The ever-increasing use of photodetectors
has recently extended to photodiodes mostly used for visual optical applications owing to
their cost-effectiveness, small size, low operating voltage, and multiple operating modes
that are the most advantageous features attracting attention over other conventional
photodetectors (S Beddar & Beaulieu, 2016). Due to the importance of fibre optic-based
systems in today’s technologies, there has been a necessity to build up photodiode-based
amplifiers as part of readout systems that allow portable and convenient data acquisition
(DAQ) for a variety of applications.
The literature shows interesting research studies which demonstrate a systematic
evaluation of multiple photodetectors for dosimetric purposes in radiation therapy (Boivin
et al., 2015). The results of these studies reveal that PMTs are the optimum selection for
applications that exhibit lower dose rates whereas PIN diodes are the most effective
photodetectors that perform well and are cost-effective for dose rates higher than 3 m
Gy/s. To the best of our knowledge, nothing is found in the existing literature describing
a system that has been fully customized for such a purpose. This chapter describes a
design for an Opto-amplifier green Light Emitting Diode (LED) testing system along with
a trans-impedance photodiode amplifier built in-house, with some associated proof-offunction tests. It then shows the suitability of the designed systems to detect the HDR 192Ir
positional sensitivities using different scintillating fibre probes for interaction with the
HDR 192Ir Brachytherapy source.

4.2. Materials and Methods:
4.2.1. Scintillating detectors:
The “BCF-60” is a scintillating single-clad polymer multimode fibre with a diameter of
1mm. The light yields for this type of fibre are about 7100 photons of wavelength 530 nm
per MeV from a minimally ionizing particle. Another scintillating detector used is CsI
(Tl) (Thallium-activated Caesium Iodide) where light is mostly emitted at the longer
wavelength of 550 nm with light yields of (52 - 56) x10³ photons per MeV. The CsI (Tl)
crystal used to obtain this result was 1 mm long with a diameter of 2 mm. A “BCF-98”
non-scintillating fibre (a standard light-guide cable) was used to guide the light emitted
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from the core of the scintillators used. The properties of the chosen scintillating detectors,
produced by Saint-Gobain Crystals (SGC) USA, have been shown previously in Materials
& Methodology Chapter (#3). Please refer to Table 3.1 & 3.2 for more details.
Fabrication of fibre optic probes with desired properties has been performed in our lab.
The desired length of clear plastic fibre was cut using a sharp cutter and then terminated
with a standard male SMA connector. Both ends of the clear fibre were finely polished to
achieve maximum light transmission and increase the optical reflection within the core.
A scintillating material with the desired length was finely cut, both ends polished, and
then optically coupled to the clear fibre by applying adhesive optical grease with a
matching refractive index so that total internal reflection is minimised to prevent
unwanted losses resulted from poor optical coupling.

4.2.2. Photodetectors (PIN photodiodes):
The selection of photodiode for radiotherapy dose monitoring basically depends on the
fibre diameter and should be chosen with a reasonable active area size that physically
covers the fibre diameter. Three PIN-photodiodes were selected with different areal size
and specific packaging structures: (TO5- S1123), (TO5- S1123-01) and (TO5- BPX61). The
properties of the PIN photodiodes used have been shown previously in the Materials &
Methodology Chapter (#3). Please refer to Table 3.3 for more details

4.2.2.1. IV characteristics of PIN photodiode with different setups:
IV characteristics and analysis of the abovementioned PIN photodiodes were performed
using the in-house adapted IV tracer system, shown in the previous chapter Fig 3.8, by
applying a bias via the diode terminals and then measuring the corresponding dark current
at the maximum voltages. Reverse current was assessed for bare photodiodes at first,
while connected to different system components in a completely dark environment and
in a normally illuminated room for comparison. A black sheath was fitted onto the fibre
probe, then a test was done to check if any light leaks into the photodiode receptacle due
to the setup. Further tests were conducted to examine if the black sheath fitted onto the
fibre probe is light-tight enough to block the light from normal room illumination which
would contribute a large unwanted signal. For relevant results please see section 4.3.3.
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4.2.3. Data acquisition system configurations:
4.2.3.1. Opto green light emitting diode (LED) testing system:
The Opto-amplifier LED test system has been designed in-house with a green LED as a
calibrated stable light source to check that the amplifier is operating properly prior to
conducting actual measurements in the real-time clinical scenario with an HDR

192

Ir

Brachytherapy source. It can be used to check the amplifier sensitivity, drift, and response
time. Likewise, the slew rate and timing of the designed CMRP system can be checked
using a pulse circuit and a monitoring oscilloscope is used for checking the response time
of the measuring system in the form of a square wave. All circuit components were
installed inside a shielded box to maintain protection against ambient light. The
scintillating fibre probe to be assessed was inserted into the LED housing with its fibre
tip being closely abutted to the LED for the sake of maximum light reception by the
sensitive volume of the fibre (scintillating part) which is then attached to 1 m of clear
fibre being which is in turn connected to the photodiode. The intensity of green light was
controlled and regulated by adjusting the current throughout the LED to a defined value
matched with the desired output voltage. The electronic circuit of the Opto green LED
testing system has been demonstrated earlier in the Materials & Methodology Chapter
(#3). Please refer to Section 3.7.4 for more details.

4.2.3.2. The in-house designed CMRP trans-impedance photodiode
amplifier:
A trans-impedance photodiode amplifier (current to voltage converter) was designed inhouse with a mounting for the photodiode, in a metallic shielded box, with the circuitry
electrically isolated from the box. Minimum & maximum sensitivity values of the
amplifier were found to be 270 mV/nA and 1620 mV/nA respectively. This photodiode
was powered by a power supply that is regulated by a Zener diode and operated in a
photoconductive mode (bias applied) where the dark current is not negligible. The dark
currents produced were accurately measured and used to compose calibration curves
characterising the devices.
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Figure 4.1: Schematic diagram illustrating the proposed photodiode amplifier system (operated in
photoconductive mode) with components of the regulated power supply at the upper right and timeconstant selector at the lower right.

The operational amplifiers CA3140 BiMOS, and LF355 were used in two stages as well
as a 1.2 Volt Ref voltage regulator (LM313).
-

First stage amplification:

In this stage, an inverting trans-impedance amplifier with a feedback resistor of 10 MΩ
was used. The CA3140 op-amp has high input impedance and low input current and with
the feedback resistor of 10 MΩ, gives approx100 nA/V at pin 6. The feedback capacitor
is used to lower the gain at high frequencies and stabilize the circuit with respect to
parasitic oscillations.

-

Second stage amplification:

Another LF355 amplifier has been used for the purpose of inverting the signal, providing
additional gain, filtering, and level shifting of the output voltage. This has been achieved
by applying an input resistor of 10 kΩ, a feedback fixed resistor of 270 kΩ, and a switch
that enables the stage gain to be adjusted from a minimum value of 270 kΩ /10 kΩ = 27
to a maximum of 6 × 27 = 162. These sensitivity adjustments enable the overall sensitivity
for both stages to be adjusted from 100 / 27 = 3.7 nA /V, to 100 /162 = 0.617 nA /V.
These values depend on the range of expected output voltage and can be altered if
necessary.

Page 4-57

The amplifier sensitivity through the amplifier circuit in loop (A) can be calculated as
follows:
𝑉 = 𝑅 × 𝐼 = 107 × 10−9 V = 10−2 𝑉

The result per 1 nA input current is:
𝑉 = 10 𝑚𝑉/𝑛𝐴

However, to calculate the gain through the amplifier circuit in loop (B) which is
corresponding to the minim gain value, the following expression is used:
Gain (dimensionless factor) =

Gain =

R feedback
R input

270 kΩ
= 27
10 kΩ

The amplified gain through different gain positions is calculated as the following:

Gain position

Preamplifier gain

Gain

Amp factor

Gain at Position (1)

10 𝑚𝑉/𝑛𝐴

27

( )

Gain at Position (2)

10 𝑚𝑉/𝑛𝐴

27

( )

Gain at Position (3)

10 𝑚𝑉/𝑛𝐴

27

( )

Gain at Position (4)

10 𝑚𝑉/𝑛𝐴

27

( )

Gain at Position (5)

10 𝑚𝑉/𝑛𝐴

27

( )

Gain at Position (6)

10 𝑚𝑉/𝑛𝐴

27

( )

Amplified sensitivity

6
6
6
5
6
4
6
3
6
2
6
1

270 mV/nA
324 mV/nA
405 mV/nA
540 mV/nA
810 mV/nA
1620 mV/nA

Table 4.1: Amplifier sensitivities for all gain switch settings

The gain is usually defined by the amplification in the output voltage (mV) produced by
a current of 1 nA. The gain values shown above can be expressed in multiple sensitivities
units which depends on the requirement of the application as seen in Table 4.4:

Sensitivity Range

(A/V)

(V/A)

(nA/mV)

(mV/nA)

1

3.70 × 10-9

2.70 × 108

3.70 × 10-3

270

2

3.09 × 10-9

3.24 × 108

3.09 × 10-3

324

3

2.47 × 10-9

4.05 × 108

2.47 × 10-3

405

4

1.85 × 10-9

5.40 × 108

1.85 × 10-3

540

5

1.23 × 10-9

8.10 × 108

1.23 × 10-3

810

6

6.17 × 10-10

1.62 109

6.17 × 10-4

1620

Table 4.2: Sensitivity range expressed in different units
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-

Stabilisation of Reference Voltage:

Reference voltage for the second stage amp (LF355) is stabilized using two 1.2-Volt
references (LM313). This voltage reference IC is together with the 10-k pot enable the
output to be set to zero before measurements begin. The range of adjustment needed
depends on the dark current of the photodiode which may be larger than needed. This can
be adjusted for optimum range and adjustment sensitivity upon final choice of photodiode
that appropriate for the application, and final testing has been carried out. The circuit
presently uses a bi-polar 9-volt power supply, but this supply could be from +/- 6 to +/15 volts. As the current taken is less than 40 mA, therefore the use of 9-volt batteries can
be an option for a short test, however, using the mains powered supply for the circuit is
more preferred as it is practically suitable for longer measuring periods.
As seen in Fig 4.1 that a vital component of the amplifier which includes two-1.2V
reference shunt regulators LM313 that improve the stability and remove any possible
drifting. While using long screened (shielded) cables from the amplifier box to the data
logger, there is a necessity of inserting a reasonable resistance value of 470 R-1K resistor
between the output of op-amp LF155 (LF355) and the cable. This sort of resistor assists
in decoupling the capacitance of the cable, which can reach thousands of pF, from the opamp output pin. Without such a resistor, the op-amp might start oscillation which will
adversely contribute to the instability of the amplifier and cause drift of the response.
Based on our ongoing experience, there are some precautions that need to be followed
when building such a system for such an application:
-

The sensitivity of the photodiode and the Quantum Efficiency (QE) must be
considered at a given wavelength in which is matched with the emission
wavelength of the scintillation detectors.

-

The photodiode must be mounted as close as possible and adjacent to the amplifier
input to reduce possible sources of unwanted noise.

-

As the cathode of the pin diode is connected to the case, it hence needs to be
electrically isolated by means of wrapping the diode’s case with a Teflon tape that
assists in isolating the case form being physically attached to the diode’s body.

-

For concerning the SMA ferrule not reaching the case, clear gel with matching
refractive index should be used so that an imperfect contact does not cause light
losses.
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-

The amplifier with all other components should be enclosed in a shielded metal
enclosure for electromagnetic shielding and to reduce noise from external
interfering sources.

-

The zero adjustment shall be set once (without diode-connected) and never
touched afterwards.

-

Hand-held multi-meter with an input resistance of 10 MΩ is most likely to be
accurate while initially conducting basics photodiode tests, Therefore, a series
resistor of 220 KΩ can be used along with the already existed 10 MΩ of the multimeter.

-

As the output voltage of the amplifier (𝑉ᴑ ) depends on the input impedance of the
meter or datalogger. Therefore, it is recommended, during real-time data
acquisition, to be larger than 10 MΩ as the signal loss in the filter would be
negligible.

-

If the amplifier is to be operated (powered) by a normal battery rather than a
regulated power supply, it must be continuously checked and assure that the input
voltage does not go below the minimum operating voltage required for the
amplifier.

-

Time constant (RC) filters:

RC filters with three different time constants were applied on the amplifier output along
with a fuse to protect the circuit if abnormally large currents are ever encountered.
Calculation is shown in Appendix 1.

Resistors (𝛺)

Capacitance (µF)

RC (m Sec)

120 × 103

0.047

5.64

120 × 10

3

1.547

185.64

120 × 10

3

6.847

821.64

Table 4.3: Time constant (RC) filters used on the amplifier output

4.2.4. Data logging system:
The data logging system, used for this purpose, has been demonstrated earlier in the
Materials & Methodology Chapter (# 3). Please refer to section 3.9.1 for more details.

Page 4-60

4.2.5. IV characteristics and reverse current of PIN-photodiodes:
This test is of a paramount significance if the PIN-photodiode is operated in a
photoconductive mode where the amount of dark current induced is non-negligible. The
aim of this IV analysis is to quantify the amount of extra leakage current induced due to
the setup of the detector combination. A current-voltage (I-V) study of the selected PIN
diodes was performed using the in-house developed IV tracer system as previously
explained in Chapter 3. A negative bias (from 0 to -20 V) was applied on the diode, and
the current was measured across the P-N junction. Reverse current of selected
photodiodes was assessed in a completely dark environment and normal ambient light
illumination for both bare photodiodes and photodiodes connected to the detector’s
components.

4.2.6. Slew rate and timing:
This test was conducted to inspect the slew rate and timing of the in-house designed
CMRP amplifier system. The slew rate was checked using a pulse circuit which switches
the LED ON and OFF. Current in the green LED is set to a value that provides a green
light approximately matching the wavelength of the selected scintillating fibre when
stimulated by HDR 192Ir detection in the Brachytherapy room. A square wave is generated
by a 555 timer IC used in a stable multi-vibrator mode. The output from Pin 3 is used to
drive the gate of a IRFUC20 FET that turns the green LED ON and OFF, and also triggers
a monitoring oscilloscope (Siglent, Model: SDS-1102CML) for checking the response
time of the measuring system. The system’s performance was evaluated in a
photoconductive (PC) mode. The output signals with different time-delay RC filters were
acquired at a sensitivity range of 102 mV/nA. For relevant results please refer to section
4.3.4.

4.2.7. In-lab stability test:
The aim of these test was to evaluate if there is any drift caused by the amplifier while no
diodes are connected, or with the diodes connected, and finally with connecting the
scintillating optical fibre to the system. These tests were performed while the detector is
inserted in a black sheath and the amplifier is also protected from light in a completely
dark room. The system stability was evaluated in a “PC” (i.e. Photo-Conductive) mode.
Data logging tests were run in the lab, at a low sampling rate of 1 sec, for a period of 30
mins each, applying the lowest RC filter (5.6 ms) at a sensitivity range of 810 mV/nA.
For relevant results please refer to section 4.3.5.
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4.2.8. In-lab LED linearity test:
An in-house simulation was performed, to simulate the interaction of photons which
would be produced by an HDR (eg:

192

Ir) source with our proposed fibre optic system

The “In-lab” linearity test for the designed system was performed in the lab utilizing the
Opto green LED test system, depicted in Fig 3.8, where a sheathed, fully scintillating
plastic fibre of 1 m length was exposed to the green LED source as depicted previously
in Fig 3.8, with different light intensities which were anticipated to match the expected
highest and lowest output voltages upon interaction with HDR 192Ir. System performance,
stability, and linearity were investigated in “PC” mode upon exposure to the green LED
light source. Data logging tests were run in the lab, at a lower sampling rate of 1 sec, for
a period of an hour, each applying the lowest RC filter of 5.6 ms at a gain setting of 810
mV/nA. For relevant results please refer to section 4.3.6.

4.2.9. Dose rate linearity & Dose linearity tests:
Both dose-rate linearity and dose linearity of the CMRP trans-impedance photodiode
amplifier were investigated using a CsI (Tl) scintillation fibre optic detector, coupled to
a 10 m optical fibre probe¸ with a 6 MV TrueBeam Linac (Varian 21ix) photon beam
energy. The tests were performed under Linac reference conditions, as shown in
Fig. 4.2, with a source-to-surface distance (SSD) of 100 cm, 10 × 10 cm2 field size (FS)
at the maximum depth dose (dmax) of 15 mm for different dose ranges as shown in Tables
4.4 & 4.5. The 10 m clear (non-scintillating) optical fibre was needed to convey the
generated light signal from the phantom to the photodiode amplifier placed in the control
room away from stray treatment room interference. Clinical measurements were taken at
a low sampling rate of 1 sec, applying the lowest RC filter (5.6 ms) at a sensitivity range
of 405 mV/nA. For relevant results please refer to section 4.3.7.
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Monitor Unit
(MU)
100 MU (9 sec)
200 MU (19 sec)

Dose
Equivalent
100 cGy
200 cGy

300 MU (29 sec)

300 cGy

400 MU (39 sec)

400 cGy

500 MU (49 sec)

500 cGy

Table 4.4: Equivalences of TrueBeam radiation Monitor Units and dose

Monitor Unit (MU)

Dose
Equivalent

30 MU @ 60 MU / min
50 MU @ 100 MU / min

30 cGy
50 cGy

100 MU @ 200 MU / min

100 cGy

200 MU @ 400 MU / min

200 cGy

300 MU @ 600 MU / min

300 cGy

Table 4.5: Equivalences of TrueBeam radiation rates and total dose

Figure 4.2: Optical fibres inserted inside a solid water equivalent (PMM) phantom under reference
conditions ; Right hand side: Datalogger
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4.2.10.

Feasibility of the CMRP system for HDR brachytherapy

quality assurance:
Fig 4.3 demonstrates the experimental setup in the HDR brachytherapy room upon the
irradiation of CsI (Tl) scintillating fibre, placed inside “solid water” (i.e. PMMA)
phantom (along the x-axis). Data was acquired at a sensitivity range of 810 mV/nA, and
the HDR Brachytherapy 192Ir movement was programmed to be in a 2 mm step size within
the phantom. Solid water slabs with different thicknesses were used to achieve different
vertical displacements (y-heights). In this experiment, the measurement was taken at three
different heights (y) of 1 cm, 2 cm, and 3 cm, and keeping the detector location at x = 45
cm and the horizontal displacements (z) of 0 cm, with respect to the HDR
Brachytherapy192Ir movement axis (x*), at various source-to-detector distances (SDDs).

Figure 4.3: World coordinate system of experimental setup
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4.2. Results & discussion:
4.3.1. Theoretical estimation of electrical current:
In this section, a theoretical estimation of electrical current produced by a plastic
scintillating fibre is demonstrated. The number of photons produced per keV for the HDR
Brachytherapy source

192

Ir, with an average energy of 380 keV, could be roughly

estimated by means of scintillation detectors based on a previous work by Aoyam et al
(Aoyama et al., 1997). The photons generated per MeV should be linear with respect to
dose, independent of dose rate and all other irradiation conditions, based on the following
parameters:
Dose (D) for a selected HDR Brachytherapy source is about 200 cGy/min, and it is
defined as the Energy deposited (E) over a mass of sensitive volume (m).

𝐷=

𝐸
𝑚

(𝑢𝑛𝑖𝑡 𝐺𝑦 = 𝐽. 𝐾𝑔−1 )

𝐸 = 𝐷. 𝑚

The mass of the scintillator can be found as follows:
𝑴𝒂𝒔𝒔 (𝒎) = 𝐃𝐞𝐧𝐬𝐢𝐭𝐲 (𝝆) × 𝑽𝒐𝒍𝒖𝒎𝒆 (𝑽)

The density (𝜌) of the scintillating fibre’s material is almost equivalent to water and is
given as follows:
𝝆𝒘𝒂𝒕𝒆𝒓 = 𝟏𝟎𝟎𝟎 𝒌𝒈 𝒎−𝟑

The volume of the scintillating fibre (cylindrical shape) can be calculated with calculating
the diameter and length of the scintillating fibre as the following:
Where d: diameter (Φ) of the scintillator core
r: radius of the scintillator core
h: length of the scintillating fibre
d= 10-3 m,

𝑟=

𝑑
2

=

10−3
2

𝑚,

𝑟2 =

(10−3 )2
4

m2
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The volume (𝑉 ) of the scintillating fibre is:
𝑉 = 𝜋𝑟 2 ℎ = 3.14 ×

(10−3 )2
4

× 5 × 10−2 m3

𝑽 = 𝟒 × 𝟏𝟎−𝟖 m3
The mass of the scintillating fibre is:
𝑚𝑠𝑐𝑖𝑛𝑡𝑖𝑙𝑙𝑎𝑡𝑜𝑟 = 𝜌𝑤𝑎𝑡𝑒𝑟 × 𝑉𝑠𝑐𝑖𝑛𝑡𝑖𝑙𝑙𝑎𝑡𝑜𝑟
𝑚𝑠𝑐𝑖𝑛𝑡𝑖𝑙𝑙𝑎𝑡𝑜𝑟 = 103 𝑘𝑔 𝑚−3 × 4 × 10−8 𝑚3
𝒎𝒔𝒄𝒊𝒏𝒕𝒊𝒍𝒍𝒂𝒕𝒐𝒓 = 𝟒 × 𝟏𝟎−𝟓 𝑲𝒈
Therefore, the Energy absorbed in 1 minute (under the HDR brachytherapy source
reference conditions) should be 200 cGy/min, and is given as the following:
𝐸 = 𝐷. 𝑚
𝐸=2

𝐽
× 4 × 10−5 𝑘𝑔
𝑘𝑔. 𝑚𝑖𝑛

𝐸 = 8 × 10−5 𝐽/𝑚𝑖𝑛
𝑬 = 𝟏. 𝟑𝟑 × 𝟏𝟎−𝟔 𝑱/𝒔𝒆𝒄

This energy released can be expressed in units of:
1 𝑒𝑉 = 1.6 × 10−19 𝐽
1.33 ×10−6

E= 1.6 ×10−19 = 8.31 × 1012 𝑒𝑉/𝑠𝑒𝑐
E = 𝟖. 𝟑𝟏 × 𝟏𝟎𝟔 = 𝑴𝒆𝑽/𝒔𝒆𝒄

The scintillator used produces 7100 photons/MeV absorbed energy,
Therefore, it can be expected that there will be a certain number of photons/secs
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝ℎ𝑜𝑡𝑜𝑛𝑠
1 𝑠𝑒𝑐
= 8.31 × 106 × 7100
= 5.90 × 1010 𝑝ℎ𝑜𝑡𝑜𝑛𝑠/𝑆𝑒𝑐

As a reasonable starting assumption, assume 1 % of the photons produced will reach the
photodiode window (i.e. Quantum Efficiency = 0.01):
QE= 0.01 => 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛 𝑓𝑙𝑢𝑥 = 5.90 × 108 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛/(1 𝑠𝑒𝑐)
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Then, the current produced is:
𝐶𝑢𝑟𝑟𝑒𝑛𝑡 (𝐼 ) =

𝑄
𝑆𝑒𝑐

=

𝑁𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛𝑠 × 𝑞 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛
𝑆𝑒𝑐

= (5.90 × 108 ) × (1.6 × 10−19 )

= 9.44 × 10−11 𝐴
The induced current produced is in the order of a nano-Amp
𝑰 = ~ 𝟎. 𝟎𝟗𝟒𝟒 𝒏𝑨

Based on the calculated signal estimation, a current of approximately 0.0944 nA is
expected. This is the case when scintillating fibres (530 nm) are irradiated with γ rays and
light is then detected using a photodiode with QE of 1%.
However, if the assumption made to detect this current with a photodiode that has QE of
40%. The expected current will be much higher as number of photons/secs by will be
increased by a factor of 40 %, as the following:
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝ℎ𝑜𝑡𝑜𝑛𝑠
1 𝑠𝑒𝑐
= 5.90 × 1010 𝑝ℎ𝑜𝑡𝑜𝑛𝑠/𝑆𝑒𝑐
QE= 40 % => 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛 𝑓𝑙𝑢𝑥 = 2.36 × 1010 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛/(1 𝑠𝑒𝑐)

Then, the current produced is:

𝐶𝑢𝑟𝑟𝑒𝑛𝑡 (𝐼 ) =

𝑄

=
𝑠𝑒𝑐

𝑁𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛𝑠 × 𝑞 𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑛
𝑆𝑒𝑐

= (2.36 × 1010 ) × (1.6 × 10−19 )

= 3.77 × 10−9 𝐴

Once again, the induced current produced is in the order of a nano-Amp
𝑰 = ~ 𝟑. 𝟕𝟕 𝒏𝑨

While voltage is proportional to current and current is proportional to the dose rate.
Therefore, voltage is also proportional to the dose rate.
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4.3.2. Estimation of electrical current based on an experimental study:

Figure 4.4: Photodiode amplifier circuit designed by Aoyama et al which was used for
electron beam therapy

In this section, a predictable assumption of electrical current produced by a BCF-60
scintillating plastic fibre is demonstrated. In a previous work by Aoyama et al. (Aoyama
et al., 1997), a photodiode amplifier system was used to measure radiation dose and
characterise electron beam qualities utilising a scintillating plastic fibre detector., By
considering the photodiode amplifier circuit shown above in Fig 4.4, it can be noticed that
a feedback resistor of 108 Ω was used with the first stage amplifier (LF351), so that the
output from the first stage will be 10 nano - Amperes (nA) per volt that would generate a
reasonable first-stage signal voltage of 10 mV (for a photodiode current of 100 picoAmperes) which is further amplified. As the second stage amplifier (LM301A) has a gain
of 100, so the final output will be 100 pico - Amperes (pA) per volt. It clearly
demonstrates that if the diode current is 100 pA, output voltage from the first amplifier
stage will be 10 millivolts (mV) and the output at the second amplifier will be 1.0 volts.
However, with such high gain, and the amplifiers being used, it is assumed that noise and
drift could be a problem. The photo-voltaic mode for the photo diode was chosen to lower
the dark current of the selected photodiode as it’s dark current is negligible in this mode.
Based on the diagram above from the presented paper, it is reasonable to estimate that
there is a current of ~ 10 nA when 4 mm of the styrene-based Bicron BCF-60 scintillating
fibres, with an emission peak of 530 nm (green) and sensitivity of ~ 7100/MeV for
minimum ionizing particles, was used. However, in our case, 5 mm or more of
scintillating fibre can be utilised, therefore, the number of photons will be much higher
by >= 1.25 times, which will increase the signal produced.
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4.3.3. IV characteristics of PIN photodiode with different setups:
4.3.3.1.

Reverse current of bare photodiodes:

It can be seen from the results shown in Fig 4.5 that the BPX61 photodiode has a flat IV
characteristic where increasing the biased voltage will be unable to cause an increase in
current as there are no more charge carriers available, so this diode thus shows almost
constant current characteristics. However, the S1123 and S1223-01 devices have sloped
IV characteristics and show a continual current increase with increasing bias and are not
saturated at 6 volts. Due to the larger receiving area size and the ready availability of this
S1123-01PIN diode, it was chosen as a default photodiode for our system.

Figure 4.5: IV characteristics of bare TO5 PIN-photodiodes

4.3.3.2.
Reverse current of photodiodes in a completely dark
environment:
Reverse current of photodiodes connected to different components in a completely dark
environment was investigated. It is observed that dark current of photodiode exhibits
distinctive characteristics upon being connected to various components. As seen in
Fig 4.6 that we observed the highest value of dark current when the photodiode was inside
an opaque box with the diode’s receiving face left open (i.e. bare and not connected to
any glass fibre or receptacle). The next highest value was when the diode was connected
to the optical receptacle but still without any receiving optical fibre. The dark current is
then relatively reduced if a jacketed optical fibre is joined to the receptacle connected to
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the photodiode. Fitting the fibre cable into a jacket of black jacket materials assisted in
lowering the reverse dark current further, and the lowest of all dark current readings were
noted when the fibre was not only jacketed but jacketed with a heat-shrinkable opaque
material which was heat-shrink onto the fibre.

Figure 4.6: Reverse current of TO-5 (S1223-01) photodiode connected to different
components in a completely dark environment

4.3.3.3.
Reverse current of photodiodes in different light
conditions:
Reverse current of photodiodes connected to different components in different light
conditions was investigated. The aim of these IV curves is to quantify of the amount of
extra leakage current induced due to the setup of the detector combination. Generally, the
most preferred IV characteristic for any photodiode is when it exhibits as small as possible
reverse-biased (or dark) current upon applying a high reversed bias across the diode
terminals. The IV characteristics of a TO-5 (S1223-01) photodiode, connected to different
components, in a completely dark environment and under normal room illumination, were
experimentally investigated. It is observed that the photodiode is behaving differently to
surrounding light conditions while being utilized in different setups. As shown in
Fig. 4.7, under darkroom conditions, the dark current of photodiode has its smallest value
while it is connected to a heat-shrink jacketed scintillating plastic fibre. It could be
summarized that the amount of dark current induced in the fibre due to connecting other
components to the diode, jacket material on the connected fibre, and normal room
illumination is of a profound significance and need to be considered if the diode is
connected in a photoconductive mood. Therefore, it is more efficient if the PIN- diode
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used for this system can be operated in a photovoltaic mode where the dark current is
almost negligible. The dark current for both jacket types seems to be larger by
approximately 50% if conducting the experiment under normal ambient illumination
condition.

Figure 4.7: Reverse current of TO-5 (S1223-01) photodiode connected to
different components in different light conditions

4.3.4. Slew rate and timing:
Slew rate and timing of the in-house designed CMRP amplifier system was
experimentally investigated. After photons to be detected are fed down an optical fibre
and presented to a photodiode, the photodiode produces a signal, and an amplifier is used
to amplify these signals (which may be quite tiny), so that the signals can be recorded or
further processed. There is a slight pay-off between amplifier sensitivity (or gain) and its
response time to track an input signal, so it is important to have options on response time
for the amplifier, and to accurately calibrate the amplifier so that its overall gain and fine
details such as slew rate in response to fast-changing signals (eg: pulse edges) are
precisely known. An amplifier for photodiode detector signals was designed, constructed
and calibrated in-house by our group in CMRP at UOW.
Fig 4.8 demonstrates the slew rate for the In-house designed CMRP amplifier with
different time constant (RC) filters. A light pulse was created by turning on the green
Opto LED and feeding its light pulse down an optical fibre and presenting it to the
photodiode input of the CMRP amplifier. The CMRP photodiode amplifier being
operated in photoconductive mode then produces a voltage signal. With the amplifier
Page 4-71

operating at the lowest RC filter setting (5.6 ms), the signal takes around 0.3 sec to reach
its final steady-state value. However, with the other longer filters 180 ms and 816 ms, the
times taken for the output to reach plateau is about 0.6 sec and 2.7 sec respectively.

Figure 4.8: Slew rate and rise time for the output of the CMRP amplifier
with different time constant (RC) filters

4.3.5. In-lab stability test:
In-lab stability test for the proposed photodiode amplifier system was experimentally
investigated. It is vitally important that the amplifier used to amplify the photodiode
detector signals for medical radiation measurement is very stable in performance and
linear in response, with known and reproducible characteristics and capability for
unwanted effects to be easily subtracted out. The CMRP-designed amplifier was checked
for stability and minimal presence of dark signal when no actual deliberate light for
measurement was presented to the photodiode front-end. At the same time, a commercial
amplifier (Gigahertz Optik™) was also characterised under identical conditions for
comparison and results will be shown in Chapter 6.

4.3.5.1.

Photodiode amplifier only connected:

Figure 4.11 represents the response of the CMRP photodiode amplifier receiving signal
from its photodiode with the selected diode fitted in a socket and connected in-circuit but
protected from light in a normal room environment. It shows stability over almost 3 h and
oscillated only as high as 4 mV and as low as -7 mV (in comparison to behaviour with
definite light sources where signals may be as high as 300 mV). Zoomed-in view of a
selected response data is demonstrated in Fig. 4.9 which represents fine response details
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for almost 1 h with a temporal resolution of 1 sec.

Figure 4.9: Response of CMRP photodiode amplifier in a dark room for a period of 3 h. Top
Inset: Magnified voltage scale view, Bottom Inset: Magnified Timescale view of 1st 500 s

4.3.5.2.
Photodiode amplifier connected to a scintillation fibre
detector:
Figure 4.10 demonstrates the response of the amplifier while the diode is connected to a
jacketed scintillating optical fibre and protected from light exposure in a completely dark
room condition. The CMRP photodiode amplifier shows reasonable stability (the stray
signal is of the order of only mV) and appears to be a kind of warm-up drift. It can easily
be subtracted from raw signal readings if measuring times are logged. The stability tests
of the amplifier system verified that the system is not susceptible to any sudden changes
in the output response or contributions from interfering sources. The designed CMRP
system shows very good behaviour of stability which assures accurate results without
having noise or drift from unwanted sources. Zoomed-in view of a selected response data
is demonstrated in Fig. 4.10 which represents fine response details for almost 1 h with a
temporal resolution of 1 sec.
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Figure 4.10: CMRP photodiode amplifier response while connected to a
jacketed optical fibre for 3h in a completely dark environment

4.3.6. In-lab LED linearity test:
In-lab linearity test for the CMRP photodiode amplifier system with the green LED input
was experimentally investigated. The manufacturer’s specification guarantees that the
device performs linearly, with output intensity being directly proportional to input
current. Figures 4.11 & 4.12 exhibit the response of the system when the input
photodiodes are connected to a jacketed scintillating optical fibre, exposed to fixed green
Opto LED light intensities, and protected from any other light by being placed in a
completely dark room. The CMRP amplifier system exhibits a linear response (Fig. 4.11
& 4.12) to the intensity of the green LED. The linearity of the amplifier systems upon
exposure to green LED was assessed by recording the increase of the output voltage upon
increasing the LED input current. The designed system shows excellent response linearity
where output voltage is proportional to input (green) light intensity and hence the output
voltage is proportional to the “dose”. The results encourage confidence that, when
ionising radiation and a scintillating detector are used instead of the green Opto LED, the
amplifier response to radiation dose should also be linear. It can be summarised that the
system is now ready to be tested under real radiation conditions.
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Figure 4.11: Response of CMRP photodiode amplifier upon exposure to green
LED signal with LED currents in the µA range

Figure 4.12: Linear response of CMRP photodiode amplifier upon
exposure to different intensities of green LED light

4.3.7. Dose rate & dose linearity tests:
The system dose linearity was investigated on a Varian TrueBeam Linac. Different doses,
different dose-rates and different dose duration sequences were programmed into the
TrueBeam Linac to assess the measuring system linearity. As Fig. 4.13 clearly shows, the
proposed fibre optic CMRP system shows dose rate independency over a wide range of
dose rates. The Linac was also programmed to produce sequentially varied dose levels
(visible in Fig. 4.14 a). As shown in Fig. 4.14 b, the fibre optic system shows a linear
response to ionising radiation, with response being strictly proportional to the deposited
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dose over a wide range of doses up to 300 MU (convertible to cGy as shown in Table
4.5). This is a pleasing result and agrees with the conclusion and prediction of dose
response linearity (when the system was calibrated with the green Opto LED).
(a)

(b)

Figure 4.13: Dose rate linearity of CMRP photodiode amplifier system

(a)

(b)

Figure 4.14: Dose linearity of CMRP photodiode amplifier system
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4.3.8. Feasibility of the CMRP DAQ system for HDR brachytherapy
quality assurance:
The feasibility of the utilization of the in-house designed CMRP trans-impedance
photodiode amplifier system for HDR brachytherapy quality assurance has been
investigated. From the foregoing measured characteristics of the CMRP photodiode
amplifier system, online detection of positional sensitivity during HDR brachytherapy
source can be acquired using the proposed DAQ system. Fig. 4.15 demonstrates the
response of the CMRP DAQ system showing the scintillation signal resulted from the
irradiation of the scintillating crystal CsI (Tl). Movement of this source to various sourceto-detector distances (SDDs) produces the relative response in three different vertical
displacements (y) of 1 cm, 2 cm, and 3 cm respectively, and keeping horizontal
displacement z of 0 cm, and the x-axis 4.5 cm constant with respect to the actual HDR
source movement axis. The peak values were found to be relative for the vertical distances
and theoreticality follow the inverse square law and HDR 192Ir dose fall-off. The response
of the fibre optic system is shown as a function of dwell time for each single dwell
position, and the output voltage was converted to the corresponding current-induced value
for each position. It can be summarized that the utilisation of a photodiode-based
amplifier system for source tracking during HDR brachytherapy is feasible and applying
such a simple system for such advanced applicant it is highly promising.
As shown in Fig 4.15, our CMRP amplifier system has successfully been capable to detect
two identical peaks that indicate online tracking the of the HDR source when being sent
from the after-loader to the first dwell position and retracted back to the machine. Another
good property related to in-vivo HDR source verification is that the amplifier system
proves to ideally able to track the submillimeter transition of the HDR source being
dwelling in a pre-determined dwell position, with simultaneous determination of dwell
time matched with the dwell time prescribed in the treatment planning system (TPS).
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Figure 4.15: Response of the CMRP system when placing a fibre probe in the middle of a
phantom (x = 45 mm), at three vertical displacements y of 1 cm, 2 cm, and 3 cm
delivering the 192Ir radiation at multiple dwell positions and varied SDDs

4.3.9. The dynamic technical properties of the proposed system:
In general, such an amplifier is known to be the most attractive option over other
conventional options as it is linear, predictable, and has very low sensitivity to
temperature changes. It is essential to ensure that it does not introduce any distortion due
to the bandwidth or the speed of the amplifier. Specification-related tests, of this CMRP
operational trans-impedance amplifier based -readout system, were carried out in the lab
prior to the actual implementation in the clinical scenario. It is required to ensure that
such a system is technically and dynamically suitable for the purpose of HDR radiation
detection. Based on the preliminary results, the capability of the operational amplifier to
be able to accurately reconstruct the HDR source position has been assessed to be feasible.
Hence, there are some important aspects that need to be discussed based on the acquired
results.

4.3.9.1.

The dynamic range of the amplifier:

The dynamic range of any amplifier should be aligned with the amount of current that is
generated at certain distances during HDR source reconstruction. The in-house designed
CMRP amplifier system has been dynamically evaluated to be suitable to detect the
maximum and minimum current produced by the scintillating fibre optic system which
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was in the range of nano-amp for the inorganic CsI (Tl) scintillation detector.
However, based on our in-clinic experimental investigations while using CMRP amplifier
system at the real HDR Brachytherapy clinical scenario, it has shown that the current
measurements taken are less than 1 nA and in fact they are in the order of pA, especially
when using polymer scintillator fibres. Therefore, it has been observed that our CMRP
amplifier system was not practically sensitive enough to detect current coming from the
photodiode when using very short lengths (< 5 mm) of polymer (plastic) scintillation
detector which produces a current in the range of pico-amp, as shown he experimental
results in Chapter 7. Therefore, there was a necessity to seek out another sensitive
amplifier with higher gain that is more sensitive to detect the signal from shorter
scintillation length that produced a very tiny current in the range of pico-amp.
Following on the initial clinical results and sequential tests obtained in a brachytherapy
room, we have perceived to reach to a stage where a manufactured instrument is to be
designed. Because the design of a high-gain amplifier in-house for such advanced
treatment technique is no longer a simple task, and technical issues related to high gain
amplification would be certainly a worry.

4.3.9.2.

Speed of the amplifier:

The amplifier used for HDR source tracking must be fast enough to be able to record the
speed of HDR

192

Ir source while dwelling constantly and measure the transition of the

HDR source from a position to another within the phantom. The source moves at approx.
50 cm/s within an HDR transfer tube over a length of 1.2 m. At the dwell point, the source
can overshoot the mark by a few mm (up to 7mm leeway) before settling into the dwell
position, but this effect is the order of fractions of a second. Based on Figs. 4.10 the
CMRP amplifier system can resolve the input signal in a very short time, the signal takes
around 0.3 sec to reach its final steady-state value. Also, Fig. 4.17 confirms that the
CMRP amplifier system is being capable of tracking the HDR source transition in realtime when sent from the afterloader to the phantom and retracting back to the afterloader.
It also shows excellent performance of detecting real-time HDR source transition of submillimetres within inter-dwell positions, the total number of dwell positions dwell time
at every single position, and total time for the entire treatment session.
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4.3.9.3.

Signal to noise (S/N) ratio:

The amplifier used for such an application requires a higher signal to noise (S/N) ratio to
distinguish the pure scintillation signal from the baseline (background). This designed
CMRP system demonstrates higher S/N ratio when using CsI (Tl) scintillating signal and,
that was clearly observed when inspecting Figs. 4.12 & 4.17. However, much lower S/N
ratio is achieved when using scintillating plastic fibre as indicated by results shown in
Chapter 7.

4.4. Conclusion:
This chapter has demonstrated the importance of carrying out some in-lab associated tests
for the design and adaptation of photodiodes, scintillating and plain optical fibres and
amplifier for HDR brachytherapy application. The preliminary results presented in this
chapter confirm that ambient light penetration is relatively significant for contributing to
the “dark current” of the photodiode. In addition, the entire system must be totally
protected from light and background radiation which assures the reduction of background
noise form unwanted interfering sources, and photodiode amplifier box must be kept
away from radiation delivery station. It has also been experimentally shown that the setup
is suitable for use in a normally illuminated room by inserting the fibre probe into a black
jacket which can totally prevent the penetration of light into the fibre core for maintaining
an appropriate level of light-shielding.
The preliminary results also illustrate that the photodiode amplifier-based system along
with scintillating optical fibre can be considered a preferred candidate and a convenient
mean for performing real-time quality assurance tests in both source verification and
dosimetry modes during HDR Brachytherapy procedures. The CMRP photodiode
amplifier dose-monitoring system when fed with signal arising from an inorganic
scintillating crystal, has been shown to have suitable characteristics such as sensitivity,
linearity and dose rate-independence suitable for both dose and source localisation
applications. The linearity of the system and its independence from dose rate was
demonstrated. Compared with some specialist commercial amplifiers, the maximum gain
of the CMRP is about an order-of-magnitude lower. Hence, when driven by polymer
scintillating fibre detectors, the CMRP photodiode amplifier dose-monitoring system
would be suitable for dose monitoring but shows insufficient spatial resolution for
determining source localisation. It would be desirable to be able to use inorganic
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scintillating fibre detectors for both dose measurement and source localisation.
The results also emphasize the capability of the designed CMRP system for performing
real-time measurements in real clinical scenarios. The CMRP photodiode amplifier dosemonitoring system has demonstrated that such a system is suitable and useful for clinical
applications. It is desirable to develop a similar system with higher gain, while still
maintaining the same levels of linearity, dose rate-independence etc. so that system is
attained which equally applicable to both dose-measuring and source localisation
applications. One of the most disadvantageous aspects of any scintillation fibre optic
systems is the production of Cerenkov induced light which is a source of unwanted signal
mixed with the pure scintillation signal. Hence, it needs to be corrected for when
measuring the radiation dose using this system. However, the aim of our experiments was
only source tracking, the separation of the simultaneous Cerenkov signals, therefore, is
not practically required.
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Design and investigation of an upgraded CMRP
MK trans-impedance photodiode amplifier for quality assurance of
high dose rate brachytherapy
II

5.1. Introduction:
Contemporary Cancer treatment options are evolving over the last decade with around
52% of cancer patients undergo radiotherapy (Delaney et al., 2005; Tobias, 1992). It is
known that internal radiation therapy, as so-called brachytherapy, has been the most
common option for prostate cancer treatment when combined with other radiotherapy
techniques (Hoskin et al., 2012; Michalski et al., 2015). Brachytherapy treatments involve
the insertion of a high dose rate (HDR) radioactive seed, typically 192Ir, inside the tumour
volume to destroy cancerous cells.

More recently, fibre optic- based scintillation

detectors have been successfully implemented in various radiotherapy applications as the
dosimeter of choice for quality assurance of both external beam (photon, electron, and
proton) and internal beam as so called brachytherapy. Polymer scintillation detectors
(PSD) possess unique properties over other conventional detectors and can bypass the
need for further correction factors when estimating the absorbed dose to patients
(Beaulieu & Beddar, 2016) (S Beddar & Beaulieu, 2016).
Quantification of radiation by means of a scintillation mechanism has been introduced in
the last century. It relays on converting the scintillation light produced to a measurable
electrical signal that can be quantified in the form of charge, voltage, or current using a
light detector that fulfils the purpose. The most common photodetectors that have been
reported in the literature are Photomultiplier tubes (PMTs), Charged-Coupled Devices
(CCD) camera, and a variety of photodiodes types (Knoll, 2010).
By investigating the literature in more depth, it has been found that photodiode amplifiers
have been widely used for a variety of optical applications owing to their ease of use,
small size, cost-effectiveness, and multiple operation modes such as photoconductive
(PC) and photovoltaic (PV) modes. Operational trans-impedance amplifiers are a very
optimal choice for light detection since they are pretty fast, have high sensitivity, and are
nearly temperature independent over normal room and lab temperatures (Beaulieu &
Beddar, 2016) (S Beddar & Beaulieu, 2016).
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Due to their unique properties, photodiode amplifiers are being successfully applied in
data acquisition systems (DAQ) used for dosimetry and quality assurance (QA) purposes
in radiotherapy treatment sessions (Beaulieu & Beddar, 2016) (S Beddar & Beaulieu,
2016). The Centre for Medical Radiation Physics (CMRP) at the University of
Wollongong has a long history of developing innovative quality assurance tools for
advanced radiotherapy applications (AB Rosenfeld, 2006). As the demand for such QA
tools is worldwide and increasing (especially for complicated treatment option such as
brachytherapy) a radiation detector based on fibre-optic technology has been designed inhouse to be used as a real-time QA tool during radiotherapy treatment sessions. The
system is particularly aimed at treatment for prostate cancer patients to assist in tracking
the treatment process, verifying the treatment plan, and stopping the treatment process if
any error is detected.
The first prototype of the CMRP photodiode amplifier system was only operated in
photoconductive mode, so it was decided to upgrade the initial version of the CMRP
amplifier (Op-Amps and discrete components on perf-board) to a newer version with a
printed circuit board (PCB) layout. It was a design requirement for the system to be in a
neat box that is sturdy, light-tight, compatible with AC and DC power supplies, and can
be easily operated in multiple modes - photoconductive (biased) & photovoltaic modes
where dark current of the photodiode is almost negligible, like an un-biased solar cell.
Also, beside the successful S1223-01 PIN-photodiode, another input channel was
provided with a wavelength-matching BPW21 PIN photodiode. It is possible to use both
inputs simultaneously so that was the scintillation signal of interest can be automatically
corrected for stem effect by providing a parallel non-scintillating fibre routed to the same
location as the main measuring fibre. Therefore, the aim of this research study focuses on
fabricating a tiny fibre optic radiation sensor which is small enough to be inserted into a
brachytherapy needle, and then feeding its optical signal to the aforementioned CMRP
photodiode amplifier. These components then form the front end of a data acquisition
system (DAQ) to convert the scintillation light produced from the interaction with HDR
radiation into to a measurable electrical quantity that can be used for dose measurement
and source localisation simultaneously. By this means, the various components cooperate
together to form an all-in-one QA tool.
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5.2. Materials & methodology:
5.2.1 Design of printed circuit board layout:
This section will demonstrate practical instructions of producing a PCB for an in-house
designed trans-impedance photodiode amplifier system:
1. The proposed amplifier circuit board layout was designed using Autotrax™
software and then printed using a laser printer onto a blue transfer film.
2. The laser-printed sheet was printed-side-down onto a sheet of Cu-coated PCB
material and ironed for 4 minutes, making sure that the pattern was transferred
correctly onto the copper surface.
3. 10 g of Ammonium Persulphate was dissolved in water then heated to 60 ᴼC.
4. The produced circuit board was held with forceps and immersed in the etchant
until all exposed copper was dissolved.
5. This process was repeated continuously till the solvent colour turned blue, which
assures that whole un-masked copper substrate has been completely dissolved
6. The board was rinsed multiple times in water to remove any remaining etchant.
7. Acetone cleaning solvent was used to remove any residual printer toner from the
etched PCB.
8. The board was sprayed with Servisol™ Protective Circuit Board Lacquer to
protect the copper tracks from oxidation.
9. The board was then dried with a fan for 30 minutes.
10. A 0.7 mm drill bit was used to drill holes for the electronic components.
11. Electronic circuit components were then inserted & soldered to the board, based
on the original design.
12. The electronic circuit was installed in a shielded-aluminium box with all
connectors and photodiodes mounted in the box. The final product becomes
compact, portable, and easy to use as depicted in the photos below.
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Figure 5.1: Practical steps for producing a Printed Circuit Board (PCB)-based photodiode amplifier

5.2.2 Data acquisition system configurations:
5.2.2.1. The upgraded CMRP MKII trans-impedance photodiode
amplifier:
The CMRP trans-impedance photodiode amplifier (a current to voltage converter) was
designed in-house with a mounting for the photodiode, in a metallic shielded box, with
the circuitry electrically isolated from the box. Minimum & maximum sensitivity values
of the amplifier were found to be 270 mV/nA and 1620 mV/nA respectively. The
amplifier is powered by a DC-coupled power supply (rechargeable SLA battery).
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Figure 5.2: Schematic diagram illustrating the upgraded CMRP photodiode amplifier system
(operated in photoconductive & photovoltaic modes) with component of the DC-coupled
power supply and RC filters on the right

The design of the upgraded version of the CMRP MKII trans-impedance photodiode
amplifier, as shown in Fig. 5.2, is almost identical to the original prototype of CMRP
amplifier as per discussed in Chapter 4. The only difference is that the upgraded version
CMRP MKII photodiode amplifier that it can be operated in two modes – photoconductive
(PC) where the dark current is highly significant and photovoltaic (PV) where the dark
current is almost negligible. However, the dark currents produced by the amplifier were
accurately measured and used to compose calibration curves characterising the device
and its various settings. The amplified gain through different gain positions is calculated
previously in Chapter 4. The gain is usually defined by the amplification in the output
voltage (mV) produced by a current of 1 nA. Its values can be expressed in multiple
sensitivities units which depends on the requirement of the application Please refer to
Table 4.3 & 4.4 for more details.

5.2.2.1.1.

Time constant (RC) filters:

RC filters with three different time constants were applied on the amplifier output with a
fuse to protect the circuit if abnormally large currents are ever encountered. Calculation
is shown in Appendix 1. Please refer to Chapter 4 Table 4.5 for more details.

5.2.2.2. Data logging system:
The data logging system, used for this purpose, has been demonstrated earlier in the
Materials & Methodology Chapter (# 3). Please refer to section 3.9.1 for more details.

Page 5-86

5.2.3 Slew rate and timing:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.2.6. This test was conducted to inspect the slew rate and timing of the in-house designed
CMRP amplifier system. The system’s performance was evaluated in a photoconductive
(PC) mode. Data was acquired at a sensitivity range of 540 mV/nA. For relevant results
please refer to section 5.3.1

5.2.4 In-lab stability test:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.2.7. The aim of these tests was to evaluate if there is any signal drift caused by the
amplifier when its photodiode is not connected, or when the diode is connected, and
finally with connecting a scintillating optical fibre to the photodiode.. The system stability
was evaluated in both photoconductive & photovoltaic modes. Data logging tests were
run in the lab, at a low sampling rate of 1 sec, for a period of 30 mins each, applying the
lowest RC filter at a sensitivity range of 405 mV/nA. For relevant results please refer to
section 5.3.2

5.2.5 In-lab LED linearity test:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.2.8. System performance, stability, and linearity were investigated in “PV” mode upon
exposure to the green LED light source. Data logging tests were run in the lab, at a low
sampling rate of 1 sec, for a period of 10 mins each, applying the lowest RC filter at a
sensitivity range of 1620 mV/nA. For relevant results please refer to section 5.3.3

5.2.6 Dose linearity test:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.2.9. Dose linearity of the upgraded PCB layout-CMRP MKII trans-impedance
photodiode amplifier was investigated using a CsI (Tl) scintillation fibre optic detector,
coupled to a 10 m optical fibre probe¸ with a 6 MV TrueBeam Linac (Varian 21ix) photon
beam energy. For relevant results please refer to section 5.3.4.
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5.3. Results & Discussion:
5.3.1 Slew rate and timing:
Slew rate and timing of the upgraded CMRP MK II amplifier system was experimentally
studied. Fig 5.3 shows the results of in-lab investigation when a green LED light is fed to
the photodiode input of the amplifier, set for unfiltered output, or on various RC timeconstant filter settings. It is clearly seen that the output signal reaches its final stable
maximum value within 0.3 sec, 1 sec, and 2.5 sec when applying RC filters of 5.6 ms,
185 ms, and 821 ms respectively.

Figure 5.3: Slew rate and timing of the upgraded CMRP amplifier when
exposed to a green LED light source applying three different RC filters

For comparison, the amplifier performance was then tested again in a clinical setting,
when the scintillating fibre was exposed to HDR radiation conditions using an

192

Ir

source. The results are shown in Fig. 5.4 which illustrates the effect of applying RC output
filters when the

192

Ir source is dwelling at multiple dwell positions (5 positions) for a

dwell time of 5 sec at each position. Both Figs. 5.3 & 5.4 results are in an excellent
agreement where the amplifier responded within a time delay similarly in both in- lab and
the clinical scenario. The important consideration that needs to be considered is that there
is a mutual trade-off between the desired level of amplifier stability, amplitude of
maximum signal attained, total dwell time, and settling time needed before recording
signal level.
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Figure 5.4: Slew rate and timing of the upgraded CMRP amplifier while exposed to an actual
HDR Brachytherapy source applying three different RC filters

5.3.2 In-lab stability test:
Stability test of the upgraded CMRP MKII amplifier system was experimentally
investigated. Fig 5.5 illustrates the stability test results of the upgraded CMRP amplifier
system over a period of 30 minutes with and without the detector connected to the
amplifier input in a PC mode and in a PV mode as shown in Fig. 5.6. The test was
investigated with all variables to allow selection of the optimal output signal conditions.
As can been seen from the graph, the system seems prone to drift and is noisy when its
output is unfiltered. Therefore, time constant (RC) filters with different time delays were
applied to the amplifier output. It is clearly noticeable that filtering of the produced signal
with an RC filter is recommended to assist in decreasing unwanted noise from interfering
sources and to enhanced signal to noise S/N ratio (or SNR) level.
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Figure 5.5: Stability test of the upgraded CMRP amplifier system without and with
detector connected, in photoconductive mode

Figure 5.6: Stability test of the upgraded CMRP amplifier system without and with detector
connected, in photovoltaic mode
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Similarly, Fig. 5.7 & Fig. 5.8 represent the response of the amplifier system with and
without optical fibre detector connected, over the same total duration of time. Based on
the comparison between the two graphs shown in both Figures shown below, it is clearly
seen that operating the photodiode in PV mode provides much better and more stable
signal than in PC mode - especially when the fibre probe is connected.

Figure 5.7: Stability test of the upgraded CMRP amplifier system without
detector connected, in both photoconductive & photovoltaic modes

Figure 5.8: Stability test of the upgraded CMRP amplifier system with detector
connected, in both photoconductive & photovoltaic modes
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5.3.3 In-lab LED linearity test:
The linearity of the upgraded CMRP MKII amplifier system photodiode amplifier system
upon exposure to green LED was assessed by recording the increase of the output voltage
upon increasing the LED input voltage. Figs 5.9 & 5.10 demonstrate the response of the
upgraded CMRP photodiode amplifier upon exposure to the green LED source through
either photodiode input while the diodes were connected to a jacketed scintillating optical
fibre, exposed to fixed LED light intensities, but protected from stray light in a completely
dark room condition. Both photodiodes exhibit a linear response to the current driving the
green LED. The green LED is known to be linear in response over a wide range of current
input (manufacturer’s specification) i.e. (for example) doubling input current will double
light output intensity. Hence, overall, it can be said that the proposed system with either
photodiode responds linearly over one order-of-magnitude change in LED light,
intensities for LED drive currents in the µA range. Both photodiodes show excellent
linearity so that amplifier output voltage is proportional to input light intensity, hence the
output voltage should be proportional to radioactive dose rate. The S1223-01 photodiode
seems to consistently have slightly higher output signal level, and this is attributed to its
higher quantum efficiency (QE) compared to the BPW21 diode.

Figure 5.9: Response of the upgraded CMRP photodiode amplifier with both
photodiodes when exposed to green LED signal with LED currents in the µA range
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Figure 5.10: Linear response of the upgraded CMRP photodiode amplifier with both
photodiodes when exposed to green LED signal with LED currents in the µA range

5.3.4 Dose linearity test:
The system dose linearity with ionising radiation was assessed on a Varian TrueBeam
Linac. Different doses, different dose-rates and different dose durations were produced
by the TrueBeam Linac to assess the measuring system linearity. A CsI (Tl) scintillating
crystal was used as a radiation detector with a 10 m length of clear optical fibre to transmit
the received optical intensity to the upgraded CMRP photodiode amplifier input. Based
on Fig 5.11, it can be clearly seen that the proposed system is linear to dose increase and
independent of dose rate over a range of about two-thirds of an order-of-magnitude.
(a)

(b)

Figure 5.11: Dose linearity of the proposed CMRP system
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5.4. Conclusion:
The proposed dose monitoring CMRP system was successfully designed and
implemented. The most crucial component of the system is the photodiode amplifier. The
upgraded version of the CMRP photodiode amplifier was assembled on a purposedesigned etched PCB using relatively inexpensive components. The resulting amplifier
was shown to be stable over time, linear over a wide range of different doses and
independent of dose rate across the range of typical clinical Linac dose rates. It is thus
eligible to be considered for use under real clinical radiation conditions and quality
assurance for HDR brachytherapy.
The upgraded CMRP photodiode amplifier dose-monitoring system when fed with signal
arising from an inorganic scintillating crystal, has been shown to have suitable
characteristics such as sensitivity, linearity and dose rate-independence suitable for both
dose and source localisation applications. Compared with some specialist commercial
amplifiers, the maximum gain of the upgraded CMRP amplifier is about an order-ofmagnitude lower. Hence, when driven by organic polymer scintillating fibre detectors,
the upgraded CMRP photodiode amplifier dose-monitoring system would be suitable for
dose monitoring but shows insufficient spatial resolution for determining source
localisation due to poor S/N ratio. It would be desirable to be able to use inorganic
scintillating fibre detectors for both dose measurement and source localisation. The
upgraded CMRP photodiode amplifier dose-monitoring system – especially in this
upgraded PCB form – has demonstrated that such a system is suitable and useful for
clinical applications. It is desirable to develop a similar system with higher gain, while
still maintaining the same levels of linearity, dose rate-independence etc. so that system
is attained which equally applicable to both dose-measuring and source localisation
applications.
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Adaptation and in-lab experimental evaluation of
Gigahertz Optik™ trans-impedance photodiode amplifier as an
optical fibre-based dosimetry system for brachytherapy quality
assurance

6.1. Introduction:
In this science and technology driven millennium, fibre optics has emerged as a state-ofthe-art technology worldwide and has witnessed a tremendous growth in recent decades.
The advantages of optical fibres are known and appreciated: they are dielectric, immune
to electromagnetic interference, flexible, and small in size, which has attracted the interest
of users around the world, and thus found various innovative applications. The
progression of fibre optic technology has been hugely noticeable, not only being used as
an ultra-fast data transferring method for telecommunications but also evolved as optical
sensors for numerous sensing applications ranging from industry to medicine. Hence,
fibre optic sensing systems have been employed in industrial environmental applications
for remote measurements and monitoring of pressure, temperature other oil industry
parameters and properties of hard-to-reach or hazardous environments. In addition,
optical fibre sensors are now used in medical applications for endoscopic imaging, and
blood flow measurement.
This chapter demonstrates the adaptation of a commercially available Gigahertz Optik™
amplifier retrofitted with a photodiode optical input instead of the original electrical input
for use as a reliable readout system within brachytherapy rooms. It then shows the
suitability of the adapted system for detecting HDR

192

Ir positional sensitivities using

different scintillating fibre probes for measuring the HDR 192Ir Brachytherapy radiation.
Finally, it suggests some recommendations and precautions, based on our practical
experience, for adapting such a system for application in brachytherapy.
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6.2. Materials and Methods:
6.2.1 Scintillating detectors:
The “BCF-60” is a scintillating single-clad polymer multimode fibre with a circular
diameter of 1mm. The light yields for this type of fibre is about 7100 photons of
wavelength 530 nm per MeV from a minimally ionising particle. Another scintillating
detector used is a CsI(Tl) (Thallium-activated Caesium Iodide) crystal where light is
mostly emitted at the longer wavelength of 550 nm with light yields of (52 - 56) x10³
photons per MeV. The CsI (Tl) crystal used to obtain this result was 1 mm long with a
diameter of 2 mm. A “BCF-98” non-scintillating fibre (a standard light-guide cable) was
used to guide the light emitted from the core of the scintillators used. Table 1 shows the
properties of the chosen scintillating detectors which are produced by Saint-Gobain
Crystals, USA.

6.2.2 Data acquisition system configurations:
6.2.2.1. The Gigahertz Optik™ trans-impedance photodiode amplifier:
A commercially available trans-impedance photodiode amplifier (Gigahertz Optik™, P9202-5) was selected with higher sensitivity and adapted in-house to fit the purpose of
our study. The photodiode front-end was operated in a photovoltaic mode (no bias
applied) where the dark current is negligible. Minimum & maximum gain settings of this
amplifier are 10-3 mV/nA and 10+4 mV/nA respectively. This amplifier system was
powered by a regulated power supply as shown in the sketch in the Fig. 6.1.

Figure 6.1: Schematic block diagram of the amplifier system (operated in photovoltaic mode) (shaded,
left) with the adapted power supply and time constant (RC filter) selector switch (right)
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6.2.2.1.1.

In-house adaptation of the commercial amplifier system:

The in-house adaptation of the commercial Gigahertz Optik operational trans-impedance
photodiode amplifier system is demonstrated. The adaptation of this commercial
amplifier is required with some modifications to fit with the radiation environment and
the requirements of the purpose of our study. The photodiode amplifier system had a
switch which will allow using it in either photoconductive or photovoltaic mode.
Therefore, it was decided to be only operated in a photovoltaic mode (not biased) which
means the photodiode behaves like a solar cell and the amount of dark current induced is
almost negligible in this mode.
The first step taken was to mount the TO-5 photodiode (S1223-01) with its receptacle on
the amplifier box as a current input. As the photodiode case is connected to the cathode,
so it was electrically isolated from the aluminium box. Another modification is that the
original socket of the original power input was removed from the amplifier box to be
fitted on the aluminium box instead. It was replaced with an additional BNC connector
for the compatibility with our own power supply. Regulated AC-coupled power supply
was in-house adapted as a mains power supply for this amplifier system.
For better enhancing the signal to noise (S/N ratio, time constant (RC) filters with three
different time constants were applied on the amplifier output along with a fuse to protect
the circuit if abnormally large currents are ever encountered. Calculation is shown in
Appendix 1.
Based on our previous experience with designing the CMRP amplifiers, some precautions
need to be followed when building such a sensitive amplifier for the HDR brachytherapy
application:
-

The sensitivity of the photodiode and the Quantum Efficiency (QE) must be
considered at a given wavelength in which is matched with the emission
wavelength of the scintillation detectors.

-

The photodiode must be mounted as close as possible and adjacent to the amplifier
input to reduce possible sources of unwanted noise.

-

As the cathode of the pin diode is connected to the case, it hence needs to be
electrically isolated by means of wrapping the diode’s case with a Teflon tape that
assists in isolating the case form being physically attached to the body of the
diode.
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-

For concerning the SMA ferrule not reaching the case, clear gel with matching
refractive index should be used so that an imperfect contact does not cause light
losses.

-

All electronic components, including the amplifier box, were then included in a
shielded diecast metal box to provide mechanical, electrical and radiation
shielding against interfering noise sources to promote accurate clinical
measurements light and electrical

-

As the output voltage of the amplifier (𝑉ᴑ ) depends on the input impedance of the
meter or datalogger. Therefore, it is recommended, during real-time data
acquisition, to be larger than 10 MΩ as the signal loss in the filter would be
negligible.

-

If the amplifier is to be operated (powered) by a normal battery rather than a
regulated power supply, it must be continuously checked and assure that the input
voltage does not go below the minimum operating voltage required for the
amplifier (operating voltage = 16 V - 22 V as stated in the datasheet).

This amplifier has an 8-position switch, allowing the sensitivity to be changed from 10-3
A/V to 10-10 A/V, meaning that the minimum & maximum gain settings of this amplifier
are 10-3 mV/nA and 10+4 mV/nA respectively. These gain values can be expressed in
different units depending on the application as the following:

Sensitivity Range

(A/V)

(V/A)

(nA/mV)

(mV/nA)

(mV/pA)

1 (Min)

1 × 10-3

1 × 103

1 × 103

1 × 10-3

1 × 10-6

2

1 × 10-4

1 × 104

1 × 102

1 × 10-2

1 × 10-5

3

1 × 10-5

1 × 105

1 × 101

1 × 10-1

1 × 10-4

4

1 × 10-6

1 × 106

1

1

1 × 10-3

5

1 × 10-7

1 × 107

1 × 10-1

1 × 101

1 × 10-2

6

1 × 10-8

1 × 108

1 × 10-2

1 × 102

1 × 10-1

7

1 × 10-9

1 × 109

1 × 10-3

1 × 103

1

-10

10

-4

4

8 (Max)

1 × 10

1 × 10

1 × 10

1 × 10

1 × 101

Table 6.1: Sensitivity range expressed in different units
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6.2.2.2. Data logging system:
The data logging system, used for this purpose, has been demonstrated earlier in the
Materials & Methodology Chapter (#3). Please refer to section 3.9.1 for more details.

6.2.3 Slew rate and timing:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.2.6. This test was conducted to inspect the slew rate and timing of the commercial
Gigahertz Optik amplifier system.

The system’s performance was evaluated in a

photovoltaic (PV) mode. Data was acquired at a sensitivity range of 1 × 102 mV/nA. For
relevant results please refer to section 6.3.1

6.2.4 In-lab stability test:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.2.7. The aim of these tests was to evaluate if there is any drift caused by the commercial
Gigahertz Optik amplifier system. The system stability was evaluated in a Photovoltaic
(PV) mode. For relevant results please refer to section 6.3.2

6.2.5 In-lab LED linearity test:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.2.8. System performance, stability, and linearity were investigated in photovoltaic mode
upon exposure to the green LED light source. Data logging tests were run in the lab, at a
low sampling rate of 1 datum per sec, for a period of 10 for each LED light intensity,
applying the lowest RC filter (5.6 ms) at a sensitivity gain setting of 1 × 104 mV/nA. For
relevant results please refer to section 6.3.3

6.2.6 Dose rate linearity & Dose linearity tests:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.2.9. Both dose-rate linearity and dose linearity of the fibre and Gigahertz
transimpedance photodiode amplifier were investigated using a CsI(Tl) scintillation fibre
optic detector, coupled to a 10 m optical fibre¸ with a 6 MV TrueBeam Linac (Varian
21ix) photon beam energy. Clinical measurements were taken at a low sampling rate of 1
sec, applying the lowest RC filter (5.6 ms) at a sensitivity range of 1 × 104 mV/nA. For
relevant results please refer to section 6.3.4
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6.2.7 Feasibility of the system for HDR brachytherapy quality
assurance:
The experimental procedure for this section was earlier described in Chapter 4, Section
4.3.8. Data was acquired at a sensitivity range of 102 mV/nA, and the HDR Brachytherapy
192

Ir movement was programmed to be in a 2 mm step size within the phantom. Fig 6.2

demonstrates the experimental setup in the HDR brachytherapy room upon the irradiation
of CsI (Tl) scintillating fibre, placed inside “solid water” (i.e. PMMA) phantom (along
the x-axis).

Figure 6.2: World coordinate system of experimental setup

6.3. Results & discussion:
6.3.1 Slew rate and timing:
Slew rate and timing of the in-house adapted Gigahertz OptikTM amplifier system was
experimentally investigated. After photons to be detected are transmitted by total internal
reflection (TIR) down the optical fibre and presented to a photodiode, the photodiode
produces a signal, and the amplifier applies large gain to amplify these signals (which
may be quite tiny), so that the signals can be recorded or further processed. There is a
slight pay-off between amplifier sensitivity (or gain) and its stability or response time to
track an input signal, so it is important to have options to control the stability and the
response time for the amplifier. The amplifier was accurately calibrated so that its overall
gain and fine details such as slew rate in response to fast-changing signals (eg: pulse
edges) are precisely known, and can be seen from Figs 6.3 which demonstrates the slew
rates for the in-house adapted Gigahertz Optik amplifier. With the lowest RC filter (5.6
ms), the signal takes around 0.01 sec to reach its stable final value. However, with the
other longer time-constant filters (180 ms and 816 ms), the time taken for the output to
reach its maximum value was approximately 0.8 sec and 3.0 sec respectively.
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(a)

(b)

(c)

Figure 6.3: Slew rate and rise time for the output of the amplifier when applying time constant
(RC) filters of a)5.6 m Sec, b) 185 m Sec, and c) 821 m Sec
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6.3.2 In-lab stability test:
In-lab stability test of the commercial Gigahertz OptikTM amplifier system was
experimentally investigated. The aim of these tests was to evaluate if there is any drift
caused by the amplifier (with no diode-connected), then with the diode, then finally with
a scintillating optical fibre connected. The tests were performed with fibre connected in
a black sheath and protected from light in a completely dark room condition. It is vitally
important that the amplifier used to amplify the photodiode detector signals for medical
radiation measurement is very stable in performance and linear in response, with known
and reproducible characteristics and capability for unwanted effects to be easily
subtracted out. The Gigahertz Optik™ adapted amplifier was checked for stability and
minimal presence of dark signal when no actual deliberate light for measurement was
presented to the photodiode front-end.

6.3.2.1. The front-end photodiode response:
Fig 6.4 shows the response of Gigahertz Optik amplifier receiving signal from the
receiving photodiode fitted into its socket and electrically connected but protected from
light in a dark room environment with applying a time constant filter of 5.6 ms. It shows
stability over almost 2 h and typically oscillated between 0 and 0.20 mV which is defined
by the amplifier gain offset, but with occasional maximum excursions from 0.10 to 0.20
mV. A. Zoomed-in view of a selected response data is demonstrated in Fig. 6.4 which
represents fine response details for 7 mins with a temporal resolution of 1 sec.

Figure 6.4: Response of Gigahertz Optik™ amplifier for a period of 2 h (RC=5.6 ms)
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Fig 6.5 represents the response of Gigahertz Optik amplifier receiving signal from the
receiving photodiode fitted into its socket, electrically connected, and protected from light
in a dark room environment with applying a time constant filter of 821 ms. It shows
stability over almost 0.5h and typically oscillated between 0 and 0.10 mV which is
defined by the amplifier gain offset. It is clearly observed that output signal was improved
when applying an RC filter of 821 ms which assisted in filtering out noise from unwanted
interfering sources. Zoomed-in view of a selected response data is demonstrated in
Fig. 6.5 which represents fine response details for almost 4 mins with a temporal
resolution of 1 sec.

Figure 6.5: Response of Gigahertz Optik™ amplifier for a period of 0.5 h (RC=821 ms)

6.3.2.2. Photodiode amplifier connected to a scintillating fibre:
Fig 6.6 demonstrates the response of the Gigahertz Optik amplifier with its input
photodiode connected to a jacketed scintillating optical fibre but protected from light
exposure in a completely dark room condition. It shows stability over almost 1.8 h and at
first slowly oscillates between about -0.5 and +1.5 mV. After about 40 minutes, this
baseline output level falls to about -1.5 to -0.5 mV. This is attributed to the amplifier
reaching a thermal and electrical steady state. The stability tests of the amplifier system
verified that the system is not susceptible to any sudden, dramatic changes in output
response or contributions from interfering sources. The adapted Gigahertz Optik system
hence shows very stable behaviour with minimal noise floor. Zoomed-in view of a
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selected response data is demonstrated in Fig. 6.10 which represents fine response details
for almost 8 mins with a temporal resolution of 1 sec.

Figure 6.6: Response of Gigahertz Optik photodiode amplifier connected to a
jacketed optical fibre for almost 2 h

6.3.3 In-lab LED linearity test:
In-lab linearity test with green LED input to the photodiode amplifier system was
experimentally investigated. The manufacturer’s specification guarantees that the device
performs linearly, with output intensity being directly proportional to input current.
Figs 6.7 & 6.8 exhibit the response of the system while the photodiode input is connected
to a jacketed scintillating optical fibre, exposed to fixed LED light intensities, and
protected from any other stray light in a completely dark room condition. The graphs
summarise the response of the system upon exposure to the green LED source. The
amplifier system exhibits a linear response to the light generated by the green LED. The
linearity of the amplifier system upon exposure to green LED was assessed by recording
the increase of the output voltage when increasing the LED input current. The
manufacturer specifies the light output intensity of the LED is linearly related to the input
current over a wide range of input current values. The adapted system shows excellent
linearity where output voltage which is proportional to input green LED current and hence
the output voltage appears linearly proportional to the “dose” rate (in this case, the green
LED intensity).
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Figure 6.7: Response of the Optik photodiode amplifier upon exposure to green LED
signal with LED currents in the µA range

Figure 6.8: Linear response of Optik photodiode amplifier upon exposure to LED

6.3.4 Dose rate & Dose linearity:
The dose rate linearity and dose linearity of the Gigahertz Optik trans-impedance
photodiode amplifiers were investigated using a BCF-60 scintillating polymer fibre
detector with a 6 MV photon beam energy from a Varian TrueBeam Linac. Different
doses, different dose-rates and different dose durations were produced by the TrueBeam
Linac to assess the measuring system linearity.
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As Fig. 6.9 clearly shows, the proposed fibre optic Optik system shows dose rate
independency over a wide range of dose rates. The Linac was also programmed to
produce sequentially varied dose levels (visible in Figs. 6.10 a&b). As shown in Fig. 6.10,
the fibre optic system shows a linear response to ionising radiation, with response being
strictly proportional to the deposited dose over a wide range of doses up to 300 MU
(convertible to cGy). This is a pleasing result and agrees with the conclusion and
prediction of dose response linearity made in the discussion following Figs. 6.7 & 6.8
above (when the system was calibrated with the green Opto LED).

(a)

(b)

Figure 6.9: Dose Rate Linearity of Gigahertz Optik photodiode amplifier system

(a)

(b)

Figure 6.10: Dose Linearity of Gigahertz Optik photodiode amplifier system
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6.3.5 The feasibility of the adapted amplifier for HDR brachytherapy
quality assurance:
The feasibility of the utilization of the in house adapted Gigahertz Optik trans-impedance
photodiode amplifier system for HDR brachytherapy quality assurance was investigated.
From the foregoing measured characteristics of the Optik photodiode amplifier system,
online detection of positional sensitivity during HDR brachytherapy source can be
acquired using the proposed DAQ system.
Fig 6.11 demonstrates the response of the adapted DAQ system with a scintillation signal
resulting from irradiation of a CsI (Tl) scintillating crystal placed at a vertical
displacement (y) of 1 cm at different horizontal displacements (z) of 1 cm with respect to
the HDR

192

Ir source movement axis. Movement of this source to various source-to-

detector distances (SDDs) produces the relative response in three different locations with
respect to the actual HDR source location. The peak values are almost identical, and the
detector provides symmetric response for all detector’s selected locations at a vertical
displacement y (height) of 1 cm, horizontal displacement z of 1 cm. -1 cm and keeping
the x-axis constant at (x, = 4.5 cm). The response of the fibre optic system is shown as a
function of time & position for each single dwell position, and the output voltage values
can be converted (if desired) to the corresponding currents induced in the photodiode at
each HDR source position. It can be summarized that the utilisation of a photodiodebased amplifier system for source tracking during HDR brachytherapy is feasible and
applying such a simple system for such advanced applicant it is highly promising.

Figure 6.11: Response of the Gigahertz Optik amplifier as a function of time when delivering the 192Ir
at vertical displacement y of 1 cm along the z-axis for multiple dwell positions, and various SDDs
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6.3.6 The dynamic technical properties of the Optik DAQ system:
In general, such an amplifier is known to be the most attractive option over other conventional
options as it is linear, predictable, and has very low sensitivity to temperature changes. It is
essential to ensure that it does not introduce any distortion due to the bandwidth or the speed of
the amplifier. Specification-related tests, of this commercial Gigahertz Optik operational transimpedance amplifier based -readout system, were carried out in the lab prior to the actual
implementation in the clinical scenario. It is required to ensure that such a system is technically
and dynamically suitable for the purpose of HDR radiation detection. Based on the preliminary
results, the capability of the operational amplifier to be able to accurately reconstruct the HDR
source position has been assessed to be feasible. Hence, there are some important aspects that
need to be discussed based on the acquired results.

6.3.6.1. The dynamic range of the amplifier:
The dynamic range of any amplifier should be aligned with the amount of current that is
generated at certain distances during HDR source reconstruction. The in-house adapted
Gigahertz Optik amplifier system has been dynamically assessed to be suitable to detect

the maximum and minimum current produced by the scintillating fibre optic system
which was in the range of pico-amp for the organic plastic scintillator and nano-amp for
the inorganic crystal scintillator.
However, based on our in-clinic experimental investigations while using Gigahertz Optik
amplifier system at the real HDR Brachytherapy clinical scenario, it has shown that the
current measurements taken are in the order of pico-amp of less than 1 nA, especially
when using the polymer scintillator fibre. Therefore, it has been observed that the adapted
Optik amplifier system was practically sensitive to detect current coming from the
photodiode when using very short lengths (< 5 mm) of polymer (plastic) scintillation
detector which produces a current in the range of pico-amp, as shown he experimental
results in Chapter 7. Therefore, the dynamic range of the amplifier was capable of
detecting the current from both organic and inorganic scintillation detectors, considering
that the range of the current produced was at the order of pico-amp and nano-amps for
both detectors respectively.

6.3.6.2. Speed of the amplifier:
The amplifier used for HDR source tracking must be fast enough to be able to record the
speed of HDR

192

Ir source while dwelling constantly and measure the transition of the

HDR source from a position to another within the phantom. The source moves at approx.
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50 cm/s within an HDR transfer tube over a length of 1.2 m. At the dwell point, the source
can overshoot the mark by a few mm (up to 7mm leeway) before settling into the dwell
position, but this effect is the order of fractions of a second. Based on Fig. 6.3 presented
earlier in this chapter, the Gigahertz Optik amplifier system can resolve the input signal
in a very short time. It is demonstrated that the signal, with the lowest RC filter (5.6 ms),
takes around 0.01 sec to reach its stable final value. However, the output signal takes
approx. 1 sec and 3 sec to reach the final state value when applying RC filters of 185 ms
and 821 ms respectively. Also, Fig. 6.11 confirms that the Gigahertz Optik amplifier
system is being capable of tracking the HDR source transition in real-time when sent from
the afterloader to the phantom and retracting back to the afterloader. It also shows
excellent performance of detecting real-time HDR source transition of sub-millimetres
within inter-dwell positions, the total number of dwell positions dwell time at every single
position, and total time for the entire treatment session.

6.3.6.3. Signal to noise (S/N) ratio:
The amplifier used for such an application requires a higher signal to noise (S/N) ratio to
distinguish the pure scintillation signal from the baseline (background). This adapted
Gigahertz Optik amplifier system demonstrates higher S/N ratio when using CsI (Tl)
scintillating signal, and that was clearly observed when inspecting Figs. 6.6 & 6.11, and
further results are shown in Chapter 8. However, much lower S/N ratio is achieved when
using scintillating plastic fibre as indicated by results shown in Chapter 7.

6.4. Conclusion:
This chapter has described the modification of a commercially available, multiple-range,
high-gain Gigahertz Optik amplifier to produce a quality assurance tool suitable for
interfacing to fibre optics for real-time HDR brachytherapy measurements. A green Opto
LED testing system was designed, constructed and tested and provided highly linear and
controllable light levels for calibrating the photodiode in the lab, without needing ionising
radiation sources. The preliminary results presented in this chapter emphasize the
capability of the investigated system for performing real-time measurements in an HDR
brachytherapy clinical setting. The results also illustrate that the photodiode amplifierbased system is an excellent and versatile system when using either a scintillating plastic
fibre or an inorganic crystal detector. The resulting system can be considered a preferred
candidate and a convenient mean for performing real-time quality assurance tests in both
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source verification and dosimetry modes during HDR Brachytherapy procedures. Based
on the results of real-time HDR source tracking shown previously, it is concluded that the
utilization of a Gigahertz Optik amplifier system for source tracking during HDR
brachytherapy is feasible. However, one of the challenging aspects of any scintillation
fibre optic systems is the production of Cerenkov induced light (a source of unwanted
signal) is mixed with the pure scintillation signal. Hence, it needs to be considered and
corrected for when measuring the radiation dose using this system. As the aim of this set
of our experiments was only targeted at HDR source tracking, it, therefore, does not
rigorously require the separation of the simultaneous stem-effect signals.

Page 6-110

Pre-clinical optimisation and characterisation of
a polymer fibre optic sensor for high dose rate brachytherapy quality
assurance

7.1. Introduction:
Modern radiation therapy requires accurate tools for radiation delivery and treatment
monitoring (Knoll, 2010). Due to the complexity of brachytherapy treatment procedures,
in terms of source positioning and dose delivery, it has been strongly advised to apply
reliable quality assurance (QA) tools for in-vivo dosimetry to assure the safe delivery of
Brachytherapy treatment doses as clinically prescribed (Fraass et al., 1998; Hendee &
Edwards, 1986; Nath et al., 1997; Valentin, 2005). Scintillating plastic fibre-optic based
detectors have proven their capabilities to be reliably implemented in clinical scenarios
owing to their water equivalence, dose rate- & energy-independence, and especially their
small size which allows for insertion into a brachytherapy catheter (Beaulieu & Beddar,
2016).
The importance of this research springs from the increasing number of people with cancer
requiring treatment worldwide. In addition, there is an increasingly high demand for realtime QA devices for dosimetric purposes in various radiotherapy applications. Moreover,
the need for such reliable QA tools has become mandatory due to the shortcomings of
currently existing tools in the clinical setup used for brachytherapy applications. The main
aim of this research study is to carry out comprehensive investigations on the
development of a portable fibre-optic dosimetry system dedicated for real-time
monitoring and verification of high dose rate (HDR) brachytherapy, with the further aim
of developing a localising system that accurately determines the location of the HDR
Brachytherapy source in-vivo. The system is based on the placement of scintillating
optical fibres within the treatment volume (through catheters) to provide a triangulated
localisation of the source in 3D space.
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7.2. Materials & Methods:
7.2.1 Scintillation detectors:
Scintillating plastic fibres (BCF-60, Saint-Gobain Crystals USA) with different crosssectional shapes (square & round) were neatly cut into desirable lengths (from 50 mm to
5 mm &1m), the exit ends polished optically flat, and then optically coupled to a 1 m length

(or 9 m length for some experiments) non-scintillating plastic fibre (BCF-98 Saint-Gobain
Crystals USA or CK-40) to guide the light to a TO-5 PIN-photodiode (S1223-01Hamamatsu) at the front end of a signal amplifier. Properties of the fibre optic-based
scintillation detectors utilized has been been demonstrated previously in Materials &
Methodology Chapter (#3). Please refer to Table 3.1 & 3.2 for more details.

7.2.2 Data acquisition system configurations:
7.2.2.1. In house designed
amplifier system:

CMRP

trans-impedance photodiode

A trans-impedance photodiode amplifier (current to voltage converter) was designed inhouse with a mount for the receiving photodiode, in a metallic box for shielding purposes,
with all circuitry electrically isolated from the box. Minimum & maximum gains of the
amplifier were 270 mV/nA and 1620 mV/nA respectively. This photodiode was powered
by Zener diode-regulated power supply as shown in Fig. 7.1 below, operated in a
photoconductive mode (bias applied) where dark current is present and needs to be
accounted for. Please refer to Chapter 4 for more details.

7.2.2.2. Gigahertz Optik™ trans-impedance photodiode amplifier
system:
A commercially available trans-impedance photodiode amplifier (Gigahertz Optik™, P9202-5) was used to measure real-time light output with simultaneous data analysis for
treatment monitoring. This amplifier minimum & maximum sensitivity range of this
amplifier are 10-3 mV/nA and 10+4 mV/nA respectively. This photodiode was operated in
a photovoltaic (PV) mode (no bias applied) wherein the dark current is negligible, and
power was supplied by a diode-regulated power supply. Please refer to Chapter 6 for more
details.
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7.2.2.3. Data logging system:
The data logging system, used for this purpose, has been demonstrated earlier in the
Materials & Methodology Chapter (# 3). Please refer to Section 3.9.1 for more details.

7.2.3 Monte Carlo (MC) simulation of the scintillation response:
A Monte Carlo simulation of the response of a scintillating material, when irradiated with
HDR 192Ir, was performed using the GEANT4 toolkit (4.9.2). It investigates the response
of a scintillation detector for three different vertical displacements with respect to the
HDR

192

Ir source location. Also, to validate the methodology behind converting signal

response to a source location. For relevant results please refer to section 7.3.2.

7.2.4 Experimental work in HDR brachytherapy room:
7.2.4.1. Treatment plan system by the Ocentra (TPS):
The 192Ir source was programmed to dwell at 37 predetermined dwell positions in 2.5 mm
steps starting from the position #10 (x, y = 0 mm, 0 mm) until reaching the other edge of
the phantom at ( x= 90 mm, y= 0 mm) at dwell position #46, for a dwell time of 10 sec at
each position. The solid water-equivalent “phantom” stack with a catheter inserted the
whole way through, was CT-scanned, and source dwell positions were digitised using the
Oncentra TCS which was used as a remote-control panel for the HDR

192

Ir afterloading

delivery. EBT3 films were used to verify planned dwell positions between the two edges
and through the centre of the phantom. Fig 7.1

Y
X

Figure 7.1: CT image used for TPS dwell position digitisation (Left), Oncentra TCS
interface for HDR brachytherapy source delivery (right)
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7.2.4.2. General experimental setup:
The experimental setup used had either the CMRP or the Gigahertz Optik transimpedance photodiode amplifiers connected to the fibre probes placed within the
treatment room, close to the radiation source afterloading machine, to measure real-time
light output. For maintaining a high level of protection against unwanted interfering noise
sources, our DAQ systems were placed at a distance of 1 m from the patient couch and
then shielded by some lead blocks. The scintillating fibre probe was placed at predetermined locations with accurately known and recorded positions within the phantom
stack, at varying distances above the 192Ir brachytherapy source located within the catheter
when dispensed by the afterloader. The experimental setup, HDR phantom design, and
placement of the DAQ system are depicted in Fig. 7.2.

Figure 7.2: Illustration showing the general “phantom” stack experimental setup performed in the HDR
Brachytherapy room. The close-up view of the phantom stack shows the fibre probe and Brachytherapy
source location within the phantom

7.2.4.3. Optimisation of experimental setup & detector’s optical
properties:
The experimental setup was investigated to decide on the optimal setup of the proposed
system. Optical properties including attenuation and signal transmission efficiency after
polishing &/or coating were investigated. These test results will be shown separately in
the result section.

7.2.4.4. Investigating the optimal length of plastic scintillating fibre:
Scintillating plastic fibres (BCF-60, Saint-Gobain Crystals USA) with different
scintillation lengths were finely cut into specific lengths from 75 mm down to 5 mm, and
then optically coupled to either a 1m or 9 m long clear plastic fibre (BCF-98, Saint-Gobain
Crystals USA).
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7.2.4.5. Investigating the positional sensitivities of the optimal fibre
length:
Scintillating plastic fibres (BCF-60, Saint-Gobain Crystals USA) with round crosssection and a scintillation length of 5 mm were polished, reflection paint-coated, and then
optically coupled to a 1m long clear plastic fibre (BCF-98, Saint-Gobain Crystals USA).
Positional sensitivities were acquired along the direction of the X axis of the HDR source
movement.

7.2.4.6. Feasibility of HDR Brachytherapy source localisation based on
triangulation method:
Three fibres probes of 3 mm of BCF-60 scintillating fibre (Saint-Gobain Crystals, USA)
was prepared in-lab to achieve the highest spatial resolution with maintain reasonable S/N
ratio. This short fibre section was then optically coupled to a 10 m long non-scintillating
plastic fibre (CK-40, Eska) to guide the light to the photodetector/amplifier/readout
system. The feasibility of response triangulation of three fibres probes, placed at three
horizontal Z positions within the solid water phantom for one vertical displacement Y to
the HDR catheter, is investigated. The HDR catheter was inserted into the solid water slab
which allow the source dwelling in a 2 mm step size over the length of the phantom and
then retracting back.

7.3. Results & Discussion:
7.3.1 Verification of the planned HDR treatment:
Four predetermined dwell positions were programmed with a mock treatment delivery to
make sure that the planned dwell positions matched the delivered ones. After placing the
film sheet underneath the phantom, it was visible that source was delivered to the exact
positions and it was concluded that treatment plan was ready for real HDR source
delivery.

Figure 7.3: EPT3 film used as verification tool of an HDR Brachytherapy treatment delivery
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7.3.2 Monte Carlo (MC) simulation of the response of a scintillating
material upon irradiation with HDR 192Ir:
Figures 7.4 & 7.5 demonstrate a Monte Carlo simulation which validates the expected
response of the scintillating plastic fibres for multiple dwell positions while
demonstrating the variance of detector response with source location. Figures clearly
show the ability of such detector to distinguish between varying source locations at
multiple dwell positions while signal to noise ratio (SNR) is maintained at a high level.
High resolution is achieved when the detector is placed closer to the source at a vertical
displacement of 0.5 cm for various SSDs and reduced when the detector is placed away
from the source at a vertical displacement of 5 cm for various SSDs. We have
experimentally investigated both scintillator length and optimal vertical displacement
later in this chapter.

Figure 7.4: Monte Carlo simulation of the response of scintillating fibres with HDR 192Ir

Figure 7.5: Relative response of a scintillator versus y-offset in cm with HDR 192Ir
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7.3.3 Pre-clinical optimisations of the produced signal:
7.3.3.1. Sensitivity of both in house designed CMRP & adapted
Gigahertz Optik amplifiers
A fully scintillating fibre, with a length of 1 m at a vertical displacement (y) of 0.5 cm
from the source movement (x) axis, was used to investigate the sensitivity of both
amplifiers. Figure 7.6 shows clearly that the adapted commercial amplifier (Gigahertz
Optik™) shows higher sensitivity than the in-house designed amplifier while applying
the maximum gain for each amplifier. It is attributed to the higher maximum sensitivity
range for the Gigahertz Optik amplifier 104 mV/nA, compared with the CMRP-designed
amplifier which has a gain of 1620 mV/nA. However, both amplifiers demonstrated long
term stability throughout the period of clinical measurements. On the other hand, the inhouse designed amplifier was more practical for clinical use when longer lengths of
scintillating fibres (3 cm or more) are to be used, since sufficient photons are generated,
and these are well within the dynamic range of the amplifier. Once the scintillation length
has been shortened to tiny lengths where signal to noise (S/N) ratio becomes relatively
poor, then the use of the Gigahertz Optik amplifier is recommended for achieving more
accurate and reliable results.

Figure 7.6: Comparison of the sensitivity of two amplifiers
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7.3.3.2. Optical properties of the multi-mode scintillating optical fibres
used:
A fully scintillating BCF-60 (green emitting) fibre 1 m long, a 7.5 cm composite fibre
attached to 1 m clear fibre, and a clear 1m fibre were used in this investigation to test the
sensitivity of these fibre probes. The source was delivered to one dwell position at a time
at a vertical displacement (y) of 0.5 cm above the source movement axis. It is notable
from Figure 7.7 that the full BCF-60 green emitter exhibits high attenuation due to the
nature of the multi-mode fibre and high probability of scintillation occurring throughout
the whole length of the fibre probe. Attenuation would be minimal if a much smaller
length of BCF-60 scintillating element is optically coupled to a clear optical fibre (Louis
Archambault, Beddar, Gingras, Roy, & Beaulieu, 2006). Hence, it is observed from
Figure 7.8 that the partially scintillating fibre (C) shows a higher signal (less attenuation)
than the fully scintillating fibre (B). However, the signal generated by the clear fibre (A)
is the lowest among the fibre probes, but is not zero, attributed to the effect of Cerenkov
light produced at a certain threshold which is obviously above the average energy of the
Iridium source of 380 keV (Therriault‐Proulx, Beddar, Briere, Archambault, & Beaulieu,
2011). It accounts for 37.59% of the main signal for the partially scintillating plastic fibre
(C) which shows otherwise constant behaviour under all of the tested conditions.

Figure 7.7: Attenuation of fully scintillating plastic fibre when interacting with HDR 192Ir radiation
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Figure 7.8: Comparison of three different plastic fibre probe responses (A, B, C)
using identical lengths and irradiating with HDR192Ir, y = 1 cm

7.3.3.3. Optical properties of multi-mode non-scintillating fibre (BCF98):
Tests were performed to investigate about the optimal bare fibre length (1 m, 9 m)
attached to plastic scintillator (7.5 cm). It would be advantageous to convey the optical
scintillation signal from the detection area (in our case, the “phantom” stack on the patient
couch) to the control room, in order to minimize the addition of “noise” from stray
radiation, stray light or electrical spikes from the equipment in the HDR brachytherapy
room. However, conveying optical signals from the therapy room to the control room
necessitates the addition of 9 – 10 m of extra (clear) optical fibre. This may be feasible,
however, there is a need to trial this and verify that the extra optical path length doesn’t
lose signal or gain unwanted extra ‘noise’ signals. The Gigahertz Optik™ amplifier was
used to perform these experiments. At first, this amplifier was placed inside the treatment
room (shielded by a lead shield from stray HDR). A 7.5 cm length of scintillating fibre
was used as detector, coupled to a 1 m clear fibre in order to reach from the phantom stack
to the measuring amplifier. For comparison, the same 7.5 cm length of scintillating fibre
was used as detector, but this time coupled to a 9 m clear fibre in order to reach all the
way into the control room where the receiving amplifier is well away from any possible
stray HDR or therapy room electrical interference. The signal with the amplifier at close
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range (i.e. 1 m of clear fibre) was verified to have higher signal, better stability, and better
resolution compared to the composite fibre of 7.5 cm scintillating fibre with 9 m clear
extender fibre with the amplifier in the control room. The multimode “clear” fibre clearly
had high attenuation. When irradiated by the

192

Ir source and after transiting 9 m length

of clear fibre, only 1mV of signal was detected at the input of the amplifier. This is only
10-20% of the scintillation signal observed with the 1 m clear extender fibre – clearly
indicating an unacceptable loss. For comparison, 1 cm of fully scintillating fibre coupled
to 1m of clear extender fibre showed a reasonable response with minimal noise when the
amplifier remained inside the treatment room.

Figure 7.9: Comparison of three different fibre probe configurations

7.3.3.4. The effect of backscatter on the signal produced:
Composite scintillating fibre cable with 1 cm scintillator long attached to 1 m clear
waveguide at a vertical displacement (y) of 0.5 cm from the source movement axis, was
used to investigate the effect of backscatter on the scintillation signal while the source
was delivered to the middle of the phantom (x= 45 mm). The effect of radiation
backscattering and dose build-up was investigated using solid water-equivalent slabs of
different thicknesses which were added gradually, starting from 0 cm to up to 5 cm above
and underneath the detector. It is noted that adding 5 cm of solid-water slabs above and
underneath the fibre led to a stabilisation of the acquired response to a steady value that
did not increase when additional slabs were added.

Page 7-120

Figure 7.10: Effect of backscatter material on the acquired response

7.3.3.5. The effect of scintillating fibre shape (round – square):
A 3.80 cm length of scintillating fibre cable were prepared, using both round & square
cross-section scintillating fibre, each of 1.00 mm nominal dimension. These were coupled
to a 1 m clear fibre and placed in the middle of the phantom (x= 45 mm) at a vertical
displacement (y) of 0.5 cm from the source movement axis. This was used to investigate
scintillation signal levels while the source was delivered to the middle of the phantom (x=
45 mm) for both cases at various SDDs. From the findings shown in Fig 7.11, it can be
observed that there are no major differences between the response of the round and the
square scintillating fibres in terms of the general trends. However, the amount of signal
transmitted by the round shape fibre is slightly larger than the transmission by the squareshaped fibre. The round-shaped scintillating fibre exhibits a higher response than the
square-shaped scintillating fibre by approximately 9% especially when the source is
dwelling directly perpendicular to the detector location. Most of this difference is
accounted for by the amount of light being lost due to the optical coupling of a squareshaped fibre of 1.00 mm side length to a round clear extender fibre of 1.00 mm diameter.
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Figure 7.11: Actual Response of 3.80 cm length round & square scintillating fibres coupled to 1 m
clear plastic fibre (left) and averaged response (right) of the same fibres for multiple dwell positions at
a vertical displacement of 0.5 cm

7.3.3.6. The effect of polishing and coating on the acquired signal:
Different lengths of scintillating fibre (9.0 cm, 2.80 cm and 0.5 cm), were coupled to a 1
m clear fibre to investigate the effect of polishing and coating on the acquired signal at a
vertical displacement (y) of 0.5 cm from the source movement axis. Fig. 7.12 show the
response of the fibre optic system and DAQ when the open end of the fibre was
mechanically polished for flatness. It was found that applying Titanium Dioxide
(TiO2) paint as a Reflective coating can assist to enhance the optical signal produced. In
Figures 7.12 – 7.14 shown below, the effects of optical polishing and/or reflective coating
the external tip of scintillating fibre section end face is noticeable. Fig 7.12 shows the
response of a 9 cm length round scintillating fibre and the effect of polishing the fibre and
coating it with TiO2 paint. The received signal shows an increase of 3.9% after the fibre
is polished and a further 17% improvement when reflectively coated, especially when the
source is dwelling directly perpendicular to the detector location. This coating clearly
assisted in enhancing the efficiency of the light containment (TIR) and transmission from
the scintillating fibre to the measuring photodiode (rather than “leaking” out of the open
tip of the scintillating fibre). All of the various lengths of scintillating fibre measured
showed a typical improvement in intensity transmission of around 13% when the open
fibre end face was coated with the TiO2 paint.
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However, polishing the open-end face of the scintillating fibres did not cause any clear
improvement to the acquired signal. The fibres were cut cleanly using a straight, sharp
cutting blade, so the cut face was quite clean and optically flat. Therefore, the need for
polishing the end face of the fibre used should probably be assessed by a quick eye check
or microscopic inspection to determine if there is any need to re-cut or further polish the
end face of the scintillating fibre. Where there is a more important, in fact crucial, need
for polishing is when terminating the clear (extender stem) fibre end face for connection
to the photodetector of the amplifier (a standard SMA connector). In particular, care needs
to be taken to remove any residual epoxy adhesive which was used for gluing the ferrule
to the body of the fibre. Any polishing operations on the fibre end faces should be done
carefully since the fibre is polymer rather than glass and the polishing action is abrasive.
Over-enthusiastic “polishing” can lead to scratches or other physical damage to the fibre
material which in turn will make its transmission of the scintillation light worse rather
than improved.

Figure 7.12: Effect of polishing and TiO2 reflective coating on the response of a 9
cm scintillating fibre coupled to 1 m long clear fibre placed on the right perimeter of
the phantom a vertical displacement of 0.5 cm
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Figure 7.13: Effect of coating on the response of 2.8 cm scintillating fibre coupled to 1 m
long clear fibre placed in the middle of the phantom at a vertical displacement of 0.5 cm

Figure 7.14: Effect of coating on the response of 0.5 cm scintillating fibre coupled to 1 m
long clear fibre placed in the middle of the phantom at a vertical displacement of 0.5 cm

7.3.3.7. TO-5 photodiode (S1223-01) induced signal with lead shielding:
The purpose of this section is to investigate the optimal clinical setup for our proposed
system. Fig. 7.15 shows the response of the DAQ system only, before any scintillator
signal was optically conveyed to the DAQ system, with only the photodiode active. The
DAQ system here was not shielded by any lead radiation shielding, and HDR source
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afterloader was kept at different distances from the DAQ system to see if it radiates any
kind of noise or signal which might be detected by the DAQ photodiode. It is clearly seen
in Fig. 7.15 that there are large signal “spikes” near the beginning and end of the data
collection. These are due to the afterloader machine and are produced with the HDR
source is first supplied to the phantom and when it is withdrawn back to the afterloader.
It is reassuring that these spikes are handled stably by the amplifier and don’t overload its
sensitivity. They are actually a useful feature because they can be used as an independent
check of where the data acquisition began and ended, to check if the total dwell time is as
requested by the treatment planning system (TPS).

Figure 7.15: Response of photodiode amplifier upon HDR 192Ir treatment delivery at multiple
dwell positions for different distances to the afterloading machine without lead shielding

Fig. 7.16 shows the response of the fibre optic system with only photodiode connected,
DAQ system was shielded by lead blocks, and HDR source dwelling at multiple positions
at a distance of 80 cm from the HDR source after-loading machine. The response of the
DAQ system, once again with only the photodiode active (no light fibres attached), and
the DAQ system being shielded or not shielded from the HDR source after-loading
machine by lead blocks. The TPS was controlling the afterloader to move the HDR source
and have it dwelling at sequential positions for about 160 seconds total duration. Once
again, it is clearly seen in Fig. 7.16 that there are clear signal “spikes” from the afterloader
when the HDR source is first supplied to the phantom and when it is withdrawn by the
afterloader.
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Figure 7.16: Response of photodiode amplifier, upon HDR 192Ir treatment delivery at
multiple dwell positions, placed at 80 cm to the afterloading machine with and without lead
shielding

Fig. 7.17 shows the response of the fibre optic DAQ system when exposing a 1 m long
non-scintillating polymer fibre to the HDR source dwelling at multiple positions at
different orthogonal distances to the detector’s location. A couple of trends can be
observed. Some signal is produced due to a combination of fluorescence and Cerenkov
(or Cherenkov) Effect. Also, there is a clear benefit to applying the lead radiation
shielding – signal levels are noticeably lower when the lead shielding is in place between
the DAQ system and the afterloader and irradiation area.

Figure 7.17: Response of non-scintillating fibre at different vertical displacements (y)
with and without lead sheading
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7.3.4 Background signal produced by clear polymer fibres:
7.3.4.1. Bare fibre probe inserted in the centre of the phantom X at
three “y” heights:
A 1 m long bare clear plastic waveguide, with no scintillator attached, was used to
investigate the effect of stem signal on the acquired signal. The fibre was placed on the
centre of the phantom at a vertical displacement (y) of 0.5 cm from the source movement
axis. In Figure 18 presented below, the response of non-scintillating polymer fibres of
different test lengths upon irradiated with the
afterloader supplied the

192

192

Ir HDR source was investigated. The

Ir source from the back of the phantom stack (i.e. high x

position values). The non-scintillating polymer fibres of different test lengths were
positioned nearer the front of the phantom stack (i.e. low x position values). Thus, more
of the test fibre is exposed to the HDR source when the source is at the larger “x” dwell
positions in Fig. 7.19. (Fig. 7.1b shows a view of the actual set-up as seen from the righthand side). The observed responses seem fairly coherent and reasonably linear with
increasing exposed length of the fibre to radiation. It is clearly noticeable that the response
acquired depends on the length of clear fibre being irradiated, the longer the fibre is, the
more signal is obtained.
There is also seems to be a logical effect when varying the distances from the HDR source
from 0.5 cm to 5 cm (As distance from source is increased, the measured signal increases
slightly. This is counter to what would be expected simply from intensity inverse square
dependence alone and is good evidence that some sort of back-scattering or adjacent
media-scattering is taking place. This aspect was explored in further detail and results are
presented below). The received signals in this setup would be due to a combination of
polymer fluorescence and Cerenkov Effect induced in the bulk of the fibre. The emitted
energy spectrum of HDR 192Ir source is known to have a gamma peak at 380 keV, which
could easily generate fluorescence.

Page 7-127

Figure 7.18: Response of clear polymer fibre sections inserted from the opposite
direction to the HDR 192Ir source catheter when irradiated at various y positions

Figure 7.19: Response of clear plastic fibre inserted from the same direction as
the HDR 192Ir source catheter when irradiated at various y positions
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7.3.4.2. Bare fibre probe placed at the beginning edge (X-axis) of the
phantom at two “y” heights:
Fig. 7.20 shows the response of the fibre optic DAQ system after placing a 1 m long nonscintillating plastic fibre at the initial edge of the phantom (x= 0) at two different heights
(y = 1 cm & 3 cm). The fibre was laid parallel to the source path when the source was
sequentially stepped to dwell at multiple positions along the x axis. The initial and final
“spikes” are created by the afterloader when the source is first presented to the phantom
and then withdrawn from the phantom. These spikes do not affect the measurements of
interest and do not overload the amplifier, which is stable enough to accommodate these
signal spikes. The stem effect signal due to all sources (Cerenkov and fluorescence) was
only 25 mV maximum when working at 3 cm height from the source and increased
slightly (to 34 mV) when working at only 1 cm from the source. As can be seen in Fig.
7.20, the DAQ system can easily handle signal levels of ~ 570 mV, so 34 mV represents
only ~ 6 % of the full-scale signal value which can be accommodated.

Figure 7.20: Response of photodiode amplifier, upon HDR 192Ir treatment delivery at
multiple dwell positions, when the bare fibre placed on the edge of the phantom at two
vertical displacements
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7.3.4.3. Bare fibre probe inserted the whole way through the (X-axis)
of the phantom at three vertical (Y) distances:
Fig. 7.21 demonstrates the response of the fibre optic DAQ system upon inserting a 1 m
long non-scintillating polymer fibre the whole way through the phantom (i.e. x varying
from 0 to 90 mm) at three different “y” heights. The maximum stem effect signal due to
all sources (Cerenkov and fluorescence) was only 26 mV when working at 3 cm height
from the source and increased slightly (to 28 mV) when working at 2 cm from the source
or 35 mV when working at 1 cm from the source.

Figure 7.21 : Response of photodiode amplifier, upon HDR 192Ir treatment delivery at
multiple dwell positions, when the bare fibre placed the whole way through the
phantom at three vertical displacements

7.3.5 Optimisation of the optimal length of the scintillating fibre:
7.3.5.1. Fully scintillating fibre:
Optimisation of the optimal length of the scintillating fibre probe, used for the purpose of
HDR brachytherapy quality assurance, was investigated. Figure 22 represents the overall
response of different lengths of scintillating fibres which were investigated. It reveals the
response of a 1 m length fully scintillating fibre when it was placed within the solid waterequivalent phantom at various distances from the HDR

192

Ir. This graph actually

represents an “image” of the HDR source strength as a function of x position (the dwell
position number corresponds to a precise distance along the x axis of the coordinate
system we have used throughout our work). Far better resolution could be obtained if the
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scintillator fibre length is reduced to an appropriate length. The optimal length is further
investigated in part B following.

Figure 7.22: Responses of a 1 m fully scintillating fibre when irradiated by HDR 192Ir
at different y heights

7.3.5.2. Composite scintillating fibre plus clear waveguide:
As can be seen from Fig. 7.23, the response of different lengths of scintillating fibre were
investigated upon interaction with 192Ir source for various x dwell positions, all with y =
0.5 cm (i.e. the detector 0.5 cm from the 192Ir dwell path. Every fibre length exhibited a
unique response, with an obvious monotonic trend of higher response for larger
scintillator fibre lengths. The change in response with changing source x position (dwell
position number) became increasingly flattened with longer scintillation fibre lengths.
Longer fully scintillating fibres clearly generated more photons than short scintillating
fibres, however, used in this orientation they have very poor spatial resolution and
flattened responses.
As shown in Fig 7.23 short scintillating fibres such as 7 cm long attached to 1 m clear
fibre demonstrated higher signal and slightly flattened response when placed was
dwelling perpendicular to the fibre position but relatively better spatial resolution than
the 1 m fully scintillating fibre. Likewise, in Fig. 7.24, other fibres with shorter
scintillation lengths (3.8 cm, 2.8 cm, 2 cm, 1 cm) exhibited a similar behaviour of
achieving a better spatial resolution but lower signal. From the figures mentioned below,
it is clearly shown that the 3 cm scintillation fibre has the capability to distinguish between
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the adjacent dwell positions of 2.5 mm step size even when the source was dwelling
perpendicular to the fibre position. Hence, the compromising between the signal and the
resolution needs to be justified. There is a trade-off between the length of scintillating
fibre and the spatial resolution which must be rationally balanced for successfully
achieving the desired spatial resolution and maintaining a reasonable (S/N) ratio.

Figure 7.23: Responses of different lengths of scintillating fibres when irradiated by HDR
192
Ir sequentially advanced through the middle of the phantom at y = 0.5 cm height

Figures 7.24 illustrate respectively the responses of 3.8, 2.8, 2 and 1 cm scintillating
plastic fibres coupled to a 1 m long clear fibre when irradiated with HDR 192Ir. The fibre
was placed in the middle of the phantom (X-axis), above the movement axis (x) of the
HDR source at various SDDs and heights. It is observed that bell-shaped curves are
acquired and clearly distinguished when the detecting fibres were close to the source at
y=0.5 cm or y=2 cm. The peak width or Full Width at Half Maximum (FWHM) decreases
when decreasing the scintillating fibre length from 4 cm to 1 cm. But the bell-shaped
profile is very diminished if the detecting fibres are placed too far away from the source
(eg: y=5 cm). Hence, these short detecting fibres are keenly affected by the inverse square
law of radiation intensity from the source. It is a trade-off between the signal and
resolution, the same as in gamma camera imaging.
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Figure 7.24: Responses of 3.8 cm, 2.8 cm, 2 cm, and 1 cm scintillating fibre coupled to 1 m long
clear fibre when irradiated with HDR 192Ir sequentially advancing through the middle of the
phantom at various y heights
Page 7-133

7.3.6 Determining the optimal distance (height y) from the detector to
the HDR source:
Different fibre lengths were used to investigate the optimal response with respect to the
vertical displacement (y). From Fig 7.25, it is seen that the signal acquired is clearly
distinguishable and has an excellent spatial resolution when a y height of 0.5 cm is used.
However, this good characteristic is slightly diminished when placing the fibre at a y
height of 2 cm. At y = 5 cm, the source location becomes barely recognisable if a short
detector fibre is being utilized. Additionally, with the combination of short scintillating
detector length and large y, there is a significant stem effect (Cerenkov and fluorescence)
skewing the observed total signal.

Figure 7.25: Responses of different lengths of scintillating fibres when irradiated with
HDR 192Ir placed in the middle of the phantom at y = 0.5 cm

Figure 7.26: Responses of different lengths of scintillating fibres when irradiated with
HDR 192Ir placed in the middle of the phantom at y = 2 cm
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Figure 7.27: Responses of different lengths of scintillating fibres when irradiated with
HDR 192Ir placed in the middle of the phantom at y = 5 cm

The profiles in Figure 7.28 below provide a summary of the responses of different
scintillating fibres coupled to a 1 m long clear fibre when irradiated with HDR

192

Ir at

various SDDs.

Figure 7.28: Responses of different lengths of scintillating fibres coupled to a 1m
long clear fibre when irradiated by HDR 192Ir placed stepping through the middle of
the phantom at various y heights

7.3.7 Investigating positional sensitivities of the proposed QA system:
From the experimentally measured data shown in the forgoing graphs below, it is
confirmed that the proposed system has the capability of providing positional sensitivity
in which is relatively changed upon changing the detector location inside the solid water
phantom. Likewise, the more scintillating length that is provided, the more the signal is
produced but there is a trade-off with poorer spatial resolution achieved.
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Figure 7.29: Responses of 2.8 cm, 2 cm & 1 cm scintillating fibres coupled to 1 m long
clear fibre when irradiated with HDR 192Ir placed at sequential x locations inside a
phantom at y = 0.5 cm
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Figure 7.30: Responses of different lengths of scintillating fibre coupled to 1 m long
clear fibre when irradiated with HDR 192Ir dwelling at different sequential x locations
inside the phantom at y = 0.5cm, different “z” locations

7.3.8 Feasibility of HDR Brachytherapy source localisation utilizing
polymer scintillation detectors:
This section demonstrates the feasibility of response triangulation of three fibres probes
placed at three horizontal Z positions within the solid water phantom for one vertical
displacement Y to the HDR catheter. Responses of the triangular response to HDR
radiation, and several features are shown noteworthy in Fig. 7.31: Despite the excellent
gain and low noise levels of the Gigahertz Optik amplifier, overall, it achieved only a
poor S/N ratio due to the very low signals obtained from such short lengths of scintillating
fibres. While the source 2 mm dwell (step) size is discernible, it is far less distinct (fuzzier)
than the analogous result with the CsI(Tl) crystal detector (that is shown in Chapter 8).
Thus, HDR source localization using this system with 3 mm plastic scintillator is not
possible, but it is highly unlikely to have sufficient resolution for accurate HDR
positioning.
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Figure 7.31: Positional sensitivity when scintillating polymer detector is placed 1 cm
(left, centred or and right) above the HDR source axis

7.4. Conclusions:
The polymer fibre optic sensor was optimised in terms of the shape of plastic scintillator
selected, and coating with a reflective paint. The efficiency of the signal obtained can be
increased using the round shape plastic scintillating fibre. However, the waterequivalence is slightly compromised if applying this coating agent as it has a high
effective atomic no. The optical fibre probes were tolerant of cutting to length and
polishing operations and coating the fibre tip with a reflective paint was proved
advantageous to conserve optical signal levels. It was demonstrated that using a relatively
long (5 cm – 1 m) scintillating fibre produces high signal levels but loses spatial
resolution, hence, a trade-off must be made between signal level obtained (or its
signal/noise level) and spatial resolution.
The proposed DAQ system has been technically optimised and pre-clinically investigated
with a commercial Gigahertz Optik™ transimpedance amplifier adapted in our lab to
become a sensitive, high-gain photodiode amplifier for optical signals. The developed
polymer fibre optic DAQ system was proven excellent for measuring dose in a specific
location of interest, because there is no need to track the radiation source. However, the
size of the scintillating fibre must be chosen on the basis of Bragg cavity considerations.
Contribution to the measured signal from clear fibre (“Stem effect”) need to be corrected
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when working at low signal levels, because fluorescence and Cerenkov effects become
considerable at low total signal levels. If good signal/noise ratio and fine spatial resolution
are needed simultaneously, then an inorganic crystal with small size should be chosen
instead of an organic fibre scintillator. This would also have the advantage that a lower
amplifier gain can be used, and there will be relatively less background signal contributed
by any clear fibre used. Overall, the proposed system shows entitlement for further
clinical investigations such as 3D source position verification and simultaneously
performing dose measurements to be clinically implemented and commercially branded
as an All-In-One HDR Brachytherapy QA tool.
•
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Characterisation of an inorganic scintillator for
HDR brachytherapy for real-time quality assurance of high dose rate
brachytherapy utilizing photodiode based- fibre optic data
acquisition systems

8.1. Introduction:
Brachytherapy (BT) is an advanced radiotherapy technique involving the insertion of a
high dose rate radioactive source, typically 192Ir, often used with a combination of other
radiotherapy options to treat prostate cancer (Hoskin et al., 2012; Michalski et al., 2015).
Delivering an HDR

192

Ir brachytherapy source, by afterloading machine through a

transfer tube into an area of interest within a treatment volume, involves several sources
of errors and measurement uncertainties arising from the machines used, cable crosstalk,
technique for estimating HDR 192Ir source positioning within the body and timing factors
(Devlin, 2015; Knoll, 2010). For preventing or minimising such errors, an initiative has
been established worldwide to introduce real-time quality assurance (QA) tools for invivo HDR dosimetry (Fraass et al., 1998; Hendee & Edwards, 1986; Valentin, 2005).
There are obvious benefits to be gained by applying such tools in the clinical setting
during HDR brachytherapy treatment for tracking the entire treatment process and
accurately verifying source positioning and timing as pre-clinically prescribed (S Beddar
& Beaulieu, 2016; Khan & Gibbons, 2014).
Previous studies by Espinoza and et al (Espinoza et al., 2013; Espinoza, Petasecca,
Cutajar, et al., 2015; Espinoza, Petasecca, Fuduli, et al., 2015) & Poder and et al (Poder
et al., 2019; Poder et al., 2018) have investigated the determination of real-time HDR 192Ir
brachytherapy source dwell time using various techniques. However, their “Magic Plate”
system was a one-off experimental system and is not widely available. Furthermore, it
was designed to monitor radiation dose over a reasonable large area simultaneously.
There is a necessity for the determination of source-to-detector distance (SDD) in a small
volume near an HDR

192

Ir brachytherapy source in real-time, having online feedback

throughout the total treatment time. The aim of this study was to propose a simple data
acquisition system based on a photodiode amplifier that is effectively capable of
performing HDR source tracking in real-time with excellent conformity to the treatment
planning system. Also, the relative source position of an HDR 192Ir brachytherapy source
with respect to a detector was also investigated with accurate feedback during the entire
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treatment data acquisition time.

8.2. Materials & Methods:
8.2.1 Scintillation detectors:
3 mm long Thallium-Doped Caesium Iodide scintillation crystal (Amcrys, Ukraine) was
prepared in-lab, and then optically coupled to a 10 m long non-scintillating plastic fibre
(BCF-98 Saint-Gobain Crystals USA) to guide the light to a TO-5 PIN-photodiode
(S1223-01- Hamamatsu). Properties of the fibre optic-based scintillation detectors
utilized has been been demonstrated previously in Materials & Methodology Chapter
(#3). Please refer to Table 3.1 & 3.2 for more details.

8.2.2 Readout data acquisition system configurations:
8.2.2.1. In house designed CMRP trans-impedance photodiode
amplifier system:
A trans-impedance photodiode amplifier (current to voltage converter) has been designed
in-house with a mounting for the receiving photodiode, in a metallic shielded box, but
electrically isolated from the box. Minimum & maximum sensitivity of the amplifier are
270 mV/nA and 1620 mV/nA respectively. Please refer to Chapter 4 for more details.

8.2.2.2. Gigahertz Optik™ trans-impedance photodiode amplifier
system:
A commercially available trans-impedance photodiode amplifier (Gigahertz Optik™, P9202-5) was used to measure the real-time light output with simultaneous data analysis

for treatment monitoring. Minimum & maximum gain settings of this amplifier are 10-3
nA/mV and 10+4 nA/mV respectively. Please refer to Chapter 4 for more details.

8.2.2.3. Data logging system:
The data logging system, used for this purpose, has been demonstrated earlier in the
Materials & Methodology Chapter (#3). Please refer to section 3.9.1 for more details.
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8.2.3 Experimental setup at brachytherapy room:
The experimental setup illustration of Fig. 8.1 demonstrates the placement of the DAQ
photodiode amplifier - either the CMRP or Gigahertz Optik trans-impedance amplifiers
connected to the fibre probe, placed within the treatment room close to the afterloading
machine, to measure real-time light output. For maintaining a high level of protection
against unwanted interfering noise sources, our DAQ systems were placed at a distance
of 1 m from the couch and then shielded by some lead blocks. A solid water-equivalent
phantom with a catheter inserted the whole way through was CT-scanned, and dwell
positions were digitised using the TPS. The scintillating fibre probe was placed at
accurately known and recorded pre-determined locations within the phantom, at varying
distances above the

192

Ir brachytherapy source located within the catheter. This

192

Ir

source was sequentially moved with dwell positions spaced in 2 mm steps for a dwell
time of either 5 sec (or 10 sec if needed) at each position, according to the test type and
signal levels encountered. The experimental setup, HDR phantom design, and placement
of the DAQ system are depicted in Fig 8.1. and the detail of phantom setup shows fibre
probe location within the phantom, and the World Coordinate System for the
experimental setup is illustrated in Fig 8.2.

Figure 8.1: Illustration showing the general experimental setup with source, phantom and processing
electronics in the HDR brachytherapy room control room.
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Figure 8.2: Detail of phantom setup shows fibre probe location within the phantom (Left), and the
World Coordinate System of experimental setup (Right)

8.3. Results & discussion:
8.3.1 The in-house designed CMRP fibre optic system:
8.3.1.1. Photodetector-induced signal:
As a “Control” experiment, the response of the “fibre optic” system was investigated with
only

the photodiode connected in the DAQ box (i.e. NO external light detector

connected), with the DAQ amplifier being shielded by lead blocks while the afterloader
was sequentially stepping the 192Ir source throughout the 500 s sampling time. It can be
clearly seen from Fig. 8.3 that the signal contribution due to the photodiode response was
about 2.6 mV or less. In addition, peaks (“spikes”) were clearly noticed at the beginning
and end of the experimental session with peak values of 31 mV and 29 mV respectively.
This is attributed to physical movement of the afterloader which is used to position the
192

Ir source, when the source seed was advanced to the phantom and then retracted again.

Figure 8.3: Response of photodiode amplifier (with a gain of 405 mV/nA) and
no scintillator while stepping the 192Ir source at multiple dwell positions placed
at 80 cm, with lead shielding between source and amplifier
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8.3.1.2. Depth response and positional sensitivities:
Fig 8.4 demonstrates that the depth response and positional sensitivities of the CMRP
fibre optic system, with CsI(Tl) scintillating crystal based-fibre probe dwelling at multiple
dwell positions, has been investigated and acquired. The response of the DAQ system
shows the scintillation signal as a function of a single dwell position resulted from the
irradiation of the crystal, placed in the middle, the left, and the right of the phantom, with
the HDR 192Ir source at varied SSDs. It is found that the peaks’ values for each position
at the three vertical distances (y = 1 cm. 2 cm, and 3 cm) to the source movement axis to
be in an excellent agreement with the inverse square law and HDR 192Ir source fall off. In
addition, Fig 8.4 also depicts the corresponding current induced in the optical scintillating
fibre for each single dwell position. It was found that the current falls into a range of pA
to nA depending on how near or far the detector is from the source. As all measurements
were taken with a gain of 810 mV/nA, then the induced current can be calculated by
dividing the detector response in mV by this gain.
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Figure 8.4: Depth response and positional sensitivities of the CMRP fibre optic DAQ system when the fibre
detector is within the phantom at three Z positions (middle, right, left) upon delivering the 192Ir at multiple
dwell positions for varied y heights 1 cm, 2 cm, and 3 cm
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8.3.1.3. Determination of dwell time and dwell position:
Fig 8.5,8.6, and 8.7 exhibit a real-time determination of dwell times and dwell positions
measured by the CMRP fibre optic system, with CsI (Tl) scintillating crystal based-fibre
probe dwelling at multiple dwell positions in three different z-axis locations, and at three
vertical heights. These graphs also show the response of the fibre optic DAQ system as a
function of time which is an excellent agreement with the pre-set dwell time (5 sec or 10
sec steps), total number of dwell position (#46), and total treatment time in seconds which
was pre-programmed into the Brachytherapy treatment planning system (TPS).
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Figure 8.5: Determination of dwell time and dwell position of the CMRP system when the fibre probe is
within the phantom in the middle Z position when delivering the 192Ir at multiple dwell positions for
varied y heights 1 cm, 2 cm and 3 cm
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Figure 8.6: Determination of dwell time and dwell position of the CMRP system when the fibre probe is
within the phantom in the right Z position when delivering the 192Ir at multiple dwell positions for varied
y heights 1 cm, 2 cm and 3 cm

Page 8-148

Figure 8.7: Determination of dwell time and dwell position of the CMRP system when the fibre probe is
within the phantom in the left Z position when delivering the 192Ir at multiple dwell positions for varied y
heights 1.5 cm, 2.5 cm and 3.5 cm
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8.3.2 The adapted Gigahertz Optik fibre optic system:
8.3.2.1. Photodetector-induced signal:
This has been previously discussed in Chapter 7

8.3.2.2. Depth response and positional sensitivities:
Fig. 8.8 reveals that the depth response and positional sensitivities of the CsI(Tl)
scintillating crystal with fibre optic system, with based-fibre probe dwelling at multiple
dwell positions, has been successfully acquired. The response of the DAQ system shows
the scintillation signal as a function of a single dwell position the irradiation of the crystal,
placed middle, left, or right of the phantom, with the HDR 192Ir source at varied SSDs. It
is found that the peak values for each position at the three vertical distances (y = 1, 2 and
3 cm) are in excellent agreement with the inverse square law for 192Ir source fall-off.
In addition, Fig 8.8 also illustrates the corresponding intensities induced in the optical
scintillating fibre for each single dwell position. It was found that the induced photocurrent falls into the range of pA to nA depending on how near or far the detector is from
the source. As all measurements were taken at a gain of 100 mV/nA (Range 10-8 A/V on
the amplifier), then the induced current can be calculated dividing the detector response
in mV by the gain
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Figure 8.8: Depth response and positional sensitivities of the Gigahertz Optik DAQ system when
sequentially the fibre is within the phantom at three Z positions (middle, right, left) when delivering 192Ir
radiation at multiple dwell positions for y heights 1 cm, 2 cm, and 3 cm
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8.3.2.3. Determination of dwell time and dwell position:
Fig 8.9, 8.10, 8.11 display a real-time determination of dwell times and dwell positions
measured by the CsI (Tl) scintillating crystal based-fibre probe and Gigahertz Optik
amplifier, with source dwelling at multiple dwell positions in three different z-axis
locations, and at two vertical heights. This graph also illustrates the response of the DAQ
fibre optic system as a function of time which is an excellent agreement with the
predetermined dwell times, number of dwell position (#46), and total treatment time in
seconds which was predefined, stored and followed by the Brachytherapy treatment
planning system (TPS).
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Figure 8.9: Determination of dwell time and dwell position of the Gigahertz Optik system when
sequentially the fibre probe is within the phantom at the middle Z position when delivering 192Ir radiation
at multiple dwell positions for various y heights
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Figure 8.10: Determination of dwell time and dwell position of the Gigahertz Optik system when
sequentially the fibre probe is within the phantom at the right Z position when delivering 192Ir radiation at
multiple dwell positions for various y heights
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Figure 8.11: Determination of dwell time and dwell position of the Gigahertz Optik system when
sequentially the fibre probe is within the phantom at the left Z position when delivering 192Ir radiation at
multiple dwell positions for various y heights
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8.4. Conclusion:
The purpose of this study was to characterise the response of the both proposed DAQbased fibre optic system, the in-house designed CMRP trans-impedance amplifier and the
in-house developed Gigahertz Optik fibre optic system with a CsI(Tl) crystal basedscintillating fibre probe while the

192

Ir HDR Brachytherapy source was dwelling at

multiple positions for different SDDs. Also, a background response was obtained for only
the photodiode/amplifier system being exposed to stray radiation without any fibre
connected. Both DAQ fibre optic systems (i.e. both amplifier systems) were capable of
responding linearly to radiation exposure and accurately determining, in real-time, the
dwell time at any given position, the total number of dwell positions and the total
treatment time which shows excellent agreement with parameters that were pre-defined
and programmed into the Brachytherapy TPS.
Based on our pre-clinical investigations obtained, the concept of localizing an 192Ir HDR
source, based on the triangulation of measured crystal responses (with detector crystal
placed at specific locations within a patient phantom), has been shown to be feasible. It
was also shown to have more reliability and accuracy when using a CsI(Tl) detector
crystal due to its higher signal to noise ratio (S/N) compared with polymer fibres which
exhibit relatively poor responses. The main findings also indicate that the developed
system is eligible and to be employed for real-time HDR source tracking in 3D space, and
a multi-channel AFE-based DAQ system could be utilized for this purpose.
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On the use of a CMRP-designed fibre-optic system
for HDR Brachytherapy quality assurance

9.1. Introduction:
Cancer is one of the leading causes of death worldwide (Australian.Government, 2019;
Australian.Institute.of.Health.and.Welfare, 2019; WHO, 2020) and implementation of
sophisticated quality assurance (QA) tools for radiotherapy treatment sessions has played
a key role in preventing errors in treatment. An important QA aspect is the discrepancy
between target and actual High Dose Rate (HDR) brachytherapy source position, which
may lead to dangerous consequences. A misplacement of an HDR brachytherapy source
of several millimeters cannot be clinically tolerated (Fraass et al., 1998; Hendee &
Edwards, 1986; Valentin, 2005). The limitations of currently used QA tools for HDR
brachytherapy have necessitated the development of innovative tools that can perform
accurate QA tests, without the need for further corrections. Scintillation-based fibre optic
detectors (SFOD) have clinically desirable properties over other conventional detectors
such as water equivalence, dose rate independence, and energy independence (Beaulieu
& Beddar, 2016). Real-time source verification and localization have been successfully
investigated in previous research work Espinoza and et al (Espinoza et al., 2013;
Espinoza, Petasecca, Cutajar, et al., 2015; Espinoza, Petasecca, Fuduli, et al., 2015) &
Poder and et al (Poder et al., 2019; Poder et al., 2018) using CMRP-pioneered “Magic
Plate” detectors, achieving high accuracy with a sub-millimeter resolution.
A system which utilizes scintillating optical fibres placed inside catheters, within the
treatment volume of an HDR brachytherapy treatment, has been pre-clinically optimized
and characterized (Al Towairqi et al., 2019), and can be used to accurately monitor
radiation doses. The aim of this research study is to investigate the feasibility of localising
an HDR Brachytherapy source in 3D space utilizing the innovative CMRP fibre optic
system developed in-house as real-time QA tool.
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9.2. Materials & Methods:
9.2.1 Scintillation detector:
3 mm long Thallium Doped-Caesium Iodide (Amcrys. Ukraine) CsI (Tl) scintillation
crystal has been in-lab prepared, and then optically coupled to a 10 m long nonscintillating plastic fibre CK-40 (Eska, USA) to guide the light wave to a light detector.
Properties of the fibre optic-based scintillation detectors utilized has been been
demonstrated previously in Materials & Methodology Chapter (#3). Please refer to Table
3.1 & 3.2 for more details.

9.2.2 Data acquisition system (DAQ) configuration:
9.2.2.1. CMRP trans-impedance photodiode amplifier system:
The CMRP trans-impedance photodiode amplifier (current to voltage converter) has been
in-house designed with minimum & maximum sensitivity ranges of 270 mV/nA and 1620
mV/nA respectively. A selected PIN-photodiode was mounted on a metallic shielded box
and was electrically isolated from being connected to the box. Please refer to Chapter 4
for more details.

9.2.2.2. Data logging system:
The data logging system, used for this purpose, has been demonstrated earlier in the
Materials & Methodology Chapter (# 3). Please refer to section 3.9.1 for more details.

9.2.3 In-clinic experimental setup at brachytherapy room:
The experimental setup diagram and placement of the DAQ system are all depicted in
Fig. 9.1 which demonstrates how the CMRP trans-impedance photodiode amplifier is
connected to the fibre probe placed within the treatment room to measure real-time light
output. A phantom, made from PMMA (“Perspex”™) with a catheter inserted the whole
way through, was CT-scanned, and dwell positions were digitised using the Treatment
Planning System (TPS).The fibre probe was placed in one of several other cavities at
accurately known and recorded positions within the phantom, at varying distances above
an192Ir brachytherapy source located within its catheter. This 192Ir source was sequentially
moved with dwell positions varied in 2 mm steps for a dwell time of 5 sec at each “x”
position.
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Figure 9.1: Illustration of the experimental setup inside the clinical HDR

9.2.4 Phantom design:
The HDR phantom tower was designed and prepared in-house for this purpose as
previously described in Chapter 3. The design of the phantom tower clamp stand
assembly with the World Coordinate System (WCS) dimensions of the phantom setup is
shown in Fig. 9.2.

Figure 9.2: Illustration of the phantom tower clamp stand assembly (Up), and World Coordinate
System and dimensions of the phantom setup (Down)
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9.2.5 Positional sensitivities for all dwell positions within the phantom:
For various physical, practical and safety reasons, practical/clinical radiotherapy
locations will require the signal processing electronics to be kept separate from radiation
delivery area, to prevent stray radiation affecting measurements or electrical circuits. For
this reason, most embodiments of the detector systems will include a long plain (nonscintillating) optical fibre as a neutral “extender” (the “stem” of the detector signal) to
convey the received signal from the area of interest to the processing /readout electronics
in an adjacent room. It is important that such an extender optical fibre can convey the
received light intensity without significant loss and without adding in unwanted noise or
spurious extra signals.

9.2.5.1. Measurement of pure scintillation signal:
Measurements of signals at a small series of detector locations were recorded when a
source was sequentially moved through a cavity (actually, inside a catheter) in the PMMA
tissue phantom assembly shown in Fig. 9.2. The HDR source was programmed to move
in 2.0 mm steps in the “x” direction by a standard automated “afterloader”, beginning at
a small “depth” near the initial side of the PMMA assembly, past the closest approach
distance to the scintillating detector and then continued to the far side (maximum “depth”)
of the phantom. Altogether, this path encompasses 46 dwell positions. The scintillating
detector was then moved and installed in one of the other location cavities (different “z”
positions) in the PMMA phantom stack and the “scanning” of the source in 2 mm steps
was repeated along the same path with the same 2 mm step size for the same total number
of dwell positions (46). Once this procedure was completed for 3 different fixed
scintillating detector positions, the detector was then moved to other PMMA levels
successively 10 mm further above the source (i.e. the “y” dimension was changed from
10 to 20 to 30 mm).The changing observed signal responses vs. time were all saved and
could be displayed in graphs Please refer to Fig. 9.3 in result section.

9.2.5.2. Measurement of stem-effect signals:
Using a plain (non-scintillating) Eska CK-40 optical fibre as a “control” allowed a clear
distinction to be made between “pure scintillation” signal and unwanted additional
fluorescence signal. This will occur in the plain optical fibre (the “Stem”) which
generates spurious optical signal that adds to the light intensity produced by the
scintillator in the region of interest. This is consequently termed the “stem effect” and
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needs to be precisely quantified in order to allow the detecting and measuring system to
be used for serious and accurate brachytherapy QA. To measure how much non-relevant
signal component was contributed by fluorescent radiation generated within a nonscintillating fibre section (the “stem”), response was measured from a clear Eska CK-40
optical fibre inserted 1 cm above an HDR source. (Please refer to Fig. 9.4 in result
section).

9.2.6 Localisation of HRR 192Ir Brachytherapy source:
9.2.6.1. Source to detector distances (SDDs) for all sampled positions:
The HDR source was programmed to move in 46 separate 2.0 mm steps by a standard
automated “afterloader” from a small or zero x “depth” near the initial side of the PMMA
assembly, and then continued to the far side (maximum “depth”) of the phantom. By
inspecting the results carefully, we found the actual x steps were 1.96 mm on average (an
accuracy of ~ +/- 2%). This source movement protocol was applied 9 times, with the fibre
detector in the range of y and z positions mentioned previously. Since all of the distances
involved in all 3 directions were accurately known and measured and/or controlled, it is
a simple matter to calculate the actual “3D” distance between the source and the detector
at any specified dwell position by applying Eqn. (1) from Section 9.2.6.2 below.

9.2.6.2. Calculating corresponding source to detector distances (SDD):
Accurate treatment doses using this SFOD dosimetry system require an accurate
knowledge of the distance between the radioactive source and a point of interest. The
following equation is used for this purpose
Distance in 3 dimensions:
SDD = √(𝒙 − 𝒙∗ )𝟐 + 𝒚𝟐 + 𝒛𝟐

. . . Eqn. (1)

Where 𝑥 = Depth of detector inside the phantom, 0 = the initial edge of the phantom
𝑥 ∗ = Depth of radiation source inside the phantom, increased in 2mm size steps
𝑦 = Vertical displacement, 10mm, 20mm or 30mm from the radiation source axis
𝑧 = Horizontal displacement. Always -10mm (to the left of the source), 0 cm (centred,
directly above the source) or +10 mm (to the right of the source).
Looking ahead to clinical applications, it would be extremely useful (and necessary) to
know the exact correlation between observed response levels and real distance between
the HDR source and a 3D coordinate (position) of interest. In a clinical treatment setting,
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this will become a precise distance between HDR source and a specified point of interest
in a tumour treatment volume. From a radiation physics point of view, completing this
process requires compiling a calibration chart which translates observed amplifier levels
(in mV) into source-to-detector distances (SDD). In order to achieve this, there is a need
to measure the received radiation response at a reasonable set of points in 3D space and
quantify the correlation between observed response levels and real distance between the
HDR source and a 3D reference (position) of interest.

9.2.6.3. Calibration curves:
By measuring the received radiation at known coordinate points in 3D space and
recording the correlation between observed response levels and real distance between the
HDR source and a 3D coordinate (position) of interest, calibration curves can be compiled
which can be used as “Look-Up charts” to allow a measured signal response to be
converted to an inferred source-to detector distance. Data was measured in the PMMA
phantom stack to allow compilation of such calibration curves. By compiling calibration
curve data for a relevant x, y and z values or source-to-detector distances (SDDs) it is
possible for a set of accurately positioned detectors to estimate accurately where a
radioactive source is located nearby. This concept is covered in more detail in the
following section.

9.2.6.4. Triangulation methodology of HRR 192Ir Brachytherapy
source:
Localisation of the HDR source was determined based on a triangulation method which
uses the responses from three successive detector measurements. Once accurate signal
response vs. SDD (or vice-versa) data has been obtained and the calibration curves
produced as described in the previous section, it is possible to reconstruct the position of
an 192Ir HDR Brachytherapy source based on a triangulation method using three detectors
which make use of the calibration curves. An algorithm has been patented by Prof.
Anatoly Rosenfeld (A Rosenfeld & Zaider, 2002) of CMRP and developed further by
work Espinoza and et al (Espinoza et al., 2013; Espinoza, Petasecca, Cutajar, et al., 2015;
Espinoza, Petasecca, Fuduli, et al., 2015) & Poder and et al (Poder et al., 2019; Poder et
al., 2018) to perform the reconstruction computations to deduce the position of the
Brachytherapy source.
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9.3. Results & Discussion:
9.3.1 Positional sensitivities for all dwell positions within the phantom:
9.3.1.1. Measurement of pure scintillation signal:
Figure 9.3 illustrates the sequentially-measured responses of the fibre optic system with
the CsI(Tl) scintillating crystal placed in in the three selected x locations described above,
which can ultimately inform the triangulation algorithm to deduce source positions of the
HDR 192Ir source dwelling parallel to the detector at varying distances.
The curves of Fig. 9.3b show a pleasing symmetry because the Fig. 9.3 data corresponds
to the case where the detector is directly above the HDR source (i.e. same “z” value as
the source, neither left nor right of it). In contrast, the responses of Fig. 9.3a were obtained
with the detector above but about 10 mm to the left of the source dwell path. Hence
Fig 9.3a appears slightly “skewed”, since there are more data points arising from large
distances where the source has been positioned beyond the closest point of approach to
the scintillating detector. Similarly, Fig. 9.3c was obtained with the detector above but
about 10 mm to the right (z = 10 mm) of the source dwell path and also appears slightly
“skewed”, since there are once again more data points arising from large distances where
the source has been positioned beyond the closest point of approach to the scintillating
detector, as for Fig. 9.3a.
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Figure 9.3: Response of fibre optic DAQ system to HDR source vs. dwell time
a) detector fibre at left (z = -10 mm), b) middle (z= 0), c) right (z=+10 mm)
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9.3.1.2. Measurement of stem-effect signal:
The main culprit for contributing unwanted light signal is the fluorescent effect of stray
radiation (backscatter) intersecting the clear cable. Cerenkov radiation is almost
negligible in the

192

Ir energy range. These effects occur in the “stem” of the detector

system and are consequently termed the “stem effect”. If the stem effect gives an
appreciable signal level, it is easy to subtract this signal level from the observed response
of the fibre detector system to reveal the response due to pure scintillation signal alone.
On the other hand, if stem effect gives negligible signal level, then the observed response
of the fibre detector system can be regarded as the response due to pure scintillation signal
alone. Fig. 9.4 shows the result obtained during a 5-minute sampling time. Close
inspection of Fig. 9.4 reveals that the largest spurious signals generated in the clear CK40 optical fibre are less than +/- 0.3 mV. Since meaningful signals were typically of the
order of 2 – 500 mV, “the stem effect” for this fibre was considered too small to even
require subtraction (as anticipated in the Methodology Section above).
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-0.20
-0.40

Dwell time (sec)
Figure 9.4: Measured signal from a clear fibre inserted 1cm above the path of the HDR source

9.3.2 Corresponding source to detector distances (SDD) for all
sampled positions:
For each position where the detector fibre was placed, and for each position where the
source dwelled, the total source-to-detector distance (SDD) can be easily computed using
Eqn. (1) from section 9.2.6.2 above. The computed SDDs are displayed in Fig. 9.5. By
combining the information of Figs. 9.3 and 9.5, it is possible to produce a calibration
curve (or set of calibration curves) which can be used to calibrate a “reconstruction
algorithm” to reconstruct the position of the

192

Ir HDR source from 3 response

measurements. The practical application of this capability is for Brachytherapy could
then be carried out by using measured responses to accurately estimate distances and
therefore absolute positions, without doing any distance measurements during patient
treatment. Measuring distances directly would only need to be done periodically in
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calibration procedures in order to re-validate or renew the SDD vs. response calibration
curves. A master table of the data was compiled, and the data was recombined to form

Source to detector distance
(mm)

SDD vs. Response (mV) curves, as shown in Fig. 9.6.
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Figure 9.5: Computed SDDs between fibre optic detector and HDR source position when
the fibre probe is placed above the source at different heights (y= 10, 20 & 30 mm) and at
different lateral positions a) left (z = -10 mm), b) middle (z= 0), c) right (z=+10 mm)
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9.3.3 Calibration curves:
The calibration curves for SDD vs. Response (mV) are non-trivial and the exact
appearance of the curves is influenced by subtle geometric effects. The most symmetric
curves are in Fig. 9.6 b), since this graph corresponds to the most symmetric arrangement
of source and detector (y coordinate minimal (10 mm, not 30 mm) and z coordinate 0
mm). Data points of the same colour indicate identical y positions (heights). The SDD
values for the first data point and the last data point on each curve do not quite overlap.
This does not indicate inaccuracy in the measurement or the operator technique but is a
tiny artefact of the particular PMMA slab geometry used. The scintillating detector was
placed at particular “depths” (x-direction) which were not quite at the midway point of
the available x values. The HDR source, on the other hand, dwelt at the complete range
of x values from the front to the back of the PMMA phantom slab. The “middle” x
position for the source did not happen to equal the pre-set x value of any of the detector
positions. (Alternatively, the x-value at the point of closest approach between the source
and the detector was not the geometric centre (the centre of travel) of the PMMA slab).
This small difference between pre-set x value of the detector position and the geometric
centre of the slab is enough to noticeably skew the symmetry of the curves and means
that the starting SDD value and the finishing point SDD value are not quite identical.
The calibration curves of Fig. 9.6 also show characteristic “loop” paths. The SDD vs.
Response curves proceed from the viewer’s left to right with SDD decreasing to a
minimum value and Response (mV) reaching maximum as the source passes the closest
distance of approach to the detector. As the source continues to move further, the SDD
values gradually rises to its final maximum whereas the response (mV) reaches a final
minimum. The path of the SDD vs. response data does not merely go down and then
return by up the same path. Instead, the SDD figures decrease to a minimum and then
track back up a path that is very similar to the initial path but slightly displaced from it,
producing a “looping” appearance. The reason for this slight “loop” appearance is that
the radioactive source “seed” is not an infinitesimally precise point or a precise tiny ball
of material (i.e. it is not a perfect sphere). Instead, it was cylindrical or capsule-shaped,
and has a much greater length in the “x” direction than in the “y” or “z” directions. In a
similar manner, the detector is not a “point” either, nor is it equi-axed in x, y and z
directions. Instead it is a small cylindrical volume (1 mm diameter, 3 mm long). These
slight shape factor difference produces the slight “loop” in the calibration curves. This is
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a powerful result and shows that our system is sufficiently accurate that it can even reveal
that the source seed and the detector are slightly elongated instead of equi-axial
(spherical). Any elongation of the source or detector in any direction at all inevitably
gives an “elongation” (i.e. offset) in the SDD values, which in turn shows up as a “loop”
displacement (a slight displacement between the data in the initial and final stages of the
source movement path) in the SDD vs. response curves.
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Figure 9.6: Calibration Curves of the fibre optic DAQ system for HDR source tracking
when the fibre probe is placed above the source at different heights (y= 10, 20 & 30 mm)
and at different lateral positions a) left (z = -10 mm), b) middle (z = 0), c) right (z = +10
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9.3.4 Localisation of HRR 192Ir Brachytherapy source:
The proposed fibre detection system was determined to be accurately capable of verifying
QA parameters such as dwell times, total number of predetermined dwell positions, and
total treatment time which shows excellent agreements with the prescribed treatment plan
from the treatment planning system (TPS). In addition, the system has shown a high S/N
ratio and measurement sstability over the whole “treatment” course (i.e. the total data
acquisition time of our pre-clinical measurements). The system also proved to be stem
effect free, and electrical response accuracy and reproducibility was within 2.0 ± 0.3 mV.
Localisation results reveal a small variation between the predicted and directly measured
dwell positions for the three different heights above the source movement axis as
demonstrated in Fig 9.7.
Based on our obtained pre-clinical results, it is clearly seen that the localization of an 192Ir
HDR source is feasible and a 3 mm CsI (Tl) crystal can report the source position to
within ~ +/-1.0 mm when the detector is at any height between 10 mm and 30 mm y value
(eg: detector directly above source but measuring at -10 mm, 0 mm and +10 mm lateral
(z) positions).
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(a)

(b)

(c)

Figure 9.7: Differences between reconstructed (triangulated) and directly measured dwell positions
of a scintillating crystal irradiated by an 192Ir source a) y = 10 mm, b) y = 20 mm, c) y = 30 mm.
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9.4. Conclusions:
The main conclusion of this section is that the utilization of the developed scintillating
crystal/fibre optic/amplifier/readout QA tool for localization of HDR 192Ir brachytherapy
source is clearly accurate and is feasible for clinical application. The localisation
measurements of the HDR source in 3D space based on triangulated calculations from
response readings has demonstrated promising results which suggest that this system is a
technology of choice for further optimization. It shows good promise for use as a QA tool
for reliable and comprehensive radiotherapy QA. Overall, the advantages of applying
such a dosimetry system can outrank other currently commercially available QA tools.
Using a comparably sized scintillating fibre detection section optically coupling into the
same developed clear fibre optic/amplifier/readout QA tool for localization of HDR 192Ir
brachytherapy source gave interesting results but is not a feasible arrangement for clinical
application in its present form. However, the low signal level (and consequent low
signal/noise ratio) of this all-fibre detector system could possibly be compensated by
using a higher-gain and lower-noise signal amplifier. This suggestion is now being
actively researched in further work by CMRP.
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Fibre optic system for HDR Brachytherapy
quality assurance: a feasibility study of HDR source localisation

10.1. Introduction:
Cancer is one of the leading causes of death worldwide (Australian.Government, 2019;
Australian.Institute.of.Health.and.Welfare, 2019; WHO, 2020) and implementation of
sophisticated quality assurance (QA) tools for radiotherapy treatment sessions has played
a key role in preventing errors in treatment. An important QA aspect is the discrepancy
between target and actual High Dose Rate (HDR) brachytherapy source position, which
may lead to dangerous consequences. A misplacement of an HDR brachytherapy source
of several millimeters cannot be clinically tolerated (Fraass et al., 1998; Hendee &
Edwards, 1986; Valentin, 2005). The aim of the research in this chapter is to investigate
the feasibility of localising an HDR Brachytherapy source in 3D space utilizing a
Gigahertz Optik™ trans-impedance photodiode amplifier modified in-house as a realtime QA tool.

10.2. Materials & Methods:
10.2.1 Scintillation detector:
As in the previous chapter 9, a 3 mm long Thallium-Doped Caesium Iodide scintillation
crystal (Amcrys, Ukraine) was prepared in-lab, and then optically coupled to a 10 m long.
Properties of the fibre optic-based scintillation detectors utilized has been been
demonstrated previously in Materials & Methodology Chapter (#3). Please refer to Table
3.1 & 3.2 for more details.

10.2.2 Data acquisition (DAQ) system configuration:
10.2.2.1. Gigahertz Optik™trans-impedance photodiode amplifier
system:
A commercially available trans-impedance photodiode amplifier (Gigahertz Optik™, P9202-5) was used to measure the real-time light output with simultaneous data analysis

for treatment monitoring. Minimum and maximum gain sensitivity ranges of this
amplifier are 10 -3 mV/nA and 10 +4 mV/nA respectively. It was adapted in-house with an
optical-coupling mount for a PIN-photodiode (S1223-01- Hamamatsu) in the same
amplifier box. Please refer to Chapter 6 for more details.
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10.2.2.2. Data logging system:
The data logging system, used for this purpose, has been demonstrated earlier in the
Materials & Methodology Chapter (# 3). Please refer to section 3.9.1 for more details.

10.2.3 . In-clinic experimental setup at brachytherapy room:
Experimental setup demonstrates that the Gigahertz Optik trans-impedance photodiode
amplifier connected to the fibre probe placed within the treatment room to measure realtime light output. As previously stated in Chapter 9, a phantom, made from PMMA
(“Perspex™”) with a catheter inserted the whole way through, was CT-scanned, and
dwell positions were digitised using the TPS. The fibre probe was placed in one of several
other cavities at accurately known and recorded positions within the phantom, at varying
distances above an192Ir brachytherapy source located within the catheter. This 192Ir source
is sequentially moved with dwell positions varied in 2 mm steps for a dwell time of 5 sec
at each x position. The experimental setup, HDR phantom design, and placement of the
DAQ system are depicted in Fig.10.1.

Figure 10.1: illustration of the experimental setup inside the clinical HDR brachytherapy room

10.2.4 . Phantom design:
The HDR phantom tower was designed and prepared in-house for this purpose as
previously described in Chapter 3. The design of the phantom tower clamp stand
assembly with the World Coordinate System (WCS) dimensions of the phantom setup
has been earlier shown in Fig. 9.2.
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10.2.5 . Positional sensitivities for all dwell positions within the phantom
For the various physical, practical and safety reasons discussed in chapter 9, when using
the CMRP amplifier, practical/clinical radiotherapy locations require the signal
processing electronics to be kept separate from radiation delivery area, to prevent stray
radiation affecting measurements or electrical circuits. Hence, this embodiment of the
detector systems also included a long plain (non-scintillating) optical fibre as a neutral
“extender” (the “stem” of the detector signal) to convey the received signal from the area
of interest to the processing/readout electronics in an adjacent room. It is important to
also quantify the “stem effect” when using the modified Gigahertz Optik amplifier. If the
stem effect gives an appreciable signal level, it is easy to subtract this signal level from
the observed response of the fibre detector system to reveal the response due to pure
scintillation signal alone. But as before, if the stem effect gives negligible signal level,
then the observed response of the fibre detector system can be regarded as the response
due to pure scintillation signal alone.

10.2.5.1. Measurement of pure scintillation signals:
Measurements of signals at a small series of detector locations were recorded when a
source was sequentially moved through a cavity (actually, inside a catheter) in the PMMA
tissue phantom assembly shown in Fig. 10.1. The HDR source was programmed to move
in 2.0 mm steps in the “x” direction by a standard automated “afterloader”, beginning at
a small “depth” near the initial side of the PMMA assembly, past the closest approach
distance to the scintillating detector and then continued to the far side (maximum “depth”)
of the phantom. Altogether, this path encompasses 46 dwell positions. The scintillating
detector was then moved and installed in one of the other location cavities (different “z”
positions) in the PMMA phantom stack and the “scanning” of the source in 2 mm steps
was repeated along the same path with the same 2 mm step size for the same total number
of dwell positions (46). Once this procedure was completed for 3 different fixed
scintillating detector positions, the detector was then moved to other PMMA levels
successively 10 mm further above the source (i.e. the “y” dimension was changed from
10 to 20 to 30 mm).The changing observed signal responses vs. time were all saved and
could be displayed in graphs (Please refer to Fig. 10.2 in result section).

Page 10-175

10.2.5.2. Measurement of stem-effect signal:
Using a plain (non-scintillating) Eska CK-40 optical fibre as a “control” allowed a clear
distinction to be made between “pure scintillation” signal and unwanted additional
fluorescence signal. This will occur in the plain optical fibre (the “Stem”) which
generates spurious optical signal that adds to the light intensity produced by the
scintillator in the region of interest. This is consequently termed the “stem effect” and
needs to be precisely quantified in order to allow the detecting and measuring system to
be used for serious and accurate brachytherapy QA. To measure how much non-relevant
signal component was contributed by fluorescent radiation generated within a nonscintillating fibre section (the “stem”), response was measured from a clear Eska CK-40
optical fibre inserted 1 cm above an HDR source. (Please refer to Fig. 10.3 in result
section).

10.2.6 . Localization of HRR 192Ir Brachytherapy source:
10.2.6.1. Source to detector distances (SDD) for all sampled positions:
The HDR source was programmed to move in the same set of 46 separate 2.0 mm steps
by the same automated “afterloader” program, as in the measurements of Chapter 9. By
inspecting the results carefully, it was verified that the actual x steps were 1.96 mm on
average (an acceptable accuracy of ~ +/- 2%). This source movement protocol was
applied 9 times, with the fibre detector in the range of y and z positions mentioned
previously. Since all of the distances involved in all 3 directions were accurately known
and measured and/or controlled, the actual “3D” distance between the source and the
detector at any specified dwell position were calculated by applying Eqn. (1) from chapter
9, section 9.2.6.2.

10.2.6.2. Calculating corresponding source to detector distances
(SDD):
Accurate treatment doses using this SFOD dosimetry system require an accurate
knowledge of the distance between the radioactive source and a point of interest, so
Equation (1) of Chapter 9 was used for this purpose. As in Chapter 9, the received
radiation response at a reasonable set of points in 3D space was measured to quantify the
correlation between observed response levels and real distance between the HDR source
and a 3D reference (position) of interest. (Please refer to Fig. 10.4 in result section).
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10.2.6.3. Calibration curves:
As stated previously in Chapter 9, by measuring the received radiation at known
coordinate points in 3D space and recording the correlation between observed response
levels and real distance between the HDR source and a 3D coordinate (position) of
interest, calibration curves were compiled to be used as “Look-Up charts” to allow the
measured signal responses to be converted to an inferred source-to detector distance. Data
was measured in the PMMA phantom stack to allow compilation of such calibration
curves. By compiling calibration curve data for the relevant x, y and z values or sourceto-detector distances (SDDs), accurately positioned detectors were again used to estimate
accurately where the radioactive source was located nearby.

10.2.6.4. Triangulation methodology of HRR
source:

192

Ir Brachytherapy

Localisation of the HDR source was determined based on a triangulation method which
uses the responses from three successive detector measurements. Once accurate signal
response vs. SDD (or vice-versa) data were obtained and the calibration curves produced
as described in the previous section, the position of the 192Ir HDR Brachytherapy source
was reconstructed, based on the triangulation method using three detectors and making
use of their calibration curves. The algorithm patented by Prof. Anatoly Rosenfeld (A
Rosenfeld & Zaider, 2002) of CMRP and developed further by work Espinoza and et al
(Espinoza et al., 2013; Espinoza, Petasecca, Cutajar, et al., 2015; Espinoza, Petasecca,
Fuduli, et al., 2015) & Poder and et al (Poder et al., 2019; Poder et al., 2018) was used to
perform the reconstruction computations to deduce the position of the Brachytherapy
source.
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10.3. Results & Discussion:
10.3.1 Positional sensitivities for all dwell positions within the phantom:
10.3.1.1. Measurement of pure scintillation signal:
Figure 10.2 illustrates the sequentially-measured responses of the fibre optic system with
the CsI (Tl) scintillating crystal placed in the three selected x locations described above,
which informed the triangulation algorithm to deduce source positions of the HDR

192

Ir

source dwelling parallel to the detector at varying distances.
The curves of Fig. 10.2b show a pleasing symmetry because the Fig. 10.2 data
corresponds to the case where the detector is directly above the HDR source (i.e. same
“z” value as the source, neither left nor right of it). In contrast, Fig. 10.2a has the detector
above but about 10 mm to the left of the source dwell path. Hence Fig 10.2a appears
slightly “skewed”. Similarly, Fig. 10.2c was obtained with the detector above but about
10 mm to the right (z = 10 mm) of the source dwell path and also appears slightly
“skewed”, since there are once again more data points arising from large distances where
the source has been positioned beyond the closest point of approach to the scintillating
detector, similar to Fig. 10.2a.
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Figure 10.2: Response of fibre optic DAQ system to HDR source vs. dwell time
a) detector fibre at left (z = -10 mm), b) middle (z= 0), c) right (z=+10 mm)
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10.3.1.2. Measurement of stem-effect signal:
The main culprit for contributing unwanted light signal is the fluorescent effect of stray
radiation (backscatter) intersecting the clear cable. Cerenkov radiation is almost
negligible in the

192

Ir energy range. These effects occur in the “stem” of the detector

system and are consequently termed the “stem effect”. If the stem effect gives an
appreciable signal level, it is easy to subtract this signal level from the observed response
of the fibre detector system to reveal the response due to pure scintillation signal alone.
On the other hand, if stem effect gives negligible signal level, then the observed response
of the fibre detector system can be regarded as the response due to pure scintillation signal
alone. Fig. 10.3 shows the result obtained during a 5-minute sampling time. Close
inspection of Fig. 10.3 reveals that the largest spurious signals generated in the clear CK40 optical fibre are less than +/- 0.1 mV. Since meaningful signals were typically of the
order of 2 – 1300 mV, “the stem effect” for this fibre was considered too small to even
require subtraction, as anticipated in the Methodology Section above.
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Figure 10.3: Measured signal from a clear fibre inserted 1cm above the path of the HDR
source when applying adapted Gigahertz Optik amplifier

10.3.2 . Corresponding source to detector distances (SDD):
For each position where the detector fibre was placed, and for each position where the
source dwelled, the total source-to-detector distance (SDD) was computed using Eqn. (1)
from the previous Chapter 9, section 9.2.6.2. The computed SDDs are displayed in
Fig. 10.4. By combining the information of Figs. 10.4 and 10.4, a set of calibration curves
was produced, which can be used to calibrate the “reconstruction algorithm” to
reconstruct the position of the 192Ir HDR source from the three response measurements.
The practical application of this capability is in brachytherapy where the measured
responses are used to accurately estimate distances and therefore absolute positions,
without doing any distance measurements during patient treatment. Measuring distances
directly now only needs to be done periodically in calibration procedures in order to rePage 10-180

validate or renew the SDD vs. response calibration curves. A master table of the data was
compiled, and the data was recombined to form SDD vs. Response (mV) curves, as shown
in Fig. 10.5 below.
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Figure 10.4: Computed SDDs between fibre optic detector and HDR source position with Gigahertz
Optik amplifier and fibre probe placed above the source at different heights (y= 10, 20 & 30 mm) and at
different lateral positions a) left (z = -10 mm), b) middle (z= 0), c) right (z=+10 mm)
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10.3.3 . Calibration curves:
The calibration curves for SDD vs. Response (mV) is non-trivial once again, and the exact
appearance of the curves shows the influence of subtle geometric effects. The most
symmetric curves are in Fig. 10.5 b), since this graph corresponds to the most symmetric
arrangement of source and detector (y coordinate minimal (10 mm, not 30 mm) and z
coordinate 0 mm). A full description/analysis/explanation of the characteristic “loop”
paths of the calibration curves of Fig. 10.5 was already provided in Chapter 9, since that
chapter describes essentially the same experiment, except for use of the CMRP amplifier
instead of the Gigahertz Optik amplifier. Once again, the results reveal the detail of both
the source and the detector being elongated instead of equi-axial (spherical) and small.
This shows up as the “loop”-shaped displacements (slight displacements between the data
in the initial and final stages of the source movement path) in the SDD vs. response
curves.
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Figure 10.5: Calibration Curves for the fibre optic DAQ system with Gigahertz Optik amplifier for
HDR source tracking with fibre probe placed above the source at different heights (y= 10, 20 & 30
mm) and at different lateral positions a) left (z = -10 mm), b) middle (z = 0), c) right (z = +10 mm)
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10.3.4 . Localisation of HRR 192Ir Brachytherapy source:
The proposed fibre detection system was determined to be accurately capable of verifying
QA parameters such as dwell times, total number of predetermined dwell positions, and
total treatment time which shows excellent agreements with the prescribed treatment plan
from the treatment planning system (TPS). In addition, the system has shown a high S/N
ratio and measurement sstability over the whole “treatment” course (i.e. the total data
acquisition time of our pre-clinical measurements). The system also proved to be
Cerenkov-radiation free, and electrical response accuracy & reproducibility when using
the modified Gigahertz Optik amplifier was within 1.0 ± 0.1 mV. Localisation results
reveal a small variation between the predicted and directly measured dwell positions for
the three different heights above the source movement axis as demonstrated in Fig 10.6.
Based on our obtained pre-clinical results, it is clearly seen that, with this system, the
localization of an 192Ir HDR source is feasible and a 3mm CsI (Tl) crystal can report the
source position to within ~ +/-0.6 mm when the detector is at ~ 10 mm height (eg: detector
directly above source and at lateral (z) positions between -10, 0 and +10 mm) and ~ +/0.8 mm when the detector is at maximum height (30 mm) at lateral (z) positions between
-10, 0 and +10 mm.
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(a)

(b)

(c)

Figure 10.6: Differences between reconstructed (triangulated) and directly measured dwell positions
of a scintillating crystal irradiated by an 192Ir source a) y = 10 mm, b) y = 20 mm, c) y = 30 mm.
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10.4. Conclusions:
The main conclusion of this section is that the utilization of the developed scintillating
crystal/fibre optic/Gigahertz Optik amplifier/readout QA tool for localization of HDR
192

Ir brachytherapy source is clearly accurate and is feasible for clinical application. The

localisation measurements of the HDR source in 3D space based on triangulated
calculations from response readings demonstrated promising results which suggest that
this system is a technology of choice for further optimization. It shows good promise for
use as a QA tool for reliable and comprehensive radiotherapy QA. Overall, the advantages
of applying such a dosimetry system can outrank other currently commercially available
QA tools.
Using a comparably sized scintillating fibre detection section optically coupling into the
same developed clear fibre optic/amplifier/readout QA tool for localization of HDR 192Ir
brachytherapy source gave interesting results but is not a feasible arrangement for clinical
application in its present form. However, the low signal level (and consequent low
signal/noise ratio) of this all-fibre detector system could possibly be compensated by
using an even higher-gain and lower-noise signal amplifier. This suggestion is now being
actively researched in further work by CMRP.
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Radiation damage study of fibre optic-based
scintillation detectors used for quality assurance of high dose rate
radiotherapy

11.1. Introduction:
The concept of scintillation detectors was introduced in the last century (Knoll, 2010).
Due to the unique favourable characteristics they possess, both inorganic and organic
scintillators have been widely implemented in advanced radiotherapy applications for
radiation detection and dosimetric purposes (S Beddar & Beaulieu, 2016). Scintillating
plastic fibres have been capable of accurately performing in-vivo dosimetry reported in
literature and to be a good candidate for radiation dosimetry due to their waterequivalence from a radiometric perspective. The main disadvantages of such PSDs are
the production of Cerenkov light in therapy energy ranges as well as slight temperature
dependence (Beaulieu & Beddar, 2016). Like any other detectors, scintillating detectors
are vulnerable to radiation damage due to constant repeated exposure to ionising
radiation. In organic scintillators, radiation absorbed by the scintillation molecules may
be dissipated thermally and results in temporary or permanent damage to the scintillator.
As it is made from polymers containing atoms and molecules, it is susceptible to radiation
damage which has been reported in previous literature (S Beddar & Beaulieu, 2016).
Different studies have reported that organic scintillators are susceptible to radiation
damage and conclude that light output decreases as a function of increasing irradiation
dose, although there is a possibility of recovery in light output in some materials.
Decreased light output is an indication of either damage done to the fluorescent
component or the light transmission being decreased due to the creation of optical
absorption centres by radical species. Chemical reactions in the scintillators have a very
big potential of causing permanent damage (S Beddar & Beaulieu, 2016). In addition, the
nature of the radiation, the dose rate, and the presence of oxygen are all factors which
play a role in degradation of scintillation output. It has been found that regardless of the
dose, there is always a certain amount of damage from which there is no recovery (Biagtan
et al. 1996) (Biagtan et al., 1996). A study by Senchishin et al. (1995) (Senchishin et al.,
1995) has demonstrated that the loss of signal is significant when typical plastics
irradiated with a cumulated dose in the range of 103–104 Gy. However, there was little
change in scintillation intensity for some radiation-resistant polymers irradiated with a
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cumulated dose in the range of around 105 Gy. Oxygen is another factor that affects the
scintillator properties during samples’s irradiation which can react to produce some
radical species causing radiation-induced damage. Damaging of the scintillator is
proportional to the oxygen found in the plastic (Zorn 1993) (Zorn, 1993). One of the clear
evidences of damaging is a colour change of the scintillator turning into yellow or brown
which is observed in some scintillators after an exposure of ~10 kGy (Wick et al. 1991)
(Wick et al., 1991). The colour change is attributed to the production of trapped electrons
and free radicals from reacted O2 molecules.
Assessment of radiation damage caused to the scintillator is considered to be useful for
maintaining acceptable levels of accuracy. It provides rough estimations for determining
the need to recalibrate the detector or modifying the designated threshold for radiation
dose where the scintillator can be considered defunct and no longer efficient. One of the
earliest studies on radiation damage was performed by Beddar et al. (1992a) (AS Beddar
et al., 1992), exposing their developed PSD to a cumulative dose of 10 kGy at a dose rate
of 7.31 Gy/min. The study revealed that the sensitivity response of the detector was
decreased by 2.8% which indicates that such a PSD is relatively radiation-resistant
compared to diodes. Another study by (Beddar 1994) (AS Beddar, 1994), investigating
the radiation damage on another type of PSD constructed with a BC-430 scintillator
attached to a polycarbonate optical fibre, which found that detector response was
decreased by 2.1% and 7.6% when exposed to an accumulative dose of 1 kGy and then10
kGy respectively. A commercially PSD system (DCT- 444s) was assessed for radiation
damage effects when irradiated with a 6MV beam for a period of 25 months. The study
revealed a loss of output signal of approx. 1% when dose was cumulated at a rate of 100
Gy per month. More recently, a research study published by Carrasco et al. (2015)
(Carrasco et al., 2015) investigating the radiation hardness of a commercial PSD, called
Exradin W1. It demonstrated a sensitivity loss of 2.8% after exposure to 10 kGy, which
is in an excellent agreement with the early investigation of Beddar et al. (1992a) (AS
Beddar et al., 1992). The Exradin W1 PSD system was further irradiated to reach an
accumulated dose of 125 KGy and exhibited only 8% loss of sensitivity. The conclusion
drawn in the light of the results obtained is that there is only a small decrease in sensitivity
loss when increasing the cumulative dose, which make this type of scintillator relatively
radiation-resistant in comparison with other detectors such as metal–oxide semiconductor
field–effect transistors and diodes (Jornet et al. 2004, Mijnheer

et al. 2013,
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Yorke et al. 2005) (Jornet et al., 2004; Mijnheer, Beddar, Izewska, & Reft, 2013; Yorke
et al., 2005).
This study aims at investigating the lifespan and assessing radiation hardness of three
newly prepared fibre-optic based scintillation detectors upon exposure to high
accumulated radiation doses (up to 100 kGy) for use as a quality assurance QA tool in the
energy range of high dose rate brachytherapy. This will assist in determining the threshold
energy of damage to the fibre materials and its optical properties so that decisions can be
made to either re-use a fibre probe for acquiring accurate data or retiring it from being
reliable for clinical use.

11.2. Materials & Methodology:
11.2.1 Scintillation optical fibre detectors:
Scintillating detectors with different scintillating materials were prepared in our lab. A 3
mm long Thallium-doped Caesium Iodide scintillating crystal CsI (Tl) with a diameter of
1.5 mm and an 8 mm length polymer scintillator fibre (BCF- 60) were optically coupled
to a 10 m bare non-scintillating optical fibre long (CK-40) which was used as a wave
guide cable for light transmission to the measuring detector. Properties of the fibre opticbased scintillation detectors utilized has been been demonstrated previously in Materials
& Methodology Chapter (#3). Please refer to Table 3.1 & 3.2 for more details.

11.2.2 . Real-time data acquisition system configurations:
11.2.2.1. Gigahertz OptikTM trans-impedance photodiode amplifier
system:
A commercially available trans-impedance photodiode amplifier (Gigahertz Optik™, P9202-5) was adapted in-house with an optical-coupling mount for a PIN photodiode as a
current input. Minimum & maximum sensitivity ranges of this amplifier are 10-03 mV/nA
and 10+04 mV/nA respectively. This photodiode amplifier system was operated in a
photovoltaic (PV) mode (no bias applied) wherein the dark current is negligible, and
power was supplied by a regulated power supply. Please refer to Chapter 6 for more
details.
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11.2.2.2. Data logging system:
The data logging system, used for this purpose, has been demonstrated earlier in the
Materials & Methodology Chapter (# 3). Please refer to section 3.9.1 for more details.

11.2.3 . Phantom design for radiation damage studies at ANSTO:
Fig 11.1 shows the design of the Tissue Phantom plate that has been used for the purpose
of irradiation of three fibre optic cables for radiation damage studies at ANSTO, Lucas
Heights NSW- Australia. The material used in this phantom is made from PMMA in order
to provide a tissue-equivalent medium that mimics the dosimetric properties of human
tissue. A 10 mm thick block was used to allow simple insertion of fibre optic cables (1
mm diameter) into the middle of the phantom to a distance of about 150 mm from the
edge. The measuring fibres then stay fixed in place for the whole period of irradiation
time, assuring a homogenous radiation delivery for all samples. The phantom block was
designed by CAD and the file downloaded to a Laser Cutter. The Laser Cutter produced
neat square sheets 300 mm × 300 mm × 10 mm thick with 4.50 mm holes with a drilled
length of 130 mm) so that the Fibre-Optic cables have a flexible fit.

11.2.4 . Irradiation of detector samples with Cobalt-60 gamma irradiator
(Co60):
Date

Average dose (kGy)

Accumulated dose (kGy)

15 Nov 2019

20.1

20.1

20-21 Nov 2019

21.5

41.6

5-6 Dec 2019

21
62.6
13-16 Dec 2019
32.2
94.8
Table 11.1: Irradiation doses given illustrating date for average dose per fraction
and accumulative doses in KGy

The total accumulated dose given was almost100 KGy in total and delivered in a fraction
of 20 KGy within five consecutive weeks as shown in Table 11.1. The prepared samples
were irradiated with a cobalt-60 gamma irradiator (Co60) at the Gamma Technology
Research Irradiator (GATRI) facility available at the Australian Nuclear Science and
Technology Organisation (ANSTO, Lucas Heights. NSW). Fig. 11.1 demonstrates the
experimental irradiation setup at GATRI with the phantom design. Upon delivering each
dose fraction, it is clearly observed that the phantom plate’s optical density was increased
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over time, with a noticeable yellowing in colour upon absorbing higher accumulative
doses as seen in Fig. 11.2.

Figure 11.1: Experimental irradiation setup at GATRI, ANSTO (left) with the phantom
holding the samples in place (right)

Figure 11.2: Detector samples inserted into a PMMA phantom, before irradiation at
0 KGy, (left) 40KGy (middle) and 100 KGy (right)

11.2.5 . Performing subsequent sensitivity tests with photon beam
energy:
The sensitivity response of three newly prepared scintillating fibre-optic detectors with
different scintillation materials was performed at the Radiation Oncology Department,
the Illawarra Cancer Care Centre (ICCC). The sensitivity response was recorded using a
Gigahertz Optik™ trans-impedance photodiode amplifier that was used as a light detector
and converts the light produced into a measurable electrical quantity. The prepared
samples were irradiated using a Varian Truebeam Linac with a 6 MV photon beam energy
under reference conditions. The experimental conditions for the pre-irradiation test, at 0
KGy were set as 100 cm for the source to surface distance (SSD) and a field size (FS) of
10 × 10 cm2 at the maximum depth (dmax) of 15 mm. Radiation intensity was delivered as
100 MU at repetition rate of 600 MU /min which has an equivalent dose of 100 cGy. The
experimental setup was set to be identical for all 3 detecting systems following postirradiation sensitivity tests. These were repeated throughout five successive weeks. As an
optical fibre is susceptible to variation in response via bending, it must be loaded in a way
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that assures no loss due to the bending of the fibre or any other factors that may affect the
smooth transition of the obtainable signal. Therefore, the experimental conditions were
kept as identical as possible. So, another important aspect is that we conducted the
experiment on the same linac (Linac 3) which is best suited where the cable can be loaded
without being bent as the distance to the control room is best matched with the length of
the fibre-optic cables.

Figure 11.3: Experimental setup at ICCC illustrating detector samples attached to optical fibres
which was inserted inside a “solid water” (PMMA) phantom under reference conditions (SSD of
100cm), with sensitivity response acquired using a datalogger

11.3. Results & discussion:
11.3.1 . Total accumulative doses given:
Fig. 11.4 demonstrates the total accumulative doses given for the irradiation plan of the
investigated samples. The graph mentions the average irradiation dose per fraction with
the total accumulative dose which was given over a period of 5 weeks. The time inbetween irradiation fractions were adequate in order to allow samples to entirely recover
from temporary damage so that permanent damage solely can be interpreted as a
degradation in the sensitivity response. The planned total accumulative dose was decided
to be around 100 kGy in total as a typical HDR Brachytherapy treatment fraction would
not exceed 20 Gy per session. Therefore, the total amount accumulative dose of 100 kGy
hence corresponds, far beyond, with the scope of the treatment application and the
purpose of our study.
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Figure 11.4: Total accumulative dose given over a period of 5 weeks

11.3.2 . Sensitivity response for the inorganic scintillating crystal, CsI
(Tl):
Fig 11.5 demonstrates the exponential decrease of the scintillation signal which can be
observed. As shown in Fig.11.5. The CsI (Tl) scintillation detector shows a remarkable
degradation in response as a function of accumulated dose over the 5-week test period,
but it needs to be borne in mind that these accumulated doses are very high (about 10,000
the amount typically delivered for a patient treatment plan). For this inorganic scintillator,
the decrease in response is around 77 % after an accumulated dose of 100 KGy. Therefore,
this scintillator detection system would need to be recalibrated after exposure to high
levels of accumulated dose.

Recalibration of such detectors for continued use in

treatments needs to be considered. Precise recalibration schedules will depend on factors
such as the actual low dose-rates and dose times and the number of patients receiving
treatment and the annual absorbed dose of a particular oncology centre.
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Figure 11.5: Response of CsI (Tl) scintillating crystal fibre probe vs. accumulated dose

11.3.3 Sensitivity response for the organic BCF-60 polymer scintillator
fibre:
Fig. 11.6 shows the degradation in response as a function of accumulated dose over the
5-week test period for the organic BCF-60 polymer scintillator fibre. Once again, it needs
to be borne in mind that the delivered doses to obtain this result were very high. For this
organic scintillator, the decrease in response is around 81 % after an accumulated dose of
100 KGy. (For comparison, the bare fibre showed a decrease in response to around 60 %
of the original performance). Once again, the polymer scintillator detection system would
need to be reassessed and recalibrated after exposure to high levels of accumulated dose.
As for the scintillating crystal detector, precise recalibration schedules would once again
depend on factors such as the typical dose-rates and dose times used and/or annual
absorbed dose in a particular oncology centre.
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Figure 11.6: Response of BCF-60 scintillating polymer fibre vs. accumulated dose

11.3.4 Sensitivity response for the non-scintillating optical fibre (clear
wave guide):
Fig. 11.7 shows how even the bare (non-scintillating) fibre (usually used merely as an
“extender” to transfer the received light signal over a distance long enough to reach the
photodiode detector in the shielded control room) showed a decrease in response to
around 64 % of the original performance after 100 kGy total dose. The Fig. 11.7 result
shows that even the bare (non-scintillator) fibre response need to be reassessed and
recalibrated after exposure to high levels of accumulated dose. Recalibration of such
detectors for continued use in a certain treatment technique need to be considered and
performed, but maybe only half as frequently as recalibrating the scintillator element
response. Precise recalibration schedules for the bare fibre will once again depend on
numerous factors such as the number of patients receiving treatment, the typical doserates and dose times used and/or annual absorbed dose at a particular oncology centre.
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Figure 11.7: Response of non-scintillating optical fibre vs. accumulated dose

11.4. Conclusion:
This study has evaluated the radiation-hardness and resistance to radiation damage of the
fibre materials when used in the energy range of the HDR brachytherapy sources. Also,
the study provided data for assessing radiation hardness of three newly prepared fibreoptic based-scintillation detectors consisting of inorganic scintillator crystal or organic
polymer fibres with a clear waveguide organic polymer fibre. The data also demonstrates
the finite lifespan of the scintillator and light guide components. This data is useful for
planning how such detectors can be applied for clinical use as a QA tool for high dose
rate brachytherapy.
The experimental investigation was carried out by exposing the sample detectors to high
accumulative radiation doses (up to 100 kGy). Overall, our developed system has shown
degradation in the sensitivity response for all samples over a wide range of high
accumulated doses. Although the dose response characteristics of these scintillation
detectors would not change significantly during a typical patient treatment plan, their
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performance needs to be reassessed and recalibrated after a predetermined amount of total
accumulated dose. Recalibration of such detectors for continued use in measuring
treatment doses need to be considered and depends on factors such as the number of
patients receiving treatment and the annual cumulative delivered doses at a given
oncology centre.
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General Discussion
This chapter is aimed at providing some brief overall discussion of the results presented
in the previous chapters.

12.1. Performance of data acquisition readout systems:
12.1.1 . The CMRP photodiode amplifier:
This thesis has demonstrated the importance of carrying out in-lab and associated tests
for the design and adaptation of scintillating and plain optical fibres, photodiodes and
amplifiers for HDR brachytherapy applications. The results presented in this thesis
emphasize the capability of the proposed systems for performing real-time measurements
in real clinical scenarios. The results also confirmed details such as the fibre system
needing to be totally protected by visually opaque sheathing with any photodiode
amplifier box being kept away from the radiation delivery area. It was experimentally
shown that the setup is suitable for use in a normally illuminated lab or patient treatment
room by inserting the fibre probe into a black jacket which can totally prevent the
penetration of light into the fibre core.
The results also illustrate that the photodiode amplifier-based system along with
scintillating optical fibre can be considered a preferred candidate and a convenient mean
for performing real-time quality assurance tests in both source localisation verification
and dosimetry modes during HDR Brachytherapy procedures. The CMRP photodiode
amplifier dose-monitoring system, when fed with signal arising from an inorganic
scintillating crystal, was shown to have suitable characteristics such as sensitivity,
linearity and dose rate-independence suitable for both dosimetry and source localisation
applications. The linearity of the system and its independence from dose rate was
demonstrated. Compared with some specialist commercial amplifiers, the maximum gain
of the CMRP is about an order-of-magnitude lower. Hence, when driven by organic
polymer scintillating fibre detector and being used for the lowest end of HDR dose
requirement, the CMRP photodiode amplifier dose-monitoring system is capable of dose
monitoring but shows insufficient spatial resolution for determining source localisation.
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12.1.2 . The upgraded CMRP MK11 photodiode amplifier:
The upgraded dose-monitoring system was successfully designed and implemented on a
purpose-designed etched PCB using relatively inexpensive components. The most crucial
component of the system is the photodiode amplifier. The resulting amplifier was shown
to be stable over time, linear over a wide range of different doses and independent of dose
rate across the range of typical clinical Linac dose rates. It is thus eligible to be considered
for use under real clinical radiation conditions and quality assurance for HDR
brachytherapy.
The upgraded CMRP photodiode amplifier dose-monitoring system driven by organic
polymer scintillating fibre detectors, the CMRP was suitable for dose monitoring but still
shows insufficient spatial resolution for determining source localisation. The system
demonstrated suitability for clinical applications, but it is desirable to develop a similar
system with higher gain, while still maintaining the same levels of linearity, dose rateindependence etc. so that a system is attained which is equally applicable to both dosemeasuring and source localisation applications.

12.1.3 . Gigahertz OptikTM photodiode amplifier:
This thesis described the modification of a commercially available, multiple-range, highgain amplifier to produce a photodiode amplifier suitable for interfacing to fibre optics
for real-time HDR brachytherapy measurements. A green Opto-LED test system was also
designed, constructed and tested and provided highly linear and controllable light levels
for calibrating the photodiode in the lab, without needing ionising radiation sources. The
results also illustrate that the photodiode amplifier-based system is an excellent and
versatile system when using either a scintillating polymer optical fibre or an inorganic
crystal detector. The resulting system can be considered a preferred candidate and a
convenient mean for performing real-time quality assurance tests in both source
verification and dosimetry modes during HDR Brachytherapy procedures.
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12.2. Characterisation of plastic scintillator detector:
It is desirable to be able to use scintillating plastic (polymer) fibre detector for both dose
measurement and source localisation, so many experiments and measurements were
performed on the scintillating plastic fibre detector systems. The optical fibre probes used
were tolerant of cutting to length and polishing operations and coating the fibre tip with
a reflective paint proved advantageous to conserve optical signal levels suitable for high
quality clinical work. The developed polymer fibre optic DAQ system proved excellent
for measuring doses in a specific location of interest. However, the size of the scintillating
fibre must be chosen on the basis of Bragg cavity considerations. Contribution to the
measured signal from clear fibre (“Stem effect”) needs to be corrected when working at
low signal levels, because fluorescence and Cerenkov effects become considerable at low
total signal levels. It was determined that, if signal/noise ratio and fine spatial resolution
are needed simultaneously, then an inorganic crystal with small size should be chosen
instead of an organic scintillating fibre. This would also have the advantage that a lower
amplifier gain can be used, and there will be relatively less background signal contributed
by any clear fibre used.
The proposed polymer fibre optic DAQ system was technically optimised and preclinically investigated with a commercial Gigahertz Optik™ transimpedance amplifier
adapted in our lab to become a sensitive, high-gain photodiode amplifier for optical
signals. It was demonstrated that using a relatively long (5 cm – 1 m) scintillating fibre
produces high signal levels but loses spatial resolution. Hence, a trade-off has to be made
between signal level obtained (or its signal/noise level) and spatial resolution.
One of the limitations of the scintillation detectors used for our experimental work such
as BCF-60 is that the (small) temperature-dependence as a function of the signal
produced. However, for ease of experimentation, the findings presented herein were all
conducted at normal air-conditioned room temperatures. Therefore, this area needs to be
further investigated. Another significant issue was considered is about the radiationhardness and resistance to radiation damage of the scintillators material when used in the
energy range of HDR brachytherapy sources. For all our experimental work, the total
accumulative dose received by our detectors was much lower than the threshold dose
which could make a change in sensitivity response.
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12.3. Characterisation of inorganic scintillator & Determination
of dwell time and position:
Both the CMRP-designed trans-impedance amplifier and the in-house developed
Gigahertz Optik fibre optic system functioned well with a CsI(Tl) crystal basedscintillating fibre probe measuring received radiation from a

192

Ir HDR Brachytherapy

source dwelling at multiple positions for different SDDs. Also, background responses
were obtained to calibrate the minimum “background” noise floor values for
photodiode/amplifier system being exposed only to stray radiation without any
meaningful signal or even a receiving fibre connected. Both DAQ fibre optic systems (i.e.
both amplifier systems) were capable of responding linearly to target radiation exposure
and accurately determining, in real-time, the source dwell time at any given position, the
total number of dwell positions and the total treatment time. These showed excellent
agreement with parameters that were pre-defined and programmed into the
Brachytherapy TPS.
From the pre-clinical investigations obtained, the concept of localizing a

192

Ir HDR

source, based on the triangulation of measured inorganic crystal responses (with detector
crystal placed at varying locations within a patient phantom), was shown to be feasible.
It was also shown to have more reliability and accuracy when using a CsI(Tl) detector
crystal due to its higher signal to noise ratio (S/N) compared with polymer detectors. The
main findings also indicate that a similar system could be employed for real-time HDR
source tracking in 3D space if a multichannel AFE-based DAQ system was utilized.

12.4. Localisation of HDR Brachytherapy source:
The original research hypothesis we came up earlier was based on the determination of
the HDR source position within prostate volume by taking advantage of the integral
response of three long scintillating plastic fibres as a function of the height and length.
Combination of responses of three fibres can be used for source localization, and the
integral response from scintillation detectors will provide the coordinate of the radioactive
source in 3D space.
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Figure 12.1: An ideological diagram showing the theoretical concept of implementing
multiple long scintillating plastic fibres

Response from detectors is provided as:
𝑟=

ℎ
cos 𝜃

According to TG 43 protocol, dose is given as function of r and 𝜃 in 2D:
𝐷(𝑟, 𝜃)
𝐷(

ℎ
, 𝜃) = 𝐷(ℎ, 𝜃)
cos 𝜃

Now:
𝑑 (𝑠𝑖𝑔𝑛𝑎𝑙) = 𝐷(ℎ, 𝜃) 𝑑𝑥

But:
𝑥 = 𝐿 − ℎ tan 𝜃

By differentiating the previous equation with respect to 𝑥, we get
𝑠𝑒𝑐 2 𝜃 =

1
𝑐𝑜𝑠 2 𝜃

Therefore:
𝑑𝑥 = −ℎ 𝑠𝑒𝑐2 𝜃
𝑑𝑥 = −

ℎ
𝑐𝑜𝑠2 𝜃

𝑑𝜃

Therefore:
ℎ

𝐷(ℎ, 𝜃) 𝑑𝑥 = − 𝑐𝑜𝑠2 𝜃 𝑑𝜃
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The signal can be obtained by integrating both sides with respect to 𝑥 and 𝜃 and is given
as:
𝐿
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𝑐𝑜𝑠 2 𝜃

𝑑𝜃

𝑑𝜃

𝑫 = (𝑳, 𝒉)
This concept is based on the integral response change of whole long plastic scintillator.
From the equations above, it is mathematically possible to determine the source position.
That can be experimentally done by designing a phantom with three fibre optic catheters,
includes three scintillating fibres, (50 mm long) as the average prostate’s dimension is
around 50mm. Also, a photodiode based-readout system is to be in-house designed which
can be used for pre-clinical data validation.
However, based on our investigation of preclinical experimental results shown in chapter
7, the response of long scintillating fibre with a length of 50 mm is almost flat especially
when HDR source dwelling closely perpendicular to the detector’s location. The flat
response can be seen almost over the whole dwell positions of the HDR source within the
prostate phantom volume. This limitation introduced poor spatial resolution of the
detector which is a main requirement for such advanced treatment option. Therefore, we
concluded that the localisation concept based on the integral response of this fibre length
is not feasible and we experimentally demonstrated that is not nicely working for all
vertical displacement (y heights) from the movement axis of the HDR source.
Much lately, we decided to apply classical triangulation algorithm patented and published
by Prof. Anatoly Rosenfeld (A Rosenfeld & Zaider, 2002) and was further investigated
from our previous research using a 2D silicon arrays such as 512 Magic Plate by Espinoza
and et al (Espinoza et al., 2013; Espinoza, Petasecca, Cutajar, et al., 2015; Espinoza,
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Petasecca, Fuduli, et al., 2015) & 900 Magic Plate by Poder and et al (Poder et al., 2019;
Poder et al., 2018). As the main scope of our research project was dedicated to source
localisation not dosimetry, so the property of water equivalence of the detector is not a
necessary requirement anymore. While high Z scintillator is more sensitive and allow us
to neglect Cerenkov radiation (like in original idea with long plastic scintillator).
Therefore, we decided to employ a high Z small scintillator, CsI (Tl) with a few
millimetres’ length of 3 mm, that can provide high spatial resolution and higher light
intensities that is ten times higher than the water-equivalent plastic scintillator. Using
triangular response of three detectors based on preliminary pre-calibration of (h, L), the
localisation based on triangulation algorithm was feasible and accurate results were
obtained.

12.4.1 . CMRP photodiode amplifier:
The developed scintillating crystal/fibre optic/amplifier/readout QA tool built around the
CMRP amplifier for localization of HDR 192Ir brachytherapy source was clearly accurate
and feasible for clinical application. The localisation measurements of the HDR source
in 3D space based on triangulated calculations from response readings demonstrated
promising results which suggest that this system is a technology of choice for further
optimization. It shows good promise for use as a QA tool for reliable and comprehensive
radiotherapy QA. When a 3mm CsI (Tl) scintillating crystal was applied, localization of
an 192Ir HDR source was shown to be feasible and it was determined that it can report the
source position to within ~ +/-1.0 mm at worst, whether the detector is at ~ 10 mm, 20 or
30 mm y-spacing from the HDR source.

12.4.2 . Gigahertz Optik photodiode amplifier:
The extra gain of the developed scintillating crystal/fibre optic/amplifier/readout QA tool
when using the modified commercial Gigahertz Optic™ amplifier for localization of
HDR 192Ir brachytherapy source produced clearly accurate results and is very feasible for
clinical application. The amplifier when modified to receive light rather than electrical
current signal had demonstrably high gain and low noise performance, which meant that
it could handle lower dose levels while still providing signal readouts with high
repeatability. This demonstrated that the modified Gigahertz Optic™ amplifier could in
many cases be applied for accurate localization of HDR sources in a clinical setting using
polymer FODs, without the necessity to switch to higher-output inorganic scintillating
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crystal detectors. When a 3mm CsI (Tl) scintillator crystal was applied, our obtained preclinical results with the modified commercial Gigahertz Optic™ amplifier clearly show
that the localization of an 192Ir HDR source is feasible and the source position is accurately
reported to within ~ +/-0.6 mm when the detector is at ~ 10 mm range (eg: detector
directly above source and closest lateral (z) position) and ~ +/-0.8 mm when the detector
is at maximum distance (eg: detector on the right or left and at y = 30 mm height). Overall,
the advantages of applying such a dosimetry system can outrank other currently
commercially available QA tools. This system is now being actively researched in further
work by CMRP.

12.5. Radiation damage studies for scintillators used in HDR
Brachytherapy:
The lifespan of three newly prepared fibre-optic based-scintillation detectors for use as
QA tools for high dose rate brachytherapy was experimentally investigated. The
scintillation detectors were found to decrease in sensitivity as a result of accumulated
dose, and even the bare (clear) fibre displayed increasing transmission losses after
repeated exposure to high doses. Overall, the three investigated scintillation detectors
showed a remarkable degradation in response as a function of accumulated dose over the
5-week test period, but it needs to be borne in mind that the delivered doses were very
high compared to a typical single-fractionated HDR Brachytherapy session. For the
organic and inorganic scintillators, the decrease in response is around 80 % after an
accumulated dose of 100 KGy. On the other hand, the bare fibre showed a decrease in
response to around 60 % of the original performance. Upon delivering such massive
accumulative doses it has been noticed that the sample fibres still appeared undamaged
to the operator’s eye (or with slight magnification) and handled mechanically the same as
it did originally. Therefore, the scintillator detection system needs to be reassessed and
recalibrated after exposure to high levels of accumulated dose. Recalibration of such
detectors for continued use in a certain treatment technique need to be considered and
performed. Precise recalibration schedules will depend on numerous factors such as the
typical dose-rates and dose times used and/or annual absorbed dose at a given oncology
centre, organs treated, and the number of patients receiving treatment.
Due to the limited dynamic range and gain of the data acquisition (DAQ) system used,
such a scintillation sample would not exhibit any further response after a certain level of
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excessive accumulated dose and thus another DAQ system with a higher gain should be
utilized for further investigation of higher levels of accumulated dose The measurements
could be extended to even higher total accumulated doses, but with the fixed dynamic
range and gain of the data acquisition (DAQ) system used, the sample signals would soon
be below the measurement threshold.
This study provided data for assessing radiation hardness of three newly prepared fibreoptic based-scintillation detectors consisting of inorganic scintillator crystal or organic
polymer fibres with a clear waveguide organic polymer fibre “stem”. Experimental
investigations were carried out by exposing the sample detectors to high accumulative
radiation doses (up to 100 kGy). Overall, our developed system has shown degradation
in the sensitivity response for all samples, but only at high accumulated dose levels. It
was verified that the dose response characteristics of these scintillation detectors would
not change significantly during a typical patient treatment plan. The data demonstrated
the fibres and detectors had a reasonably long but finite lifespan. This data is useful for
planning fine details of how such detectors can be applied for clinical use as a QA tool
for high dose rate brachytherapy, and how frequently they need to be re-calibrated or
retired/replaced.
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Conclusion & Future Directions:
The proposed fibre optic system has been technically optimised and pre-clinically
investigated. The tests conducted revealed that the in- house design CMRP systems and
adapted Gigahertz Optik transimpedance photodiode amplifiers have been suitable for the
purpose of HDR source positioning and verification. However, Gigahertz Optik was
found to be more sensitive due to higher gain amplification which allows implementing
both organic and inorganic scintillators, and for this reason, it is the applicable and
suitable QA for successfully conducting the most of pre-clinical treatment verification.
The tiny current produced with relatively poor S/N ratios varied over clinical conditions
must be considered, and thus high gain proper RC filter to be applied for filtrating out the
noise-induced with the scintillation signals. In addition, careful preparation of optical
fibre probes including polishing and coating the fibre tip should be well-thought-out for
maintain up a higher quality of such targeted clinical work. Overall, the proposed system
shows promising findings for 3D source positioning and verification. It also shows the
possibility of further clinical investigations and the efficacy of simultaneously performing
both in-vivo HDR source verification and relative dose measurements. Thus, the system
could be reliably implemented in-clinic and commercially branded as TWO-IN-ONE
HDR Brachytherapy QA tool.
A potential future direction to further extend this project is to use a real-time multichannel
readout system to allow immediate online feedback while the patient is laying on the
couch. The today’s increasingly demanding property on real-time data acquisition
requires the implementation of multichannel data acquisition system that is capable of
providing simultaneous data acquisition for our fibre optic system that is especially
designed for quality assurance of HDR Brachytherapy. The commercial electrometer
AFE0064 was formerly developed to readout for some portable imaging devices such flat
panels. However, AFE has been latterly adapted by the CMRP’s research group to be
utilized as the electrometer for the in-house developed DAQ systems which can feature
64 individual integrator circuits for each channel, with a full scale of selectable global
sensitivity charge that ranges in eight steps from 0.13 pC up to 9.6 pC. AFE is compatible
with Field Programmable Gate Array (FPGA) master board which serves as information
storage and as well as is responsible for Analogue-to-Digital (ADC) Converter data
transfer to the PC.
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Our hoped solution was to incorporate the multichannel AFE system along with the
multiple photodiodes as Multichannel photodiode-based Analogue Front End data
acquisition system. The Analogue Front End (AFE) data acquisition (DAQ) system
utilizes the commercial electrometer AFE0064 which is factory-made by Texas
Instruments (Texas Instruments, Dallas, United States of America) is used along with four
TO-5 PIN-photodiode (S1223-01) mounted into female SMA-receptacles. The FPGA
master board used for communication of ADC data processing & transfer between the
FPGA and PC which basically occurs over the standard Universal Serial Bus (USB) link.
The AFE Readout chips with electronic components such as USB port, power switch, and
power input were all applied to fulfil the purpose of measurements. In this section, the inhouse adaptation of the photodiode based multichannel AFE DAQ system is carefully
demonstrated. For the purpose of HDR radiation measurements, the commercial AFE
system was adapted to have four channels of TO-5 PIN-photodiode that were wrapped
off with a Teflon tape for achieving a proper electrical isolation due to that fact that the
cathode of the PIN-diode is connected to the case. Those four PIN-photodiode were
inserted into our female SMA-receptacles which were mounted in an equally spacing
manner on the font face of the DAQ system’s box. A shielded aluminum box, with a size
that is physically adequate to include all components, was utilized to include the AFE
Readout chips with other electronic components mentioned previously.
The final prototype for the photodiode based multichannel AFE DAQ system is presented
below:

Figure 13.1: Illustration for physical components of the CMRP-adapted photodiode-based
multichannel AFE DAQ system

Page 13-208

It has been mentioned in the literature that such scintillation detectors used in this project
are temperature-dependent and show some variations in sensitivity response as
temperature increases. The findings presented herein were all conducted at normal airconditioned room temperatures, and eventually will be implemented to real-patients’
scenario where a typical body temperature predominate at 37 ⁰C. Thus, future work could
consider and investigate the effect of temperature variations on the signal produced
especially with our PIN photodiode amplifier based-DAQ system as it shows some
variations with temperature changes.
Our concept of HDR source localisation has been initially investigated using water
equivalent solid-water and Perspex phantoms (dimensioned 9 cm × 9 cm) to mimic the
property of the prostate., the initial results confirmed that idea was working well Based
on these phantom studies, and we have been able to localise the HDR source within submillimetres accuracy. The potential outlook is to move on and have a step ahead moving
toward a semi-real prostate. This could be done by investigating the same localisation
concept with a 3D printed prostate (dimensioned 7 cm × 7 cm) that offers the exact typical
dimensions and physical properties of a real prostate. Considering the density of the real
prostate, inhomogeneous medium, and signal attenuation which may adversely affect the
accuracy of obtained results.
In today’s rapid-growing world of advanced technologies, artificial intelligence (AI) has
been one of the hot topics that are now being applied in the medical field to provide the
best health care to cancer patients. Nowadays, the whole world is currently being
threatened by the uncontrollable spread of the novel Corona Virus (COVID-19). Thus,
the World Health Organisation has established regulations and recommendations for both
patients and health care providers which basically ensure to take preventive measures and
apply social and physical distancing to lower the risk of the virus transmission and reduce
the severe consequences that might occur from radiotherapy side-effects as a result of the
weak immune system. Therefore, it would fantastic to apply the AI assisting to implement
this concept and applying the system to achieve a contactless clinical procedure,
especially in hard-to-reach clinical environments due to such an infective disease.
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The successful completion of this project has led to broad prospects for designing and
developing innovative scintillation fibre0-optic detectors with high resolution, high
sensitivity, and more efficiency. Also, safe delivery of accurate dose for diverse types of
cancer is the benefit which will be given when carrying out this project. Personally, I
think that fibre optics technology is one of the creative applications of the era of
technology. Therefore, it should be empirically investigated in order to come up with new
ideas and innovations that might lead to fantastic inventions; hopefully, no one suffers
from cancer as long as there is a presence of creativity and medical physicists. Extra work
should be intensively directed toward this area to meet the needs of today’s health care in
radiotherapy departments.
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Appendices
• Appendix 1:

Time constant (RC) calculation
𝐑𝐂 =

𝐕𝐨𝐥𝐭
𝐀𝐦𝐩𝐞𝐫𝐞

×

𝐀𝐦𝐩𝐞𝐫𝐞 × 𝐬𝐞𝐜
𝐕𝐨𝐥𝐭

=𝛺×F

𝐑𝐂 = 𝐓𝐢𝐦𝐞 𝐂𝐨𝐧𝐬𝐭𝐚𝐧𝐭 (𝐓𝐂) = 𝐒𝐞𝐜

RC1 = 120 × 103 V⁄A × (0.047) × 10−6 A. sec⁄V
RC1 = 5.64 × 103 × 10−6
𝐑𝐂𝟏 = 𝟓. 𝟔𝟒 × 𝟏𝟎−𝟑 𝐒𝐞𝐜
RC2 = 120 × 103 V⁄A × (1.5 + 0.047) × 10−6 A. sec⁄V
RC2 = 120 × 1.547 × 103 × 10−6
𝐑𝐂𝟐 = 𝟏𝟖𝟓. 𝟔𝟒 × 𝟏𝟎−𝟑 𝐒𝐞𝐜
RC3 = 120 × 103 V⁄A × (6.8 + 0.047) × 10−6 A. sec⁄V
RC3 = 120 × 6.847 × 103 × 10−6
𝐑𝐂𝟑 = 𝟖𝟐𝟏. 𝟔𝟒 × 𝟏𝟎−𝟑 𝐒ec
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